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Abstract 
 
The ability of the histidine-rich peptides, histatin-5 (Hst-5) and -8 (Hst-
8), to support the generation of reactive oxygen species (ROS) during the 
copper-catalyzed oxidation of ascorbate and cysteine has been evaluated. 
High levels of hydrogen peroxide (70-580 mol/mol Cu/hr) are produced by 
aqueous solutions containing Cu(II), Hst-8 or Hst-5, and a reductant, either 
ascorbate or cysteine, as determined by the post-reaction Amplex Red (AR) 
assay. When the reactions are conducted in the presence of superoxide 
dismutase (SOD), the total hydrogen peroxide produced is decreased, more 
so in the presence of the peptides (up to 50%), suggesting the intermediacy 
of superoxide in these reactions. On the other hand, the presence of sodium 
azide or sodium formate, traps for hydroxyl radicals, has no appreciable 
effect on the total hydrogen peroxide production for the Cu-Hst systems. 
Electron paramagnetic resonance (EPR) spectroscopy spin-trapping studies 
using CYPMPO (5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-
pyrroline N-oxide) in the cysteine/Cu(II) reactions reveal the formation of the 
CYPMO-hydroperoxyl and -hydroxyl radical adducts in the presence of Hst-8, 
whereas only the latter was observed with Cu alone. 
As in vitro ROS production involved copper ions, the complex 
formation of the peptide-metal species was also of interest. The specific 
residues involved in coordinating the copper were investigated using nuclear 
magnetic resonance spectroscopy (NMR) experiments, specifically by 1H-15N 
xxi 
 
heteronuclear multiple bond correlation (HMBC), heteronuclear single 
quantum correlation (HSQC), and 1H-13C HSQCAD experiments. Protonation 
of Hst-8 and model poly-imidazole ligands resulted in distinct downfield shifts 
of proton, carbon and nitrogen resonances of the imidazolyl units. Tight 
binding metal complexes of model compounds were also observed to have 
downfield resonance shifts upon binding Cu(I). Unfortunately, Hst-8 does not 
bind copper tightly enough to permit observations of downfield shifted peaks. 
Peaks were instead observed to be broadened and in some cases absent. 
However, because these were localized to only certain residues, 
assignments were made on the basis of which resonances exhibited such 
behavior. This evidence in addition to computational results led to the 
conclusion that residues histidine 3, histidine 6, and histidine 7 are involved 
in the binding of Cu(I) in Hst-8 at a 1:1 Cu(I):Hst-8 ratio of concentration in 
DMSO. 
The conformational structure of Hst-8 in DMSO, both in the presence 
and absence of a copper (I) ion, has also been investigated using NMR 
experiments. The Nuclear Overhauser Effect (NOE), which is a nuclear spin 
transfer through space, was used in experimental series to identify protons in 
nearby space. This was useful in determining the larger three dimensional 
picture of the peptide in solution when the identities of the proton resonances 
were identified via total correlation spectroscopy (TOCSY) and 1H-13C HSQC 
experiments. After the spatial contacts were identified, boundary restriction 
data was generated by MARDIGRAS and the restriction data was input into a 
xxii 
 
molecular dynamics (MD) simulator CNS, which output the structure. We 
found that Hst-8 did not have either beta strand or alpha helical secondary 
structural elements, in DMSO either as a free ligand or in the presence of 
Cu(I). 
 
1 
 
Chapter 1: Introduction 
 
1.1: Histatins and Antimicrobial Peptides 
The histatins (Hst) are a group of 30 structurally related histidine-rich 
cationic salivary peptides (15-30 µM in healthy people) that are important 
members of the non-immune defense system and are essential to good oral 
and dental health.1-5 The entire family of Hst are encoded by only two genes6, 
7
 and expressed in the salivary glands.8, 9 Of the 30 known Hst, there are 
only two that are directly encoded, Hst-1 and Hst-3.6, 7 Others are produced 
via an as yet undetermined proteolytic pathway or via distinct mRNA 
sequences.10 Curiously enough Hst-1 is posttranslationally modified to be 
phosphorylated at Ser2 and have its tyrosine residues partially sulfated.11, 12 
Sulfation numbers of between 1 and 4 on Hst-1 occur only for Hst-1 
produced in the submandibular salivary gland; Hst-1 produced in the paratoid 
and sublingual glands was not sulfonated.11, 12 Most of the phosphorylation of 
Hst-1, on the other hand, occurs in the paratoid gland.12 Hst are found only in 
old world apes and higher primates, including western gorillas, bonobos, 
chimpanzees, and humans.9, 13 Hst-8 and Hst-5, which form the basis of this 
study, have in common a 12-residue, His4-segment - Lys-Phe-His-Glu-Lys-
His-His-Ser-His-Arg-Gly-Tyr (K-F-H-E-K-H-H-S-H-R-G-Y). Several studies 
have shown to be essential to their antimicrobial properties. The Hst have 
diverse antimicrobial activity, effectively killing a variety of fungal and yeast 
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species, including pathogenic Candida albicans1-3 and Candida 
dubliniensis,14 as well as several families of bacteria.15 
Yeast cellular membranes have a negative charge on the exterior by 
virtue of the incorporation of phospholipids on their exterior lipid bilayers. 
This allows for an electrostatic attraction between evolved cationic 
antimicrobial peptides and their microbial targets. The mode of action that 
most cationic antimicrobial peptides operate by is membrane intercalation by 
individual peptide units followed by a conformational change to an alpha helix 
while immersed in the membrane. Then the individual alpha helices 
aggregate and form pores through which the cellular contents are 
subsequently leeched into extracellular environments. Given this mode of 
action secondary structure is very important in terms of effective antimicrobial 
function. Initially, these peptides need to lack alpha helical structural 
elements so that intercalation into the membrane is possible. Then given the 
change of solution conditions while in the membrane, an alpha helix must 
form.  
Hst, however, do not operate in this fashion. Firstly, active transport 
across cell membranes is required to move histatins into the cellular matrix 
as opposed to passive introduction through the lipid bilayer. Hst-5 has been 
shown to bind to heat shock protein Ssa 1/2.16, 17 Upon binding, the Hst is 
actively transported inside. Indeed, microbes that have reduced respiration 
capacity are not as susceptible to Hst. This provides greater support for the 
active transport hypothesis, in that organisms with less energy available will 
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not be as able to actively transport as much Hst-5 into the cytosolic 
environment as those of the wild type variety. Hst-5 and other histidine rich 
peptides have been shown to disrupt endosomes; this property allows for 
Hst-5 escape into the greater cellular environment.18 Secondly, in terms of 
the mode of action for antimicrobial activity, histatins do not operate by pore 
formation. Indeed, only a few species exhibit an increased concentration in 
extracellular fluids, including potassium ions, chloride ions, ATP, and a few 
smaller nucleotides, like NADH.19, 20 Pore formation would result in a 
leeching of all types of cellular material into the extracellular environment. A 
few studies have suggested that the selective leeching is due to Hst 
interaction with Trk1p, a potassium ion transporter.21-23 However, this does 
not explain the chloride and ATP release. 
Another line of inquiry has been made into the question of Hst-5 
introduction into the cellular environment, membrane destabilization, and 
membrane pore formation using liposomes as model membrane systems.24, 
25
 Liposomes are lipid bilayers vesicles that mimic cell membranes with no 
proteins. Translocation of species across liposomal membranes then would 
only occur via passive transport consisting of association with the membrane, 
intercalation into the membrane, and entry into the liposome. In both studies 
membrane association was observed.24, 25 Also in the study that investigated 
membrane translocation, Hst-5 was observed to have very little capacity for 
membrane translocation and virtually no capacity for pore formation as 
determined by leeching experiments, which combined together, caused the 
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authors to conclude that either active transport was at work or some other 
intrinsic feature of cellular membranes enhanced Hst-5 membrane 
translocation.24 Thus, pore formation as a mode of action by the Hst is further 
discounted. Internalization by active transport is further supported and more 
evidence provided that Hst can interact with negatively charged membranes, 
like those of Candida and mitochondria in general. 
Hst has also been noted to cause marked changes in cell morphology. 
Cells and their organelles have been observed in the presence and absence 
of Hst-3 and Hst-5. By use of light microscopy, it was noted that cells in the 
presence of Hst had markedly decreased cell volumes, resembling deflated 
balls, which suggests either an alteration of cytoskeletal components or an 
osmotic imbalance.26 Fluorescence microscopy revealed mitochondrial 
swelling, decreased mitochondrial charge potential, and atypical dye 
distributions.26-28 As the mitochondria maintain structural integrity, as inferred 
by exclusion of fluorescent dye, pore formation in the mitochondria as a 
mode of action for the antimicrobial activity for the Hst is also excluded.26, 27 
Transmission electron microscopy (TEM) confirmed the observations of 
mitochondrial swelling and decreased cell volume, but it was also noted that 
most organelle structures were hardly identifiable, save for the nucleus, the 
slightly enlarged mitochondria, and the massively swelled vacuole.26 The 
loss of organelle structures it would seem contributed to the atypical 
fluorescent dye uptake. High resolution scanning electron microscopy 
(HRSEM) revealed in addition to the markedly decreased cell volumes and 
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mitochondrial swelling, the cells had much smoother cellular membranes, a 
further indication of a change in the structural membrane makeup.26 A 
subsequent study would show that using freeze fractionated TEM that there 
were areas of smooth membrane and areas of rough membrane; essentially 
incubation with Hst-5 resulted in aggregation of intramembranous particles.28  
Once on the interior of the cell, Hst localizes primarily on the 
mitochondrial membranes.27, 28 This localization has been inferred by 
observations made with fluorescence microscopy, light microscopy, TEM, 
and HRSEM.26-28 It has also been inferred from the studies done with 
liposomes, which were negatively charged like the mitochondrial membrane, 
whereby depolarization as a result of association was argued.24 Since the 
liposomes lack any external proteins, the cationic nature of the Hst-5 was 
sufficient to allow for association. Direct detection of FITC-labeled 
(fluorescein isothiocyanate) Hst-5 location has been done by means of 
labeling anti-FITC mouse antibodies with gold followed by observation with 
TEM.28 Results here indicated that Hst-5 was internalized and had 
association with internal cellular structures, namely mitochondrial 
membranes and the internal cell membrane.28 Though electrostatic attraction 
maybe one component of the association of Hst-5 to the mitochondrial 
membrane additional factors should not be ruled out. 
Here, the respiratory chain is inhibited, ATP is released, and reactive 
oxygen species (ROS) are generated.19, 20, 27, 29-32 Use of the non-specific 
ROS probe 2',7'-dichlorodihydrofluorescein diacetate (H2-DCFDA) showed 
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that Hst-5 triples the total ROS levels in Candida cells.32 Fluorescence 
microscopic imaging of Hst-3,5-treated Candida albicans cells showed 
mitochondrial ROS generation (with the non-specific ROS probe 
dihydrofluorescein diacetate (DHF)) and a decrease in mitochondrial 
potential (using the potential-sensitive probe tetramethylrhodamine methyl 
ester, TMRM).27  
However, the validity of the central hypothesis of ROS production by 
Hst has been questioned.20 Dihydroethidium (HEt), which was used as an 
ROS indicator in early trials, is oxidized to ethidium by ROS. Both HEt and 
ethidium are fluorescent, though ethidium fluoresces red and HEt fluoresces 
blue. Water can quench the fluorescent activity, while intercalation into DNA 
can effectively protect the ethidium from water and lead to greater 
fluorescent activity. ROS are produced at the mitochondria and its negatively 
charged membrane electrostatically attracts the oxidized ethidium cation to it. 
Mitochondrial membrane depolarization would have the effect of reducing 
positively charged ethidium at the surface of the mitochondria due to a 
reduction of electrostatic potential and allow for it to effectively spread 
throughout the cell. Hst-5 is certainly known to cause mitochondrial 
membrane depolarization.24,27 Thus it is not inconceivable that the ethidium 
could be having secondary interaction with nuclear DNA resulting in 
enhanced fluorescence. Secondly, introduction of ROS scavenger TEMPO 
was observed not only to have no effect on the HEt / ethidium fluorescence, 
giving more support to the hypothesis that fluorescence increase is derived 
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from interaction with nuclear DNA as a result of membrane depolarization, 
but also TEMPO showed no effect on killing assays.20 When TEMPO-AC 
was used as an ROS indicator, no ROS increase was observed and H2-
DCFDA was claimed to have a background reaction making it unsuitable for 
ROS detection studies.20 This does not represent a deathblow to the ROS 
production hypothesis. Although, HEt may react with nuclear DNA, data from 
HEt assays used to detect ROS production in cell free environments, which 
was done in one study on isolated mitochondria with Hst-5, should be 
completely valid.30 In this study, enhanced ROS production upon exposure to 
Hst-5 was supported.30 In the case where H2-DCFDA was used to detect 
ROS in vivo, the critique concerning its background reaction interfering is not 
well founded.20 Appropriate control conditions can distinguish a real reaction 
from a background reaction, though the results may not be as solidly 
quantitative. Another issue, of course, is the nature of the ROS probes 
themselves, in that they are all primarily radical ROS detectors. If the ROS in 
question is hydrogen peroxide, these probes, in competition with other 
processes, such as cellular catalase, would not be the best choice. Also, 
though the ROS scavengers have been tested for their ability to permeate 
into the cytosol, mitochondrial membrane permeability has not been 
evaluated. Thus if ROS production inside the mitochondrial matrix is elevated 
then the scavengers might be ineffective. 
Another problem with the ROS hypothesis has been the inability to 
detect cellular changes resulting from an increased ROS concentration level. 
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An increase in the intracellular ROS levels would be expected to result in 
oxidative damage to proteins; yet when Candida albicans were subjected to 
exogenous Hst-5 (31 µM 30 min) no increase in protein carbonylation was 
observed. However under identical conditions a tripling of intracellular ROS 
was observed32. Though when Hst-5 was expressed by Candida albicans 
mutants, protein carbonylation was found to be increased, even compared to 
a mutant control.32 
Apoptosis is programmed cell death. Cells activate apoptotic 
pathways for a variety of reasons, but the reason most relevant to the ROS 
production argument for Hst microbicidal activity is extensive oxidative 
damage. The markers of apoptotic pathways such as chromosomal 
conformational changes, DNA fragmentation, and cytochrome c release from 
mitochondria were investigated. The DNA was analyzed by SDS-PAGE and 
was observed to be normal in the Hst-5 producing cells, cells subjected to 
exogenous Hst-5, and the two other controls.32 Cytochrome c release was 
probed by SDS-PAGE analysis followed by immunoblotting of isolated 
mitochondria exposed to exogenous Hst-5 (31 µM 30 min) and no increase 
was observed.32 Finally, the SOD mutants, sod1/SOD2, SOD1/sod2, and 
sod1/sod2 were prepared and subjected to exogenous Hst-5 (31 µM 1 hr). 
No statistically significant difference was found between the control and 
those incubated with Hst-5.32 So, though ROS production is clearly 
enhanced, it may be ancillary to the antimicrobial mechanism as no clear link 
can be established between the enhanced ROS production and cellular 
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death. Though again, it bears repeating that in each of these cases the 
cytosolic area of the cell is being investigated. Hst may cause disruption in 
mitochondrial processes or enhanced ROS production inside the 
mitochondrial matrix, which results in cell death. 
Osmotic balance is clearly affected upon exposure to Hst-5 as 
evidenced by the aforementioned microscopy studies which observed 
cellular volume reduction and mitochondrial swelling.26-28 This has led to a 
hypothesis of antimicrobial activity derived from these observations. 
Potassium ions are a major species that are observed to have an increase in 
extracellular concentration as a result of Hst exposure. As potassium ion 
concentrations are also a major source of osmotic pressure due to 
bioaccumulation of potassium, it is of course reasonable to investigate this 
line of thinking. When Candida albicans cells are pretreated with anionic 
channel inhibitors, diisothiocyanatostilbene-2,2’-disulfonic acid (DIDS), 
niflumic acid, or 5-nitro-2-(3-phenylpropylamino) benzoic acid, prior to 
exposure to Hst-5, cellular volume disruption and cell cycle arrest are either 
prevented or attenuated.33 Also deletion of the TRK1 gene, which encodes 
for the major potassium ion uptake system in Candida albicans, resulted in 
near complete protection of cells from the antimicrobial effects of Hst-5.21 
Given the highly charged nature of Hst-5, the likelihood of Hst-5 interacting 
with both anion and cation transmembrane regulatory proteins is low. 
Generally, channels for cations are negatively charged to attract the cations 
and anion channels are positively charged to attract the anions. The Hst 
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being cationic would be electrostatically repelled by the positive charge. 
Consider, too, that the localization of Hst-5 in the interior of the cell was 
primarily the mitochondria.27, 28 So although the hypothesis is reasonable; a 
conclusion drawn from the data concerning interaction with anion channels is 
somewhat unsatisfying. The explanation of osmotic regulation disruption is 
certainly better and more inclusive than either one of the independent 
hypotheses; one that invokes Hst interaction and disruption of Trk1p, a 
potassium channel, or the other that invokes Hst interaction and disruption of 
an anion channel. 
To further investigate the antimicrobial mechanism of Hst-5, a study of 
gene expression profiles was done for the entire Candida albicans genome 
to observe which proteins exhibited different expression profiles upon Hst-5 
exposure.34 Upregulated genes included those involved in cellular stress 
(both oxidative and osmotic), cellular metabolism, and mitochondrial genes. 
The majority of cellular metabolism regulating genes that were upregulated 
were primarily involved with the production of glycerol, which is used to help 
mitigate the effects of osmotic stress. This combined with the evidence 
gathered in the down-regulation of genes used to create proteins involved in 
plasma membrane transport of amino acids, GAP2; ion homeostasis, CSA1; 
and monosaccharide transport, NAG1, and the down regulation of genes 
involved in aerobic respiration point to the possibility that interference with 
the osmotic regulation of the cell is the primary mode of action for Hst-5.34 
Glycerol is produced from anaerobic respiration. So the change in production 
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of proteins related reducing aerobic respiration can be explained on the basis 
of osmotic stress. Further, it provides an alternative explanation for the 
observation that aerobically stressed mutants were better able to protect 
themselves from Hst-5 antimicrobial activity.35 Lastly, the work investigated 
how pretreatment of cells with various agents affected cell survival rates. In 
both radial diffusion assays and candicidial assays, Hst-5 pretreatment 
resulted in increased susceptibility to sorbitol, which is used as an osmotic 
stress inducing agent, but had no effect on cells treated with H2O2.34  
Although most of the genes that were observed to have altered 
transcription regulation were involved in the HOG1 pathway, two notable 
exceptions that are observed to have increased production involved in 
oxidative stress responses are CAP1 and SOD2.34 Both are HOG1 pathway 
independent.34 It then remains possible that Hst-5 involves both ROS 
production and osmotic regulation interference. 
 
1.2: Reactive Oxygen Species (ROS) and Metal Ions 
ROS is a generic term referring to any oxygen species that is more 
reactive than triplet oxygen. The production of ROS; particularly hydrogen 
peroxide, superoxide, and hydroxyl radical, is widely associated with 
reactions of redox active metal ions, particularly Fe(II,III) and Cu(I,II) or their 
complexes, with hydrogen peroxide or oxygen with a reductant.36-39 ROS in 
the cellular environment are very well controlled in viable cells. They can be 
produced intentionally as a direct means of fighting against other cells or for 
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other purposes like instigating lignin production for cell wall construction. 
ROS are often times also produced as unwanted byproducts of cellular 
respiration activities. ROS production is a source of oxidative stress, and a 
loss of ability to adequately control ROS results in oxidative damage. 
Oxidative stress has been associated with the cellular aging, aging process, 
and many diseases, including arteriosclerosis, neurodegenerative disorders, 
such as Alzheimer's and Parkinson's diseases, and cancer.40-49 Oxidative 
damage can also induce apoptosis. As aforementioned, apoptosis is 
programmed cell death. Some of the major systems that life forms have 
developed to manage ROS include SOD and catalase (CAT) enzymes. SOD 
enzymes take two equivalents of superoxide and two protons and produce 
one equivalent of hydrogen peroxide and one equivalent of oxygen (equation 
1.2.1). Life has evolved very efficient systems to control superoxide. SOD 
enzymes are usually rate limited by diffusion rates. CAT, then, can dismutate 
the hydrogen peroxide produced into water and oxygen (equation 1.2.2). 
 eqn. 1.2.1 
 eqn. 1.2.2 
In the system illustrated four equivalents of superoxide will have been used 
to generate two equivalents of oxygen and two equivalents of water. A 
potentially damaging ROS has been converted to materials required for 
aerobic survival, oxygen and water. 
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Although few quantitative comparisons have been made, it generally 
appears that metal ion coordination to a ligand, peptide, or protein can 
reduce or eliminate the metal ion’s ROS-generating activity as well as alter 
the types of ROS produced.50-52 Due to free copper and iron species ability to 
generate ROS combined with the need of cells to utilize both copper and iron 
in metalloproteins and elsewhere, cells have evolved systems to sequester 
and manage these biologically important yet dangerous metals. Some of the 
most notable iron containing metalloproteins includes hemoglobin and 
myoglobin, which are both involved in oxygen transport, here the iron is held 
as a heme unit. The enzyme cytochrome c oxidase (also known as complex 
IV) is one of many metalloenzymes involved in the respiration. Using its two 
heme iron moieties, CuB, and CuA centers, cytochrome c oxidase receives 
electrons and protons to reduce molecular oxygen to water via a series of 
one electron reductions.53 ROS production by copper and/or iron containing 
metalloenzymes include the production of hydroperoxyl alkenes by the 
lipoxygenases, hydroxyl radical production by peroxidases, superoxide 
generation by xanthine oxidase, and of course oxygen radical production by 
horseradish peroxidase. As aforementioned; Cu, Zn SOD uses copper to 
help control both intentional and unintentionally generated ROS.54-57 ROS 
production and handling by such complexes also can result in oxidative 
damage to the protein itself.58-62  
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Biomimetic complexes have also been created. These complexes also 
use transition metals and can also serve to mediate subsequent ROS 
transformations, e.g. superoxide disproportionation.63-65  
A potential source for a transition metal in yeast could be a recently 
identified non-proteinaceous pool of copper.66 This pool contains 
approximately 5 x 105 atoms in a soluble complex and acts as a copper 
buffer of sorts, responding to copper concentrations in the cytosol.66 This 
then would allow for a source of copper ions by peptides like Hst, which 
contain metal binding motifs as well as metalloproteins synthesized by the 
organism. 
 
1.3: Imidazole and Histidine 
 
Imidazole is a well known ligand for transition metals. As illustrated in 
figure 1.3.1, nature has evolved an amino acid that incorporates the 
imidazole motif, histidine. Histidine is one of the least encoded amino acids. 
According to BLAST primary sequence data of the proteome, histidine 
N
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Figure 1.3.1. Illustration of structures; (left) 
imidazole and (right) histidine. 
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comprises a mere 1.8%-3% of all primary structure as calculated from a 
database of nonredundant proteins by R. F. Doolittle.67 When histidine is 
found in the primary sequence of proteins, it is often involved in metal binding 
activities; Cu-Zn SOD, soybean lipoxygenase, and Auxin binding protein 
each use multiple histidine residues in their metal binding pockets. Certain 
sequences containing histidine have been shown to often be involved in 
metal binding interactions. Common Zinc binding motifs include His-X-His-X-
His-X-X and His-His-Y-Z-His.68 In addition to being a good zinc binding motif, 
the His-X-Y-Z-His sequence is also a good copper binding motif, particularly 
when X is a glutamate residue.68 Though this list is far from complete, a final 
example of a metal binding primary sequence utilizing histidine is the amino 
terminal copper/nickel-binding motif (ACTUN) is Asp1-X2-His3. This particular 
sequence has often been observed to be involved in metal binding.69 The 
primary sequence of Hst-5, D-S-H-A-K-R-H-H-G-Y-K-R-K-F-H-E-K-H-H-S-H-
R-G-Y, contains four of these types of motifs, an ACTUN and three variations 
of the histidine sequences. Furthermore, its primary sequence is 29% 
histidine. Hst-8, K-F-H-E-K-H-H-S-H-R-G-Y, contains variations of the metal 
binding histidine sequences and a histidine in the third position of the 
sequence which is a critical part of the ACTUN sequence. Hst-8 too is 
histidine rich; 25% of its primary structure is histidine. 
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1.4: Histatins, Metal Ions, and ROS 
The respiratory inhibition and ROS generation induced by the 
histatins, their histidine-richness, their primary structures’ similarity with 
metal-binding proteins, and relevant chemical studies suggest a possible link 
between the bioactivity of the histatins and metal ion binding.70 Indeed, 
strong Zn2+, Cu2+ and Fe2+ binding to Hst-5 (Ka ca. 2x107 M-1 for Cu2+ and ca. 
105 M-1 for Zn2+) has been demonstrated using isothermal calorimetry (ITC).71 
In the study they found that there were three distinct binding events for Hst-
5.71 Cu2+ coordination to Hst-5 at the N-terminal D-S-H (Asp, Ser, His) 
domain was suggested by a later study based on NMR line broadening from 
added Cu2+.36, 37 As aforementioned this is an ACTUN region. ESI-MS 
studies have shown that 1-4 Cu2+, 1-4 Ni2+ and 1-2 Zn2+ ions bind to Hst-3,-
5.38 The strong metal ion-binding histatins could potentially recruit Cu or Fe 
ions. The resulting metal/peptide complex could then activate molecular 
oxygen or hydrogen peroxide to produce damaging ROS.39, 72-74  
The ITC, NMR, and MS studies together have added valuable 
information to the picture of metal binding by Hst. However, there are some 
gaps that remain to be filled in the knowledge base. The ITC work using the 
whole peptide does little to elucidate the precise binding motif involved in the 
binding events. Whereas the NMR study, in effect, proves what the 
researchers already knew. By utilizing only that fragment of Hst-5 that 
corresponds to the ACTUN region, the researchers were capable of proving 
metal binding to a known metal binding region. They neglected the potential 
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for competitive or synergistic interaction of the other type of known metal 
binding regions present in Hst-5, the His-X-Y-Z-His type regions. Another 
aspect of concern is that none of these studies addresses the issue of Cu(I) 
binding. The intracellular environment is a reducing environment, so copper 
species are likely to spend at least some of their time in a partially reduced 
state. This is an important point as the coordination environment of Cu(I) is 
different than that of Cu(II). Cu(I) generally prefers a tetrahedral environment 
whereas Cu(II) prefers a square planar geometry. Certainly there remains 
work to be done both in terms of identifying the metal binding moiety the full 
Hst-5 but also in those 19 other Hst fragments that do not possess an 
ACTUN region.75 
Chemical reactivity studies too are similarly lacking in terms of their 
treatment of the peptide systems. In vitro work done on two synthetic 
analogues of Hst-5 indicated pro-oxidant activity.76 However, here again they 
used first of all a fragment of Hst-5, and one that even lacks the potentially 
competing His-X-Y-Z-His motifs. The first peptide (DSHAKRAHGY) 
represented the first 10 residues of Hst-5 with an H7/A7 mutation the other 
(DSAAKRAHGY) was the first 10 residues of Hst-5 with H3/A3 and H7/A7 
mutations.76 The observation of ROS production by a copper bound in an 
ACTUN type environment is hardly surprising. Previous work has shown that 
such a complex can be involved in oxidative cleavage of DNA.52, 77  
However, one should not be so quick to rule out the other binding sites 
for metal binding and ROS generation. Indeed in vitro studies have 
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demonstrated that Hst-8 copper complexes are capable of generating ROS 
at levels comparable to those of Hst-5 copper complexes.70 Again, though 
Hst-5 maybe the most active in terms of antimicrobial activity, 19 of the Hst 
thus far identified have no de facto ACTUN motif.75 Meanwhile many of those 
peptides discussed in the previous sections have active sites containing 
multiple histidine residues for metal ion binding purposes and are involved in 
handling ROS. Clearly scientific investigation into the possibility of multiple 
histidine residues binding copper ions in native Hst peptides is warranted. 
 
1.5: Conformation and Bioactivity 
Primary structure is only the beginning of the discussion of proteins. 
Since not all metal binding is done by residues in close proximity by virtue of 
sequence, a discussion of three-dimensional conformation is very important. 
Indeed, the conformation of proteins is so important that denaturation often 
results in loss of function. In addition misfolded proteins have been shown to 
be the cause of several diseases not the least of which are Kuru, Creutzfeldt-
Jakob Disease, and others. Studies of Hst-5 and Hst-8 have been done in 
both water and lipid mimicking solvents such as DMSO and 
hexafluoroacetone (HFA). Though Hst-5 is lacks alpha helical or beta strand 
secondary structure in water, it adopts an alpha helical conformation in the 
membrane mimicking solvents DMSO as determined by NMR techniques 
coupled with in silico MD simulations.78 Hst-8 has been determined to be a 
beta strand in pH 4.0 water and pH 4.0 DMSO, but alpha helical in an HFA 
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water solution by utilization of similar methodology.79 Other techniques used 
to probe the conformation of Hst in solution include CD and FTIR.80-82 Just as 
conformation can affect metal binding, so too can metal binding influence 
conformation. One of the best studied examples of such are the zinc fingers, 
which give rise to conformationally compact domains for DNA binding, as a 
consequence of binding a zinc ion. In addition to the aforementioned 
conformation studies, information can also be gathered on the metal and its 
local environment by NMR and EPR spectroscopies. 
 
1.6: In silico modeling and studies 
As computers become ever more powerful, chemists have been using 
them to solve ever more sophisticated problems. Peptides and proteins 
contain a large number of atoms and have traditionally been investigated 
using molecular mechanics (MM) and semi-empirical methods. Each of these 
methods has its own assets and liabilities as a result of assumptions made 
for that particular methodology. MM initially assumes that bonds of a given 
bond order have a set of properties, such as rotation and length, based upon 
the generally user specified bond order. Semi-empirical methods, such as 
PM3 and AM1 begin to treat bonding between atoms as a result of electron 
density. However, only the electrons involved in bonding are considered, and 
many of the parameters of the bonding electrons have been set by using 
parameters from real molecules. This is done for calculational simplicity. A 
limitation is that only molecules most similar in structure to those molecules 
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used to build the parameters will have the most accurate structures. Ab initio 
and density functional methods (DFT) once practical only for small molecules 
have increasingly been used for investigating larger systems up to and 
including short peptides. Ab initio methods are attractive in that bonds and 
bonding electrons are now treated as electron systems without external 
reference to other molecules. In effect, far fewer assumptions are made 
about the system as a whole, including treatment of core electrons. However, 
this accuracy comes at a price in terms of calculation size and time. For 
larger proteins and enzymes mixed methods, which use molecular 
mechanics and semi-empirical methods for the majority of the structure allow 
higher levels of theory to be applied directly to the active site. 
 
1.7: Statement of Objectives 
We have sought to add to the knowledge base of the antimicrobial Hst 
peptides in terms of meeting several project objectives. First, as there is still 
debate as to if ROS are implicated in the antimicrobial activity of the Hst, we 
sought to investigate the possibility in an in vitro system. In this way all 
external variables and possible side reactions would be eliminated and there 
would be definitive and quantifiable evidence for specific ROS production by 
Hst systems.  
Another major gap identified in the scientific literature is the lack of 
conformational knowledge of the Hst when involved in metal binding. Many 
studies have already been done both on Hst conformation in the free state 
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and Hst metal binding activity, however, there has yet been no study that has 
integrated both metal binding and global conformation of the peptide.  
Along the same lines, there has not yet been a definitive study on the 
metal binding environment of the peptides themselves. Many peptide 
analogues have been made and their metal binding activity studied. However 
as most of them delete histidine residues, and are very short in length, a 
comprehensive understanding of the metal binding environment has yet to be 
investigated. 
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Chapter 2: Study of Reactive Oxygen Species in vitro 
 
2.1: Introduction 
We sought to study specific ROS production by a copper metal 
complex in a reducing aerobic environment and quantify those species 
produced. Previous studies had used only general probes in quantification of 
ROS. Moreover, in vivo experiments make an absolute quantification of 
many ROS impossible, given the presence of enzymes, such as superoxide 
dismutase and catalase, as well as other ROS scavengers. In order to 
quantitatively identify specific ROS we conducted in vitro experiments, 
however, we took several steps to ensure that the results were as biologically 
relevant as possible. The cellular environment is a reducing environment, 
and many biologically relevant reductants exist, including ascorbate, 
cysteine, NADH, and GSH. Also given the Hst affinity for copper ions as well 
as a recently identified labile pool of copper in yeast,66 we chose to utilize 
copper as our transition metal.  
The system was buffered at pH 7.4. The pH was chosen due to its 
biorelevance. However, the buffer selection was one of the most difficult 
decisions to make. The ideal buffer should not interfere with metal ion 
binding of Hst to metal, not be oxidizable under the conditions of the 
experiment, not be capable of being used as a reductant nor interfere with 
the assay being utilized. Phosphate is often used as a buffer in vitro for 
several reasons. The buffering capacity occurs in the biologically relevant 
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range and humans use phosphate species as buffering agents. It is not 
oxidizable and is not utilized as a reducing agent. However phosphate is not 
suitable for our purposes, since it has been shown to form complexes with 
copper ions83, 84 and perhaps most importantly has been shown to have 
adverse effect for study of ROS producing systems.85 We selected 
morpholinopropylsulfate, MOPS, as our buffer after some initial work with 
phosphate buffered systems. Though MOPS is oxidizable,85 we wanted to 
ensure that ROS generation was due exclusively to Hst-cupro complexes 
and not from free metal ion species as MOPS does not engage in copper ion 
binding.84, 86, 87  
 eqn. 2.1.1 
 eqn. 2.1.2 
 eqn. 2.1.3 
 eqn. 2.1.4 
 eqn. 2.1.5 
The first ROS we sought to investigate was the formation hydrogen 
peroxide. As shown by the series of equations listed above (equations 2.1.1-
2.1.5) there are a number of ways by which oxygen can be converted to 
hydrogen peroxide in a reducing environment. Equation 2.1.1 illustrates 
superoxide being generated by a single electron transfer, SET, to molecular 
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oxygen. Hydrogen peroxide can then be created from superoxide by a 
subsequent SET in the presence of protons according to equation 2.1.2. 
Another possibility exists utilizing the superoxide and adding a proton to 
obtain the hydroperoxyl radical (equation 2.1.3), which can then be further 
reduced in a separate step in the presence of a proton to get hydrogen 
peroxide (equation 2.1.4). Of course the most direct way to obtain the 
hydrogen peroxide from molecular oxygen is a two electron transfer in the 
presence of protons (equation 2.1.5). Addition of a transition metal catalyst to 
the system can complicate thing further because each of these steps could 
happen while substrate or product is bound to the metal or if it is free in 
solution. As described in the previous narrative, there is a distinct possibility 
that superoxide plays a role in the formation of hydrogen peroxide. Thus we 
sought to investigate the possibility of free superoxide’s intermediacy in the 
formation of hydrogen peroxide, the first ROS we sought to investigate. 
These two major ROS provide the foundation of this study. 
To assess the viability of metal-Hst complexes for ROS production, we 
report on our study of the Cu-Hst-promoted aerobic reactions with the 
bioreductants ascorbate and cysteine, which shows that hydrogen peroxide 
and superoxide are produced at high levels and catalytically by both Cu-Hst-
5 and Cu-Hst-8 complexes. The major findings of this study have already 
been published.70  
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2.2: Amplex Red Assay 
 
As shown in figure 2.2.1, Amplex Red (AR) can be used to 
spectrophotometrically monitor hydrogen peroxide. Hydrogen peroxide 
produced can be determined by the horseradish peroxidase (HRP) catalyzed 
reaction with AR to give resorufin.88-90 
 eqn. 2.2.1 
We initially chose to utilize ascorbic acid as the reducing agent as it is 
readily available in the cellular environment. Also, ascorbate had previously 
been shown to be able to reduce molecular oxygen to hydrogen peroxide at 
neutral pH both with91-93 and without transition metal catalysts.91, 94 The 
autooxidation of ascorbate to yield superoxide and hydrogen peroxide has 
been shown to proceed at a rate of 1x10-10 M-1 s-1.94 The reaction of interest 
is profiled in equation 2.2.1. Here the ascorbic acid and molecular oxygen 
are reacted together in the presence of the Hst-Cu complex to 
dehydroascorbate and hydrogen peroxide. Reactions conducted in the 
Figure 2.2.1. The transformation of Amplex Red to resorufin by 
horseradish peroxidase in the presence of hydrogen peroxide at pH 7.4. 
26 
 
presence of a transition metal exhibit a different kinetic profile and much 
greater activity than reactions carried out in the absence of a transition metal. 
This leads to the conclusion that though the autooxidation pathway exists as 
a potentially competitive reaction, the preferred reaction route involves the 
transition metal complex. Further, copper had been shown to catalyze this 
reaction and the rate of catalysis was dependent on the ligand set and 
coordination geometry.92, 95 Experiments were done to ascertain what 
concentration of copper ion would be best for the system. These initial 
screenings were done in phosphate buffer without addition of ligands and an 
arbitrary concentration of hydrogen peroxide. 
 
Figure 2.2.2 is an illustration of the effects of addition of CuCl2 to a 
solution of 50 µM hydrogen peroxide, which was then assayed with the 
Figure 2.2.2. Illustration of the effects of addition of CuCl2 
to a solution of 50 µM hydrogen peroxide, which was then 
assayed with the Amplex Red assay. 
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Amplex Red assay. It shows a test conducted with a constant amount of 
hydrogen peroxide and a variable amount of copper in a phosphate buffered 
system utilizing the AR assay for hydrogen peroxide. The expected result 
would be a constant level of absorbance across the continuum of the assay. 
However, due to interference of copper at high concentrations the assay is 
not suitable for millimolar concentrations of copper and higher. However, 
since we are primarily concerned with micromolar concentrations and lower, 
this interference should not pose a problem with our experiments. The 
micromolar range, which is the most bio-relevant, is certainly within the linear 
region. The drop in response is likely due to denaturation of the HRP, though 
Fenton chemistry cannot be ruled out. Fenton chemistry involves redox-
active transition metals, usually iron or copper complexes, and produces 
hydroxyl radicals and hydroxide equivalents using hydrogen peroxide as a 
substrate as shown in equation 2.2.2.96, 97  
 eqn. 2.2.2 
 eqn. 2.2.3 
 eqn. 2.2.4 
eqn. 2.2.5 
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In order to regenerate the reduced metal species hydrogen peroxide 
again acts as a substrate as shown in equation 2.2.3. Alternatively, oxygen 
can be reduced to superoxide to regenerate the oxidized metal as shown in 
equation 2.2.4. This clearly then directly interferes with the ability to observe 
the hydrogen peroxide using the AR assay (figure 2.2.1 and equation 2.2.5). 
We conducted some preliminary studies of systems with variable 
copper ion concentrations in constant concentrations of peptide (if present) 
and ascorbic acid in pH 7.4 phosphate buffer (data not shown). The wells 
were incubated for 1 hr and then developed with AR working solution. In 
these initial studies we observed Hst-8 copper systems produce ROS at a 
concentration similar to that of free copper similar to the systems discussed 
later. The Hst-5 copper system had fivefold greater activity However, as 
aforementioned phosphate buffer engages in complexing behavior with 
copper.83, 84 This of course creates an issue with the identification of the 
compound responsible for ROS production. That is why we chose to focus on 
a buffer system that would not be engaging in complexation. 
Our initial study focused on the production of hydrogen peroxide by 
Cu-Hst systems. In these experiments aerobic aqueous solutions (MOPS 
buffer, pH 7.4) containing Cu(II) (0.0 - 0.00125 mM), Hst-5, 0.0- 0.025 mM) 
or Hst-8, 0.0- 0.025 mM) and ascorbate as the stoichiometric reductant (1.25 
mM) were incubated at room temperature for 60 min. As aforementioned, 
though MOPS is oxidizable,85 we wanted to ensure that ROS generation was 
due exclusively to Hst-cupro complexes and not from free metal ion species 
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as MOPS does not engage in copper ion binding.84, 86, 87 The hydrogen 
peroxide produced was then determined by its horseradish peroxide-
catalyzed reaction with Amplex Red to give resorufin, monitored 
spectrophotometrically (570 nm).88 Figure 2.2.3 illustrates the hydrogen 
peroxide production in the three ascorbate/oxygen systems: A) with Cu2+ 
only (as CuCl2); B) with Cu2+/Hst-8; and C) with Cu2+/Hst-5 as a function of 
the copper concentration. The key findings are: 1) all three systems catalyze 
the efficient generation of hydrogen peroxide with similar activity, with 
turnover numbers (TON, mol H2O2/mol Cu) measured at 0.1875 nanomoles 
Cu present of up to 130 for Hst-5/Cu, 107 for Hst-8/Cu, and 140 for free Cu; 
2) in the absence of added Cu2+, hydrogen peroxide generation is negligible; 
and 3) hydrogen peroxide production increases approximately linearly with 
copper concentration in all three systems up to ca. 2:1 Cu/Hst for B,C.  
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The similar catalytic activities of the oxidizing systems in the presence 
and absence of the Histatin peptides raises the possibility that much of the 
peroxide activity is derived from free copper ion catalysis.98, 99 Since it has 
been shown that Ka for Cu(II) binding to Hst-5 is 107,16 a set of reactions was 
conducted at a high (100:1) Hst/Cu ratio to ensure virtually complete Hst-5 
binding to Cu2+ (> 99 % calculated). Under these conditions hydrogen 
peroxide is still produced at high levels with a TON up to 136 (figure 2.2.4). 
This TON is similar to that obtained in the lower Hst:Cu concentration ratio 
indicating that hydrogen peroxide formation in the Cu-Hst systems is derived 
primarily from peptide-bound copper species. 
Figure 2.2.3. Copper(II)-dependent hydrogen peroxide 
generation with ascorbate. Reactions contain 62.5 nmol 
ascorbic acid, 0.0625 nmol peptide (if present), and a varied 
amount of copper (II) chloride in pH 7.4 MOPS buffer 
(background subtracted). 
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Another bio-relevant reductant, cysteine, is also effective for the 
production of hydrogen peroxide by Cu-Hst catalyst systems. Figure 2.2.5 
shows the Cu-dependent hydrogen peroxide production by aerobic cysteine 
solutions (MOPS, pH 7.4) after one hr using the Amplex Red assay. Key 
features include: 1) similar, high H2O2 activity for both the Cu-only and Cu-
Hst-8 systems with TONs of 300-500/hr; 2) hydrogen peroxide production 
increases approximately linearly with copper concentration up to ca. 1:1 
Cu/Hst-8; and 3) hydrogen peroxide formation is negligible in the absence of 
copper. 
Figure 2.2.4. H2O2 production at high Hst/Cu(II) 
with ascorbate. 62.5 nmol ascorbic acid, 1.25 
nmol Hst and 0-0.0625 nmol CuCl2 in pH 7.4 
MOPS. 
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We have shown that in situ generated copper/Hst-5 copper/Hst-8 
complexes are capable of generating hydrogen peroxide at levels similar to 
that of free copper in reducing environments. Ligands can greatly affect the 
ability of copper to generate ROS. Some, like EDTA can completely inhibit 
the ability of copper to undergo such chemistry. However, even in systems 
with a high Hst:Cu ratio, we were still able to observe ROS production 
catalyzed by an Hst/Cu complex (figure 2.2.4).  
However, given such a high concentration of Hst relative to Cu, it 
should be pointed out that the complex formed under such conditions may be 
different than one formed under lower concentration ratios. Specifically, there 
Figure 2.2.5. Copper (II) dependent H2O2 generation by 
cysteine. Reactions contain 62.5 nmol cysteine, 0.0875 nmol 
peptide (if present), and a varied amount of copper (II) 
chloride in pH 7.4 MOPS buffer (background subtracted). 
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exists a high probability that multiple peptides are associated with a single 
copper ion. Also one should not forget that Hst-5 has multiple binding sites. 
So a complex formed by utilization of multiple intrapeptide binding motifs 
would be disfavored at high Hst-5:Cu ratio. 
It is also worth noting that we observe similar trends in activity using 
either cysteine (figure 2.2.5) or ascorbic acid (figure 2.2.3) at low Hst:Cu 
concentration ratios. Both of these external reductants are biorelevent. 
Ascorbic acid is of course vitamin C and cysteine is the reducing equivalent 
in the glutathione. In both cases ROS production for the peptide copper 
complexes was at a level similar to that of free copper. 
2.3: Amplex Red with SOD Assay 
 
Figure 2.3.1. SOD effects on H2O2 production by an ascorbate system. 
0.0625 nmol CuCl2, 62.5 nmol ascorbic acid, and 0.188 nmol peptide (if 
present) in pH 7.4 MOPS. 
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 eqn. 2.3.1 
 eqn. 2.3.2 
 eqn. 2.3.3 
 eqn. 2.3.4 
 
To probe further the mechanism of hydrogen peroxide formation in the 
Cu-only and Cu-Hst catalyst systems, we investigated the effects of 
superoxide dismutase (SOD) on the ascorbate-oxygen reactions. A previous 
study had already established the ability of the SOD-Amplex Red-HRP linked 
assay system to detect superoxide.89 To understand the observed SOD 
effects, it must be understood that hydrogen peroxide was quantified after a 
one hour reaction period. In one set of experiments no SOD is added and in 
the other, SOD is present from the initiation of the reaction. Since SOD 
catalyzes the conversion of superoxide to hydrogen peroxide and oxygen 
(equation 2.3.1), if superoxide is an intermediate in the formation of hydrogen 
peroxide according to equation 2.3.2, but is instead effectively trapped by 
SOD present during the reaction via equation 2.3.1, a decrease (up to half) in 
the total amount of H2O2 produced would be anticipated.  
The reactions of ascorbate/oxygen with the Cu-only and Cu-Hst 
systems were conducted as previously in the presence of 0.5-13 units of 
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SOD and the H2O2 formed was again assayed after the one hr reaction via 
the AR/HRP method. Figure 2.3.1 compares the effects of SOD on the 
ascorbate oxidation by Cu alone, Cu-Hst-5 and Cu-Hst-8. Although the H2O2 
production of all three reactions is decreased with increasing SOD, there are 
significant quantitative differences. The Hst-containing systems show a 
dramatic decrease in H2O2 production, up to ca. 50%, with only 1-4 units 
(8.64 x 10-2 – 3.46 x 10-1 nmol) of added SOD, whereas the free copper 
system requires over 10 units (8.64 x 10-1 nmol) of SOD for an approximate 
40% decrease. As a control ascorbate in the presence of only SOD showed 
activity no greater than the ascorbate alone. These results indicate that while 
both the free Cu and Hst-Cu systems likely produce superoxide as an 
intermediate, there are differences in the extent to which superoxide 
contributes to the total hydrogen peroxide production in these systems, 
suggesting a difference in mechanisms of ROS generation in the presence 
and absence of the peptides. Due to the thiol oxidase activity of Cu/Zn-
superoxide dismutase55-57, 100, 101 (equations 2.3.3 and 2.3.4), it was not 
suitable for use with the cysteine reducing agent systems. 
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2.4: Amplex Red Assays with Hydroxyl Radical Traps 
 
Some aerobic copper/ascorbate systems have been reported to 
generate hydroxyl radical.93 To assess the possible intermediacy of hydroxyl 
radicals and their contribution to hydrogen peroxide formation in the Cu/Hst-
catalyzed reactions, the ascorbate oxidations were conducted in the 
presence of variable concentrations of the established hydroxyl radical 
traps,54, 102-104 sodium formate and sodium azide, in separate trials, followed 
by determination of the hydrogen peroxide produced. It can be seen (figure 
2.4.1) that they did not decrease H2O2 generation, even when in large 
excess. In fact we observe the opposite, observable hydrogen peroxide is 
increased. We conclude, therefore, that hydroxyl radical is not a major 
intermediate generated by the ascorbate-Cu systems in the presence of the 
Figure 2.4.1. Effects of hydroxyl radical traps on hydrogen peroxide 
production by ascorbate systems. 
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histatins. 
Although we will observe that hydroxyl radical is generated by both 
peptide/Cu and free copper systems (Section 2.7), these are either 
generated by a competing pathway or the result of a decomposition of 
hydrogen peroxide or some form of hydroperoxyl adduct. As addition of these 
hydroxyl radical traps results in an increase in hydrogen peroxide assayed, 
they are protecting the formed hydrogen peroxide from a decomposition 
pathway, are protecting intermediate superoxide from a decomposition 
pathway, and/or are themselves used as an external reducing agent by the 
Hst/Cu system for hydrogen peroxide production. Such an investigation, 
however, would be a major undertaking, a project unto itself, and would 
serve to remove focus from the central ROS already identified, the hydrogen 
peroxide and superoxide. 
 
2.5: Nitrotetrazolium Blue Assay 
 
Figure 2.5.1. Production of diformazan from NTB by superoxide and 
protons. 
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Given the results obtained in the AR with SOD trials (section 2.3), we 
sought to further investigate the generation of superoxide by the peptide 
bound copper complexes. As shown in figure 2.5.1, nitrotetrazolium blue 
(NTB) has been shown in previous studies to be reduced by superoxide in 
the presence of protons to diformazan.105, 106 This of course would be ideal 
for extending the experimental evidence for a difference in the mechanism 
and specific ROS produced by peptide bound and peptide free copper in a 
reducing environment. However, there exists some discrepancy in the 
literature concerning the compatibility of NTB with ascorbic acid. One study 
used ascorbic acid concentrations at 3 mM over a varying range of pH and 
claimed success in detecting superoxide with NTB.107 To add support to their 
claim of superoxide detection in the presence of ascorbate, they added SOD 
and observed complete inhibition of the reduction of NTB to diformazan.107 
This is not to say that such a report of superoxide detection has been limited 
to only one report, in fact there exist several, Petyaev, I. and Weng, M. as 
well as references therein back such claims.108, 109  
On the other hand NTB has been used to evaluate ascorbate oxidase 
activity of cell lysate fractions.110 Cell lysate fractions were separated by 
SDS-PAGE. The resulting gels were washed in an ascorbic acid solution (25 
µM) and then developed with an NTB solution. Fractions that were observed 
to have ascorbate oxidase activity were denoted by their lack of color. In 
effect they observed that NTB reacted with ascorbic acid to form the 
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diformazan because if ascorbic acid oxidase activity is present in the fraction 
no ascorbic acid is present to reduce the NTB.  
Our studies suggest an incompatibility of NTB with ascorbic acid. We 
observed direct reduction of NTB by ascorbic acid (data not shown). The 
reaction was so fast at pH 7.4 in MOPS buffer that there was no real 
possibility for even subtraction of a background reaction. We observed during 
trials for potential backgrounds that the only variable that mattered was 
concentration and presence of ascorbic acid (data not shown). Thus we 
sought to uncover another bio-relevant reductant that would be compatible 
with the NTB. We ultimately found that thiols were compatible with NTB and 
produced superoxide in the presence of copper. 
 
 
Figure 2.5.2. Effect of varying copper concentrations on 
superoxide production in systems containing 1.25 mM 
cysteine and 1.75 µM of peptide (if present) in pH 7.4 MOPS 
buffer as assayed by NTB assay. 
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Figure 2.5.2 illustrates the effects when we varied copper 
concentration on superoxide production by a system that utilizes cysteine as 
a reductant. The data indicates that there is increasing superoxide production 
with increasing copper concentrations. Though the system has a slightly 
increasing superoxide production in response to increasing copper 
concentration as shown in figure 2.2.5 there is a much larger effect for 
production of hydrogen peroxide in response to increasing copper 
concentrations. We can then conclude that the superoxide is rapidly 
converted to hydrogen peroxide in the presence of copper and that the rate 
at which it is converted to hydrogen peroxide by the copper or copper peptide 
complex is faster than the conversion of the NTB to the formazan.  
 
2.6: NTB with SOD 
Data for the NTB systems containing SOD is not shown because the 
SOD effectively quenched all superoxide that was produced when it was 
present at any level. Of course, an alternate explanation is that SOD was 
engaging in thiolase activity55-57, 100, 101 and turning over the cysteine and N-
acyl cysteine into hydrogen peroxide and the disulfide, neither of which is 
detectable using NTB. This was described earlier in equations 2.3.3 and 
2.3.4. It had been reported that superoxide is generated by SOD engaging in 
thiolase activity as observed by diformazan produced by reduction of NTB.55 
However, we did not observe such activity. Our observations of systems 
containing cysteine and SOD showed no production of diformazan from NTB. 
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Given the results of the effective quenching of diformazan formation 
from NTB, the observation of formation of diformazan from NTB in the 
absence of SOD, as well as studies done with the spin trapping agent 
CYPMPO (Section 2.7), we feel confident in stating that Hst/Cu catalytic 
systems generate free superoxide when cysteine is utilized as an external 
reducing agent. Further, given the results obtained from the Amplex Red 
assay in presence of SOD, the Hst/Cu catalytic system also generates free 
superoxide. Taken together all of this points to the conclusion that the 
addition of Hst changes the nature of the ROS produced as an intermediate 
on the pathway toward hydrogen peroxide generation. 
 
2.7: Spin Trapping ROS with CYPMPO 
 
Spin trapping of reactive oxygen species is often utilized to indicate 
the types of species formed.111 Figure 2.7.1 illustrates the structures of three 
compounds used in radical spin trapping studies. CYPMPO (5-(2,2-dimethyl-
1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide) is structurally 
similar to DEPMPO, 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide, 
Figure 2.7.1. Structures of the spin traps CYPMPO, 
DEPMPO, and DMPO. 
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and they both derive from the DMPO (5-dimethyl-1-pyrroline N-oxide).112 The 
spectral signatures and hydroperoxyl adduct stabilities of CYPMPO and 
DEPMPO are very similar. However, the slight structural difference between 
the two compounds leads to greater stability of the CYPMPO.112, 113 The 
phosphoryl unit is very important for hydroperoxyl adduct stability. Both 
CYPMPO and DEPMPO have hydroperoxyl adducts that are more than two 
orders of magnitude more stable than the DMPO hydroperoxyl adduct. 112, 113  
We have already seen that Cu-Hst-5,8 complexes can produce 
hydrogen peroxide and have very strong evidence for free superoxide being 
an intermediate on the pathway. In an effort to further establish the 
intermediacy of superoxide in the Cu-histatin (Hst) systems we undertook 
spin-trapping studies with CYPMPO.112 As aforementioned, CYPMPO is a 
derivative of the common radical trap DEPMPO.112 Both of these compounds 
are superior to the older DMPO (5,5-dimethyl-1-pyrroline N-oxide) in terms of 
their ability to capture and form long-lived adducts with superoxide and 
hydroxyl radicals.112, 114 Due to EPR interference by the ascorbyl radical115 in 
the ascorbate oxidations, only cysteine was a suitable reducing agent for the 
CYPMPO/Cu/Hst-systems.  
Figure 2.7.2 shows EPR spectra of the CYPMPO-hydroxyl radical 
adduct generated under various conditions. The top spectrum is of a 1% 
hydrogen peroxide solution irradiated in the presence of CYPMPO, 
established conditions for generation of hydroxyl radical and its CYPMPO 
adduct,112 the middle EPR spectrum was obtained from aerobic cysteine 
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oxidation in the presence of CYPMPO by Cu(II) alone; and the bottom 
spectrum is a simulated spectrum of the CYPMPO-hydroxyl radical adduct.  
 
The spectra contained in figure 2.7.2 clearly show that our conditions 
could easily detect CYPMPO-OH. This is demonstrated in the top spectrum 
where using standard conditions we detected the CYPMPO-OH. Further, we 
clearly show that CYPMPO-OH is produced by the free copper system using 
cysteine as a reductant. 
Figure 2.7.3 shows the EPR spectra of the CYPMPO-hydroperoxyl 
radical adduct generated experimentally for reference and simulated. The top 
spectrum was obtained via UV irradiation of a 10% solution of hydrogen 
Figure 2.7.2. (top) EPR 
spectrum from irradiation of a 
solution of 0.326 M H2O2 with 
10 mM CYPMPO, the 
CYPMPO hydroxyl radical 
adduct; (middle) EPR 
spectrum of solution with 3.33 
µM copper (II), 26.67 mM 
CYPMPO, and 1.67 mM 
cysteine in MOPS buffer (pH 
7.4); (bottom) simulated EPR 
spectrum of the hydroxyl-
CYPMPO adduct. 
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peroxide in the presence of CYPMPO.112 The bottom spectrum is the 
simulated spectrum of the CYPMPO-hydroperoxyl radical adduct.  
 
 
Figure 2.7.3. (top) EPR spectrum after irradiation of a solution that 
is 3.26 M H2O2 and 10 mM CYPMPO, primarily CYPMPO-OOH; 
(bottom) simulated EPR spectrum of the hydroperoxyl-CYPMPO 
adduct. 
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Clearly our experimental conditions were also suitable for observation 
of the hydroperoxyl adduct, CYPMPO-OOH (figure 2.7.3), as well as 
CYPMPO-OH (figure 2.7.2). This is demonstrated by the comparison of the 
CYPMPO-OOH adduct and CYPMPO-OH under standard conditions 
compared to their respective simulations. In addition to the excellent 
agreement to their simulated spectra, there is also excellent agreement with 
their respective literature values.112 
Finally, the spectra in figure 2.7.4 indicate the combined presence of 
CYPMPO-hydroperoxyl and –hydroxyl radical adducts. The top spectrum 
was obtained from the system of Hst-8, CuCl2, cysteine, and CYPMPO. The 
bottom spectrum is a combination of the two simulated spectra figure 2.7.2 
bottom and figure 2.7.3 bottom. The intensity of the simulated CYPMPO-
hydroperoxyl adduct (figure 2.7.3 bottom) contribution set at three tenths that 
of the simulated CYPMPO-hydroxyl adduct (figure 2.7.2 bottom). A 
comparison of the simulated spectrum of mixed CYPMPO-radical adducts to 
the experimentally obtained spectrum from the Cu-Hst-8 system (figure 
2.7.4) shows good agreement, indicating the presence of both CYPMPO- 
hydroxyl and –hydroperoxyl adducts. This contrasts with the nearly exclusive 
detection of the CYPMPO-OH adduct in the absence of the peptide, i.e. 
cysteine/Cu(II) and CYPMPO only (figure 2.7.2).  
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2.8: Conclusion 
From our study on the catalytic production of ROS by an Hst/Cu 
system we have reached several conclusions. First, we have found that the 
Hst/Cu systems produce hydrogen peroxide at approximately the same rate 
as free copper. This is true whether the Hst:Cu concentration ratio is less 
than 1:1 or 100:1. The similarity in activity is observed in systems utilizing 
either ascorbic acid or cysteine as a biorelevant external reducing agent. 
These observations were made using our Amplex Red assay.  
Figure 2.7.4. (top) 
EPR spectrum of a 
solution with 3.33 µM 
copper(II), 4.44 µM 
Hst-8, 26.7 mM 
CYPMPO, and 1.67 
mM cysteine; (bottom) 
simulated EPR 
spectrum from 
combination of the two 
simulated spectra 
(figure. 2.7.2 bottom 
and figure 2.7.3 
bottom) with the 
hydroperoxyl adduct 
being three tenths the 
intensity of the 
hydroxyl radical 
adduct. See 
experimental section 
for simulation 
parameters. 
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However, though the rate of hydrogen peroxide production may be 
similar, we have conclusively demonstrated that the pathway to generate the 
hydrogen peroxide by the Hst/Cu system differs from the pathway that the 
free copper ion catalyzed system uses. As demonstrated by the Amplex Red 
assay in the presence of SOD, the Hst/Cu utilizes free superoxide as an 
intermediate to hydrogen peroxide generation whereas free copper systems 
do not. This conclusion is evidenced by the near halving of hydrogen 
peroxide assayed by AR in the presence of SOD with the Hst/Cu systems. 
Free copper systems did not exhibit similar sensitivity to the presence of 
SOD. The intermediacy of free superoxide was further established by our 
spin trapping studies with CYPMPO. A CYPMPO-OOH adduct was clearly 
detected in Hst-8/Cu systems using cysteine as a reductant, but were absent 
when Hst-8 was not present. 
 
2.9: Experimental Section 
 
2.9.1: General Materials/Methods 
Commercial materials were obtained as follows: Amplex Red (AR) 
from Molecular Probes; nitrotetrazolium blue chloride (nitro blue tetrazolium, 
NTB), N-acetyl-L-cysteine (Sigma grade ≥99%), and Superoxide dismutase 
(SOD, Bovine Erythrocytes, 98% 4470 U/mg) from Sigma; Peroxidase (from 
Horseradish roots, EIA Grade, purified, single basic isozyme 500U/mg) from 
Worthington. L-Ascorbic acid (99+% A.C.S. reagent) was obtained from 
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Aldrich. Hydrogen peroxide (30% aqueous solution) was obtained from EMD. 
Sodium phosphate dibasic (A.C.S. reagent grade anhydrous), sodium 
phosphate monobasic (USP/NF grade anhydrous), sodium hydroxide (A.C.S. 
reagent grade), and Becton Dickinson Microtest 96, tissue culture treated by 
vacuum gas plasma, polystyrene, sterile, individually packaged, 96 well 
plates were obtained from Fisher. Zinc chloride hexahydrate (analytical 
reagent) and copper chloride hexahydrate (analytical reagent) from 
Mallinkrodt, MOPS from Research Organics Inc. and L-cysteine from Sigma 
both generous gifts from Prof. Paul Cook’s Lab. CYPMPO, (5-(2,2-dimethyl-
1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide) was the 
generous gift of Dr. Yashige Kotake and may be obtained commercially from 
Cayman Chemicals or Radical Research Inc. 
A 0.05 M pH 7.4 MOPS buffer solution was produced by dissolving 
MOPS in Chelex-treated double distilled DI water. This was then adjusted to 
pH 7.4 by addition of 0.1 M NaOH with Chelex resin present throughout the 
addition process. The solution was then diluted to 10 mL in a volumetric flask 
by addition of DD DI water.  
Amplex Red solutions were prepared by dissolving 5.0 mg of AR in 
1948 µL DMSO. This solution was divided into 60 µL aliquots which were 
frozen in amber vials in a blacked out dessicator until used. The Amplex Red 
working (assay) solution was created by mixing 4850 µL MOPS buffer with 
100 µL of 10 U/mL HRP and 50 µL of the Amplex Red in the DMSO aliquot 
above. 
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A SOD stock solution was produced by dissolving the contents of the 
15,000 unit vial in 1.0 mL DI H2O; a serial dilution series was created from 
that and the remainder of the SOD stock solution was frozen until needed. 
An NTB stock solution was prepared by dissolving 50 mg of NTB into 
611 µL DI H2O. This is then divided into 45 µL aliquots. These were stored 
frozen in amber vials in a blacked out dessicator. NTB working solution was 
created by dissolving a 45 µL aliquot of NTB stock solution in 4955 µL pH 7.4 
MOPS buffer solution. 
Hydrogen peroxide stock solutions were standardized 
spectrophotometrically (Perkin-Elmer Lambda 3 UV/Vis Spectrophotometer) 
from its absorbance at 240 nm with ε = 40 M-1 cm-1. 
Histatin-8 was purchased as a crude solid phase preparation product 
(55-60% purity depending on batch) from the Molecular Biology Proteomics 
Facility of the University of Oklahoma Health Sciences Center. It was isolated 
and purified by HPLC by dissolving the sample in a small volume of 0.1% 
TFA/water followed by injection onto a C18 RP-Prep-HPLC column (Biorad 
BioLogic). Elution with a linear solvent gradient from 100% water (0.1% TFA) 
to 60% H2O (0.1% TFA) / 40% 4:1 acetonitrile:H2O (0.1% TFA) (4 mL/min) 
over 74 min afforded Hst-8 with a typical retention time of 9 min. The Hst-8 
fraction was determined by ESI-MS. 
Histatin-5 was obtained from stimulated human saliva.116 Whole 
human saliva was collected, chilled and kept at 4 °C. T his was then 
centrifuged to remove high molecular weight proteins in a Centricon Plus 70 
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35 Kdal cutoff (Millipore). The filtrate was then adjusted to 500 µM ZnCl2 by 
addition of ZnCl2 hexahydrate. This solution was adjusted to pH 9 using 0.01 
M NaOH and centrifuged at 25000 G to precipitate and isolate the Zn-bound 
peptides. After decantation of the supernatant solution, the precipitate was 
dissolved in a small volume of 0.1% TFA/water and followed by injection onto 
a C18 RP-Prep-HPLC column (Biorad BioLogic). Elution with a linear solvent 
gradient (4 mL/ min) from 100% water (0.1% TFA) to 60% H2O (0.1% TFA) 
40% 4:1 acetonitrile:H2O (0.1% TFA) over 74 min afforded Hst-5 with a 
typical retention time of 30 min. The identity of the Hst-5 fraction was 
established by ESI-MS. 
 
2.9.2: Hydrogen Peroxide Generation by Ascorbate- or Cysteine-
Copper-Histatin Solutions 
In a typical set of experiments using a 96-well microtiter plate 12.5 µL 
of 0-0.1 mM peptide stock solution was first added to a well, followed by 12.5 
µL of 0-0.005 mM copper chloride hydrate solution, and then 12.5 µL of 
Chelexed DD DI water (or SOD). To start the reaction 12.5 µL of 5 mM 
ascorbate (or 5 mM cysteine) solution in MOPS buffer was added. The 
mixture was allowed to incubate at room temperature (20-22 °C) for 60 min. 
After this time the reaction was quenched by adding 50 µL of Amplex Red 
working solution to the well. The absorbance of the well(s) was then 
measured at 570 nm with a Molecular Devices Thermomax UVT-07092 
Microplate Reader (96 well UV/Vis plate reader-spectrophotometer) with 
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Softmax software version 2.35. The hydrogen peroxide concentration was 
then determined by comparison of the absorbance readout with the working 
curve produced from standardized hydrogen peroxide solutions and the 
HRP-Amplex reagent.88 
 
2.9.3: SOD Effects on Hydrogen Peroxide Generation by Ascorbate-
Copper-Histatin Solutions 
In a typical set of experiments using a 96-well microtiter plate 12.5 µL 
of 0.007 mM peptide stock solution was first added to a well, followed by 12.5 
µL of 0.005 mM copper chloride hydrate solution, and then 12.5 µL of 0-3000 
U/mL concentrated SOD solution. To start the reaction 12.5 µL of 5 mM 
ascorbate solution in MOPS buffer was added. The mixture was allowed to 
incubate at room temperature (20-22 °C) for 60 min. After this time the 
reaction was quenched by adding 50 µL of Amplex Red working solution to 
the well. The absorbance of the well(s) was then measured at 570 nm with a 
microplate reader as above. The H2O2 concentration was then determined by 
comparison of the absorbance readout with the working curve produced from 
standardized H2O2 solutions and the HRP-Amplex reagent.88 
 
2.9.4: Effects of Hydroxyl Radical Traps on Hydrogen Peroxide 
Generation by Ascorbate-Copper-Histatin Solutions 
In a typical set of experiments using a 96-well microtiter plate 12.5 µL 
of 0.007 mM peptide stock solution was first added to a well, followed by 12.5 
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µL of 0.005 mM copper chloride hydrate solution, and then 12.5 µL of the 
hydroxyl radical trap solution (either sodium azide or sodium formate) was 
added. To start the reaction 12.5 µL of 5 mM ascorbate solution in MOPS 
buffer was added. The mixture was allowed to incubate at room temperature 
(20-22 °C) for 60 min. After this time the reaction w as quenched by adding 
50 µL of Amplex Red working solution to the well. The absorbance of the 
well(s) was then measured at 570 nm as above with a microplate reader. The 
hydrogen peroxide concentration was then determined by comparison of the 
absorbance readout with the working curve produced from standardized 
hydrogen peroxide solutions and the HRP-Amplex Red reagent.88  
 
2.9.5: Superoxide Generation by Cysteine- and N-Acylcysteine-Copper-
Peptide Systems 
In a typical set of experiments using a 96-well microtiter plate 12.5 µL 
of 0-0.1 mM peptide stock solution was first added to a well, followed by 12.5 
µL of 0-0.005 mM copper chloride hydrate solution, and then 12.5 µL of 
Chelexed DD DI water (or SOD). 50 µL of NTB working solution was next 
added. To start the reaction 12.5 µL of 5 mM N-acylcysteine (or 5 mM 
cysteine) solution in MOPS buffer was added. The mixture was allowed to 
incubate at room temperature (20-22 °C) for 60 min. The absorbance of the 
well(s) was then measured at 570 nm with a Molecular Devices Thermomax 
UVT-07092 Microplate Reader (96 well UV/Vis plate reader-
spectrophotometer) with Softmax software version 2.35. 
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2.9.6: EPR Spin Trapping Studies 
In a typical experiment the reactants were mixed in an Eppendorf tube 
with an order of addition of peptide, metal ion, CYPMPO, water, and reducing 
agent. These were then immediately drawn into a quartz flat cell and placed 
in the microwave cavity. The instrument was a Bruker EMX EPR system 
using an ER041XG X-band microwave bridge and an ER4102ST microwave 
cavity. Spectra were collected using the 32-bit WinEPR ver. 4.32 Rev. 10 
software from Bruker. Typical spectral acquisition parameters for the 
experiment were modulation frequency 100 kHz; modulation amplitude 1.0 
G; microwave power 10 mW; amplifier time constant 0.1 s; and filed sweep 
rate 150 G / 80 s. The static field was set at 3480 G. Generally, 16 scans 
were collected per spectra. 
 
2.9.7: Irradiation of EPR Samples 
A Rayonet Srinivasan-Griffin Photochemical reactor (Southern New 
England Ultraviolet Company, RPR-100) was used for irradiation of hydrogen 
peroxide-CYPMPO samples to produce the CYPMPO-OH and CYPMPO-
OOH adducts. Samples were irradiated for between 0.5 and 2 min while in 
the quartz flat cell. 
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2.9.8: EPR Simulation Parameters 
WinRad ESR simulation program (Radical Research Inc, Hino Tokyo 
Japan) was used to simulate the desired spectra. The CYPMPO-OOH 
spectrum was simulated using the following parameters (1 mT = 10 G): 
diastereomer 1: AH = 1.11 mT, AN = 1.26 mT, AP = 5.25 mT, LW = 0.13 mT, 
relative conc. = 1; diastereomer 2: AH = 1.04 mT, AN = 1.27 mT, AP = 5.1 mT, 
LW = 0.13 mT, relative conc. = 1. The CYPMPO-OH spectrum was simulated 
using the following parameters: diastereomer 1: AH = 1.37 mT, AN = 1.37 mT, 
AP = 4.98 mT, LW = 0.11 mT, relative conc. = 1; diastereomer 2: AH = 1.23 
mT, AN = 1.35 mT, AP = 4.8 mT, LW = 0.11 mT, relative conc. = 1. 
Assignments of these spectra were based on Kamibayashi et al.112 The 
combination spectra were generated by combining the spectra that were the 
resultant of the previous simulations in a 1:0.3 CYPMPO-OH:CYPMPO-OOH 
ratio. 
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Chapter 3: Metal Binding Studies 
 
3.1: Introduction 
Uncovering the ligand environment of the copper ion in the Cu/Hst 
complexes of Hst-5, D-S-H-A-K-R-H-H-G-Y-K-R-K-F-H-E-K-H-H-S-H-R-G-Y, 
and Hst-8, K-F-H-E-K-H-H-S-H-R-G-Y, is of interest. It has already been 
shown that different ligand environments give rise to different ROS both in 
my own work and in other literature examples.50-52, 70, 91, 95 Most notably, we 
were able to observe production of a free superoxide intermediate on the 
pathway to produce hydrogen peroxide in both Hst-5 and Hst-8 containing 
systems.70 Thus it is of interest to investigate the metal binding environment 
to add to the knowledge base information correlating specific ROS 
production to ligand environment. Unlike Hst-5, Hst-8 has no ACTUN 
environment, amino terminal copper/nickel-binding motif (Asp1-X2-His3). Yet, 
Hst-8/Cu systems produce ROS at a rate similar to that of both free copper 
and Hst-5/Cu systems. We chose to use several different techniques to 
investigate the possible structures for both Hst-8 and associated model 
complexes, among them were NMR, EPR, and computational study.  
 
Figure 3.1.1. Primary structures of Hst-8 and Hst-5. 
Hst-5, D-S-H-A-K-R-H-H-G-Y-K-R-K-F-H-E-K-H-H-S-H-R-G-Y 
Hst-8                                               K-F-H-E-K-H-H-S-H-R-G-Y 
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As discussed in the introductory chapter, imidazolyl motifs are 
commonly used as metal ligands. Hst-5 and Hst-8 contain these imidazolyl 
units by virtue of inclusion of the histidine residues. Several different types of 
coordination modes can be imagined, though there are a few motifs that are 
most likely to be involved. The ACTUN motif illustrated in figure 3.1.2 is the 
one present in Hst-5 shown coordinating copper. All ACTUN motifs use the 
terminal amine nitrogen, the amide nitrogen atoms that connect the first three 
residues together, and the imidazolyl unit of the histidine, which must be the 
third residue to coordinate the metal ion. Although, classically ACTUN 
regions have an aspartic acid residue as the first residue, it is not requisite to 
engage in metal binding. Hst-5 has a classical ACTUN motif as illustrated in 
its primary structure, figure 3.1.1 and figure 3.1.2. Hst-8 though lacking the 
Figure 3.1.2. ACTUN fragment of 
Hst-5 coordinating copper. 
Figure 3.1.3. H-E-K-H-H fragment 
(common to both Hst-5 and Hst-8) 
coordinating copper as a tridentate 
ligand. 
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aspartic acid has a histidine as the third residue. The other commonly 
observed metal complexing motifs are those that of the His-X-Y-Z-His and 
the His-X-Y-His-His motifs. Figure 3.1.3 illustrates tridentate metal binding of 
a His-Glu-Lys-His-His sequence to copper. The sequence illustrated is 
common to both Hst-5 and Hst-8. Another possible mode of binding would be 
bidentate coordination though it is not shown. Imidazolyl units are each 
involved in these common binding motifs, thus for our studies in the metal 
binding activity we focused on not only the aforementioned motifs, but also 
the imidazolyl units. 
NMR spectroscopy is an excellent technique to probe the ligand 
environment. Protons are very sensitive to their environments and changes 
to that environment are easily observed given the relative abundance of 1H 
nuclei and their sensitivity to radio frequencies. Other atomic nuclei can also 
be used; however, results often take substantially longer to obtain due to 
lower concentrations of heteronuclear atoms that have spin at natural 
abundance and their comparatively lower sensitivities. To overcome the 
challenge posed by investigation of the heteronuclear environments, two 
dimensional proton coupled heteronuclear experiments are utilized. In these 
experiments we are able to utilize the high natural abundance and sensitivity 
of protons to indirectly observe those nuclei that have much lower natural 
abundance and sensitivity. In this way we can observe the chemical shift 
differences in the free and metal bound peptide of the nuclei involved in the 
metal binding. As suggested by studies on ACTUN type complexes and 
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indeed the host of other material, nitrogen nuclei, particularly those on 
imidazolyl motifs are often involved with metal ion binding. 1H-15N HSQC and 
1H-15N HMBC experiments are therefore likely to give very good information 
about metal binding activities. 
In addition to the two dimensional experiments we can also get 
information about where metals bind by observing the one dimensional 
proton spectrum. Changes in chemical shift and line broadening are often 
observed for protons located in the vicinity of metal binding. Further, if the 
complex is engaging in ACTUN type binding as illustrated in figure 3.1.2, the 
displacement of the amide protons will be observed. 
Although many NMR studies that involve metal binding studies use Cd 
due to its own NMR activity,117, 118 we decided that Cu was a better choice. 
Indeed Cu(II) has been used in metal ion binding studies done by NMR.105, 
119, 120
 It was observed to quench the NMR signal when it was added in sub-
stoichiometric quantities. This loss of signal was due to paramagnetic 
relaxation alteration and could easily result in a complete loss of signal for 
the entire peptide in a protein as small as Hst-8. Thus Cu(I) was selected to 
be the metal ion used for binding studies.  
Cu(I) has been successfully used in a great number of studies, studied 
both directly and indirectly by NMR.121-124 As with other metal complexation 
studies done with NMR, copper complexation results in downfield shifts of 
the imidazolyl unit’s and other proton resonances of residues involved in 
metal binding.121, 123 It was also noted that those resonances of adjacent 
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residues were sometimes shifted, though distant resonances had little if any 
chemical shift differences.121, 123  
 
Figure 3.1.4 illustrates some of the correlations that would be possible 
to observe in a 1H-15N HMBC experiment. These indirect detection 
experiments allow for much easier observation of nitrogen nuclei. As we 
hypothesize that the nitrogen nuclei are most likely involved in metal binding 
observation of their chemical shift resonances is important. Combined with a 
1H-15N HSQC experiment, which illustrates only single bond correlations, the 
two or three bond correlations of the 1H-15N HMBC become apparent. Using 
this methodology one can uncover which nitrogen nuclei, whether they are 
part of an amide or imidazole, are involved in metal ion binding. Carbon 
nuclei adjacent to metal ion binding sights also have been observed to 
undergo changes in chemical shift. These too have been investigated using 
similar techniques. 
Figure 3.1.4. 1H-15N HMBC 
correlations in a his-phe dipeptide. 
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EPR spectroscopy, unlike NMR spectroscopy, requires the presence 
of an unpaired electron spin to work. Thus the Cu(II) system was investigated 
utilizing EPR spectroscopy. Though we had to look at the Cu(I) and Cu(II) 
systems independently with different techniques, both oxidation states are 
important in terms of investigation of the ROS production. Considering that 
the generation of superoxide from molecular oxygen involves a single 
electron transfer, the cycling of Cu(I) to Cu(II) is of considerable importance. 
Though a given oxidation state of the metal may be transitory in the overall 
catalytic reaction, it none the less plays an important role. We sought to 
investigate the ligand binding environment by investigation of the hyperfine 
coupling constant (hfcc). Here the unpaired electron spin on the copper is 
split by the spin state of nuclei of adjacent atoms. This would then allow for a 
diagnostic splitting pattern that would allow for inference of atoms and by 
extension moieties involved in binding the metal ion. 
Finally computational models of various complexes were created and 
evaluated to explore binding of the Hst-8 to metal ions. 
 
3.2: 1H-15N HSQC and 1H-15N HMBC 
Before investigating complicated peptide systems, model complexes 
were initially investigated. A major factor contributing to the complexity of the 
peptide systems was their relatively large size. Another factor was the proton 
exchange that occurs on the imidazolyl unit. The proton exchange illustrated 
in figure 3.2.1 occurs between the nitrogen atoms on the imidazolyl unit. 
61 
 
Distinct isomers are formed as a result of this proton exchange. The figure on 
the left of the equilibrium arrows has its imidazolyl unit attached at the C4 
position, whereas the structure on the right of the arrows has its imidazolyl 
unit attached at the C5.  
 
Though we would like to use an HSQC experiment to observe the 
chemical shifts of the nitrogen atoms indirectly, the exchange illustrated in 
figure 3.2.1 and the exchange of the proton with others available in solution 
prohibit our use of this particular experiment. An HSCQ experiment is clearly 
more desirable than an HMBC in terms of sensitivity. The N-H J value for an 
HSQC experiment is 93 Hz which is an order of magnitude greater for the 
multibond J value used for HMBC experiments of 3-8 Hz. Though less 
sensitive than an HSQC experiment, the HMBC experiments hold promise to 
observe the nitrogen nuclei’s resonances. Though the nitrogen atoms 
themselves are engaged in a proton exchange, the C2 position remains the 
C2 position regardless of which nitrogen contains the proton. So though the 
Figure 3.2.1. The proton exchange results in 
4(5) isomerism of histidine. 
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nitrogen nuclei are likely to be a single signal averaged resonance as a result 
of the exchange, at least we will be able to observe them.  
Other possibilities remain for use of HSQC experiments to monitor 
nitrogen resonances. In systems where the imidazolyl units of histidine and 
model complexes have been exhaustively protonated, the exchange maybe 
prevented. Also when the imidazolyl units are involved in complexation of a 
metal exchange of the proton on and off the nitrogen not involved in metal 
binding may be prevented. In both of these systems HSQC experiments 
have some probability for success.  
We started out with simple histidine systems utilizing just one 
dimensional proton and two dimensional 1H-15N HMBC for the purposes of 
investigating instrument parameters and collection times. Though we were 
able to obtain good one dimensional data, despite our best efforts we were 
unable to obtain satisfactory two dimensional data using natural abundance 
histidine and histamine samples within reasonable experimental times. The 
one dimensional data essentially was a 1H NMR spectrum that only had 
protons present that had a coupling to nitrogen nuclei. So though we could 
see the proton chemical shifts in the one dimensional 1H-15N HMBC, we 
could not observe any nitrogen chemical shifts.  
Thinking that N1-N3 proton exchange may be at the cause of our 
problem in obtaining good two dimensional 1H-15N HMBC spectra, we then 
decided attempt 1H-15N HMBC experiments with the completely protonated 
histidine methyl ester dihydrochloride. This molecule will no longer engage in 
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exchange since both nitrogen atoms on the imidazolyl unit will be protonated 
as well as the amino terminus. 
 
Figure 3.2.2 is the 1H NMR spectrum of histidine methyl ester 
dihydrochloride. We can see the HC2 peak at 9.01 ppm, the HC5 peak at 7.52 
ppm, the Hα peak at 4.74 ppm, the Hmethyl peak at 3.73 ppm and the Hβ peak 
at 2.5 ppm. The integrations fit nicely at a 1:1:1:3:2 ratio. 
Figure 3.2.2. 1H NMR spectrum of histidine methyl ester 
dihydrochloride. 
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Figure 3.2.3 is the 1H-15N HMBC spectrum of histidine methyl ester 
dihydrochloride. The F1 axis is the chemical shift of the nitrogen nuclei and 
the F2 axis is the chemical shift of the hydrogen nuclei. There are two 
separate and distinct nitrogen absorptions. One is at 190 ppm and is a bit 
streaked due to some lingering N1-N3 exchange. However, very strong 
correlations are observed to the C2 proton (9.2 ppm) and C5 proton (7.6 ppm) 
on the imidazolyl ring. Also, substantially weaker correlation to the water 
dissolved in DMSO (3.4 ppm) is observed. We noted that the ammonium 
nitrogen at 50 ppm has a correlation to the water dissolved in DMSO (3.4 
ppm) and a weak correlation to the C2 proton (9.2 ppm). Again, the 
correlation to the water dissolved in the DMSO is the result of proton 
exchange. 
Figure 3.2.3. 1H-15N HMBC spectrum of histidine methyl 
ester dihydrochloride. 
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This experiment gave us a point to compare with the standard 1H 
NMR of histidine (data not shown). The HC2 of histidine is at 7.79 ppm and 
the HC5 is at 7.05 ppm. The completely protonated histidine methyl ester 
dihydrochloride has peaks that are substantially downfield shifted. This of 
course is expected as the electron poor proton withdraws electron density 
from the aromatic imidazolyl unit. The result being that the HC2 and HC5 of the 
histidine methyl ester dihydrochloride are both deshielded and their 
resonances appear farther downfield, 9.2 ppm and 7.6 ppm respectively. 
With these results we then went forward to another simple imidazolyl system, 
one which would allow us to get resonances for the nitrogen nuclei of 
uncomplexed or unprotonated imidazolyl units. 
2-Tris(N-methylimidazolyl)carbinol (2-TMIC) is readily synthesized and 
has been used as a metalloenzyme’s metal binding active site mimic.36 It has 
a NMR spectrum that is simpler than histidine in that there is no exchange 
possible of protons on the imidazolyl portion. This then should allow for us to 
obtain 1H-15N HMBC spectra of both the free ligand and copper complex. 
 
Figure 3.2.4. 2-Tris(N-methylimidazolyl)carbinol (2-TMIC). 
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The 2-TMIC 1H NMR spectrum in figure 3.2.5 clearly shows the C4 
protons at 6.7 ppm which are clean doublets coupling to the C5 protons at 
6.96 ppm which are of course also doublets. We obtained the expected 
integration of 3:1:1 for the methyl unit, the C4 proton, and the C5 proton. 
Figure 3.2.5. 1H NMR spectrum of 2-tris(N-
methylimidazoyl)carbinol (2-TMIC). 
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In figure 3.2.6, which illustrates the 1H-15N HMBC spectrum of 2-TMIC, 
we can observe two nitrogen nuclei very distinctly. The N1 (166.8 ppm) has a 
strong correlation to the methyl moiety (3.25 ppm) and a strong correlation to 
the C5 proton at 7.15 ppm. Whereas the N3 (168.4 ppm) has the strongest 
correlation to the C4 proton at 6.78 ppm. There may be weak correlations of 
the N1 to the C4 proton and the N3 to the C5 proton, but they would be 
underneath the stronger correlations already identified. Note that the 
difference in the chemical shifts of the protons from figure 3.2.5 and figure 
3.2.6 are due to the referencing. For figure 3.2.5 the reference used was the 
solvent, D2O, and the reference for figure 3.2.6 was TMS.  
We were able to observe distinct nitrogen chemical shifts for each of 
the two nitrogen atoms in the imidazolyl unit in 2-TMIC. In previous 
experiments using histidine and histamine had been unable to observe any 
Figure 3.2.6. 1H-15N HMBC spectrum of 2-TMIC. 
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nitrogen resonances. Using the histidine methyl ester dihydrochloride, we 
had been able to observe the chemical shifts of an imidazolium species. 
However, due to the protonation of the imidazolyl motif of the histidine methyl 
ester dihydrochloride the proton and nitrogen chemical shifts were 
substantially downfield shifted. Covalent attachment of a methyl unit to the N1 
allowed us to overcome the problems that arose from the proton exchange 
and allowed us to visualize the 2-TMIC free ligand.  
Given our success in visualizing 2-TMIC as a free ligand, we then 
proceeded to add one equivalent of Cu+ in the form of copper 
tetrakis(acetonitrile) hexafluorophosphate, Cu(CH3CN)4PF6. Hopefully we 
would be able then to visualize a downfield shift of both the proton and 
nitrogen resonances as a result of metal binding. 
 
Figure 3.2.7. 1H NMR spectrum of 2-TMIC with 
Cu(CH3CN)4PF6. 
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As shown in figure 3.2.7, the 1H NMR spectrum of 2-TMIC with 
Cu(CH3CN)4PF6, we see the C5 protons at 7.05 ppm, the C4 protons at 6.73 
ppm, and the methyl protons at 3.31 ppm. Also present are the acetonitrile 
protons at 1.83 ppm. Notice that the peaks are clearly broader than that of 
the free ligand, and also the coupling information of the imidazolyl protons is 
lost. However, the integration is 1:1:3:4 (3:3:9:12) for the HC4: HC5: Hmethyl: 
Hacetonitrile.  
Curiously, the proton shifts of 2-TMIC are not substantially shifted 
downfield as a result of copper complexation. However, we were able to 
observe line broadening in the one dimensional proton spectrum, which 
would seem to indicate binding as some of the copper may be present as 
Cu(II), which would result in paramagnetic line-broadening or it could result 
from the averaging of signal resulting from the equilibrium exchange of the 
ligand on and off the metal. The strong signal obtained from the acetonitrile 
in the 1H-15N HMBC (not shown) forced a reduction in the gain. This in turn 
led to unsatisfactory results in that we were unable to observe the nitrogen 
nuclei of interest within a reasonable timeframe. Another possible 
explanation for the inability to observe the nitrogen peaks in the 1H-15N 
HMBC was discussed at length by H. Fujii et. al. He noticed that when 
performing NMR experiments on 63Cu and 13C that when weakly binding 
ligands were used, they were unable to observe signal for either the 63Cu or 
the 13C in the ligand binding the copper.124 By switching to a stronger ligand 
(from acetonitrile to carbon monoxide), they were able to once again observe 
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both 63Cu and 13C signal.124 Both hexafluorophosphate and acetonitrile are 
weak ligands, so it remains a possibility that this was a cause for our inability 
to observe signal in the two dimensional 1H-15N HMBC spectrum. 
So we moved to a different source of Cu(I) for investigation of 
imidazolyl motif complex behavior. Copper was added as CuCl2 and then 
reduced in situ by addition of ascorbate. Figure 3.2.8 illustrates the probable 
products of the reduction of a 2-TMIC-CuCl2 complex by ascorbic acid, which 
are the ascorbyl radical, 2-TMIC-CuCl, and an equivalent of hydrochloric 
acid. The results are illustrated in figure 3.2.13, which will be discussed later. 
However, since we are adding another component to the system, we include 
the initial structure (figure 3.2.9) and the 1H NMR spectrum (figure 3.2.10) of 
ascorbic acid. 
 
Figure 3.2.8. Structure of probable products from 2-TMIC-CuCl2 
reduction by ascorbate. (from left) Ascorbyl radical, 2-TMIC-Cu(I) 
chloride, and 1 equivalent of hydrochloric acid. 
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The 1H NMR spectrum (figure 3.2.10) is not very clear, though the 
peaks are quite apparently a triplet at 3.9 ppm, a doublet at 3.55 ppm, and a 
doublet at 1.0 ppm. The diastereotopic protons on the Cε (3.55 ppm) are set 
at two and appear in the expected position. The Cδ proton though in the 
correct position (3.9 ppm) integrates to only half of its expected value. The Cγ 
proton was obscured by solvent so was thus unobserved, though we would 
Figure 3.2.9. Structure of ascorbic acid. 
Figure 3.2.10. 1H NMR spectrum of ascorbic acid. 
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have expected to observe it at around 4.5 ppm. It is unclear what the upfield 
doublet at 1.0 ppm is. Also, the upfield doublet and the downfield triplet are 
significantly less than one.  
Regardless, in a system composed solely of 2-TMIC and ascorbic acid 
(figure 3.2.11), we do not see a significant downfield shift of the imidazolyl 
protons. Here we see the HC4 peak at 6.94 ppm and the HC5 peak at 7.13 
ppm compared to the corresponding resonances in the free ligand (figure 
3.2.6) at 6.78 ppm and 7.15 ppm respectively. The N-methyl remains at 3.28 
ppm. The integration again is in good agreement 1:1:3 for the 2-TMIC portion 
of the spectrum. The contribution of ascorbic acid to the spectrum is in good 
agreement too. The Cδ proton is in the correct position (3.83 ppm) along with 
the Cε protons at (3.52 ppm). The Cγ proton was again obscured by solvent. 
This time the integration of the Cδ proton to Cε protons is the expected 1:2 
and we observe only a slight contribution of the contaminant at 1.0 ppm. 
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Once copper (II) chloride is added to the 2-TMIC and ascorbic acid 
solution in DMSO (figures 3.2.12 and 3.2.13), a dramatic downfield shift of 
the imidazolyl protons is observed; the HC4 peak is found at 7.2 ppm and the 
HC5 peak is found at 7.5 ppm compared to the corresponding resonances in 
the free ligand (figure 3.2.6) at 6.78 ppm and 7.15 ppm respectively. We 
chose to focus solely on the chemical shifts of the imidazolyl protons, 
because we did not have standard spectra for ascorbyl radical, which is 
expected to be the result of the reduction of Cu(II) to Cu(I) by ascorbic acid. 
The integration of peaks in figure 3.2.12 is no longer meaningful as a result 
of the complexation to the copper. The influence of the quadrupolar nucleus 
of the Cu, is known to affect relaxation times. Also as a result of 
complexation of the 2-TMIC to the Cu(I), the coupling of the imidazolyl 
protons to each other was lost. 
Figure 3.2.11. 1H NMR spectrum of 2-TMIC and 
ascorbic acid. 
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In terms of the 1H-15N HMBC spectrum of the complex (figure 3.3.13), 
the N1 signal remains in the same region as the free ligand at 172 ppm and 
strong correlations are observed to the C5 proton at 7.5 ppm and the methyl 
Figure 3.2.13. 1H-15N HMBC spectrum of 2-TMIC with 
CuCl2 and ascorbic acid. 
Figure 3.2.12. 1H NMR spectrum of 2-TMIC, CuCl2, 
and ascorbic acid. 
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protons at 3.4 along with a slightly weaker correlation with the C4 proton at 
7.2 ppm. The N3, which is involved in copper coordination, has been 
substantially shifted downfield to 240 ppm and from 168.4 in the free ligand. 
Also it has only one correlation to the C4 proton at 7.2 ppm. 
 
As summarized in table 3.2.1, one can clearly see downfield shifting of 
resonances of imidazolyl peaks as a result of binding interactions and 
protonation with one exception. The 2-TMIC free ligand has an HC5 peak at 
7.15 ppm. The HC5 peak remains in the same place in the presence of 
ascorbic acid. Although the peak would seem to be upfield shifted when 
Cu(CH3CN)4PF6 is added to the free ligand this is merely the result of 
referencing differences. I should note that the HC5 peak at 6.73 ppm and HC4 
peak at 7.05 ppm of the 2-TMIC with Cu(CH3CN)4PF6 are in nearly the same 
places as that of the 2-TMIC (figure 3.2.5), which was referenced to solvent 
rather that TMS, showing a HC5 peak at 6.7 ppm and a HC4 peak at 6.96 
ppm. It has been noted in previous studies that ligand field is very important 
in NMR investigations of 63Cu and 13C of Cu(I) species.124 It was noted that 
both copper and carbon signals were not present when weakly coordinating 
HC2 HC4 HC5 N1 N3 
histidine methyl ester dihydrocholoride 9.2 7.6 ~190 ~190 
2-TMIC 6.78 7.15 166.8 168.4 
2-TMIC with Cu(CH3CN)4PF6 6.73 7.05 N.P. N.P. 
2-TMIC with ascorbic acid 6.78 7.15 N.P. N.P. 
2-TMIC, CuCl2, and ascorbic acid 7.2 7.5 172 240 
 
Table 3.2.1. Summary of chemical shifts of histidine methyl ester 
dihydrochloride and 2-TMIC NMR studies in ppm. (N.P. - not present) 
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ligands were used, even if it was at only one of the four coordination sites. 
Merely changing the fourth weakly coordinating ligand to a stronger ligand 
resulted in NMR spectra with observable signal for carbon and copper nuclei. 
The 2-TMIC, CuCl2, and ascorbic acid sample has very clear downfield shifts 
of all peaks as a result of complexation compared to the free ligand or even 
the ligand with ascorbic acid. Although all peaks are downfield shifted, 
perhaps the most dramatically different is the N3 peak, which would be the 
peak involved in coordination of the copper ion. It moved from 168.4 ppm in 
the free ligand to 240 ppm in the 2-TMIC, CuCl2, and ascorbic acid system. 
The HC5 peak at 7.5 ppm approaches the 7.6 ppm peak of the histidine 
methyl ester dihydrochloride. This evidence points to the conclusion that in 
the 2-TMIC, CuCl2, and ascorbic acid system, a stable 2-TMIC-Cu(I) complex 
is formed. As the hexafluorophosphate ligand is known to be a comparatively 
much weaker than chloride in terms of its coordination strength, this may 
help to explain why we were able to observe a downfield shift in the 2-TMIC, 
CuCl2, and ascorbic acid system and not in the simple 2-TMIC with 
Cu(CH3CN)4PF6. 
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Given our success with 2-TMIC, namely our ability to observe 
downfield shifts of proton and nitrogen resonances of the imidazolyl units 
when binding Lewis acids, we next moved to a 4-trisimidazolylcarbinol (4-
TIC). 4-TIC is related to 2-TMIC, but incorporates many of the features that 
histidine has, which is illustrated in figure 3.2.14. The attachment at the four 
position of the imidazolyl unit and the possibility of isomerism brought about 
by proton exchange makes this compound much more similar to histidine 
than the 2-TMIC. The 1H NMR spectrum of 4-TIC, as illustrated in figure 
3.2.15, was already very complex as a result of the aforementioned issues of 
exchange and isomerism. One can clearly distinguish three separate peaks 
in the imidazolyl region for each of the protons in the C5(4) and C2 positions. 
The 1H-15N HMBC and HSQC experiments turned out to be of little use as no 
meaningful results were obtained (data not shown) as no peaks were 
observed. This is again due to the isomerism that arises from the N1-N3 
proton exchange. We also attempted to use CPMG-HSQC pulse sequences, 
which often help to observe exchangeable protons. Although we were able to 
Figure 3.2.14. 4-Trisimidazoylcarbinol (4-TIC). 
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see something, a streaked proton resonance at 11.2 ppm, the most intense 
correlation to a nitrogen resonance at 155 ppm was barely greater than the 
noise and thus barely meaningful. The nitrogen peak was in the expected 
place, but the experiment did not seem worth pursuing given the noise level 
that persisted in the spectrum (data not shown). This is likely due to the 
proton exchange of the imidazolyl nitrogen atoms that results in the 4(5) 
isomerism, which occurs on the NMR timescale. 
 
Figure 3.2.15. 1H NMR spectrum of 4-
trisimidazolylcarbinol (4-TIC). 
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As seen with histidine in previous experiments, exhaustive protonation 
proved to yield data concerning the chemical shifts of the nitrogen atoms in 
the imidazolyl unit as illustrated in figure 3.2.16, which is a 1H-15N HMBC 
spectrum of 4-TIC and 3 eq. TFA. We clearly observed a downfield shift of 
the C2 proton to 8.9 ppm and the C5(4) proton to 7.42 ppm. Both nitrogen 
peaks are in the same general area N3 is at 197.5 ppm and N1 is at 183 ppm. 
These assignments are made as a result of the intensity of the correlation 
observed to the C5(4) proton. The N1, having only three bonds between the C5 
proton has a much stronger correlation than the N3, which has 4 bonds 
between the interacting nuclei. 
Figure 3.2.16. 1H-15N HMBC spectrum of 4-TIC and 3 
eq. TFA. 
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Given our ability to obtain clear distinct and interpretable data of the 
NMR experiments when 4-TIC was protonated, we decided to move to metal 
complexation. Again, Cu(II) was reduced in situ with ascorbic acid to produce 
a Cu(I) species. Notice in the 1H NMR spectrum of the complex in figure 
3.2.17, the C2 (9.2 ppm) and C5 (7.5 ppm) protons are now simplified as 
there is no longer any exchange and the ligand is in one form, attached at 
the C4 position to the central carbon. Also the protons have been 
substantially shifted downfield as a result of complexation compared to the 
free ligand (figure 3.2.15). 
Figure 3.2.17. 1H NMR spectrum of 4-TIC, CuCl2, 
and ascorbic acid. 
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In figure 3.2.18 we show the 1H-15N HMBC spectrum of the solution 
mixture of 4-TIC, CuCl2, and ascorbic acid. The N1 (183 ppm) has an intense 
correlation peak with the C2 proton and a weaker peak with the C5 proton. 
The N3 peak (188 ppm), on the other hand, only correlates to the C2 proton. 
Curiously, the N3 peak is not shifted as far downfield when coordinating the 
copper (figure 3.3.18) as it is when protonated by the TFA (figure 3.2.16). For 
the sake of completeness we sought to obtain an 1H-15N HMBC or 1H-15N 
HSQC of the free 4-TIC, so that we might be able to make a statement as to 
how far the nitrogen nuclear resonances shifted. Despite experiments that 
involved changing solvents and sometimes adding base, we were unable to 
obtain acceptable spectra. Even changing to a 1H-15N CPMG-HSQC 
experiment we were unable to get anything other than streaked peak at 11.2 
Figure 3.2.18. 1H-15N HMBC spectrum of 4-TIC, CuCl2, 
and ascorbic acid. 
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ppm across the nitrogen range indicating exchange (not shown). However, 
this was better than previous 1H-15N HSQC, which had no meaningful data. 
 
As summarized in table 3.2.2, we can clearly observe a downfield shift 
of resonances in 4-TIC as a result of complexation or protonation. Histidine 
methyl ester dihydrochloride is included as a reference point. With the 
exception of the free 4-TIC all of the species have chemical shifts of their 
respective resonances in the same region. This is expected because each of 
those species except the free ligand is donating electron density from the N3 
to a relatively electron poor species, whether that be a proton or a Cu(I). 
Figure 3.2.19 is an illustration of the probable complex resulting from 4-TIC, 
CuCl2, and ascorbic acid solution. The downfield shifts of the proton 
resonances compared to that of the free ligand are indicative of binding 
activity. This has been established in both our protonation studies of 4-TIC as 
well as other model complexes (2-TMIC and histidine methyl ester 
dihydrochloride). In addition the metal binding of 2-TMIC with Cu(I) followed 
the same trend. 
HC2 HC5 N1 N3 
histidine methyl ester dihydrocholoride 9.2 7.6 ~190 ~190 
4-TIC 7.5 6.6 N.P. N.P. 
4-TIC, 3 eq. TFA 8.9 7.42 183 197.5 
4-TIC, CuCl2, and ascorbic acid 9.2 7.5 183 188 
 
Table 3.2.2. Summary of chemical shifts of various nuclei in ppm. 
(N.P. - not present) 
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We now decided to move to examine Hst-8 using these and some 
other NMR experiments. We wished to establish that an Hst/Cu complex 
forms in situ. This would add to the evidence already gathered that an Hst/Cu 
complex is responsible for ROS production. As with our model complexes, 
we first attempted a 1H-15N HSQC experiment. Unlike, our model complexes 
we were able to visualize some resonances. Although, as with previous 1H-
15N HSQC experiments on the model complexes, we failed to observe any 
signals originating from nitrogen hydrogen correlations in imidazolyl units. 
We were however able to observe the amido resonances (data not shown). 
We attempted to visualize the imidazolyl protons by protonation with 
TFA. The proton NMR spectra exhibited a marked sharpening as shown in 
figures 3.2.20 and 3.2.21 after 9 equivalents of TFA were added, thus 
leading us to hope for promising results from the 1H-15N HMBC and possibly 
even the 1H-15N HSQC experiments. 
Figure 3.2.19. Probable complex resulting from 
4-TIC, CuCl2, and ascorbic acid solution. 
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Even after addition of 9 equivalents of TFA, we were still unable to 
visualize the imidazolyl proton signals by 1H-15N HSQC, though the amido 
resonances remained unchanged (data not shown). Again we are able to 
observe imidazolyl C2 and C5(4) protons correlating to imidazolyl nitrogen 
Figure 3.2.21. 1H NMR spectrum of Hst-8 + 9 eq. 
TFA in DMSO. 
Figure 3.2.20. 1H NMR spectrum of Hst-8 in DMSO. 
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atoms by means of an 1H-15N HMBC experiment as demonstrated in figure 
3.2.22. HC2 is at 8.98 ppm and the HC5(4) is at 7.35 ppm. Those protons both 
correlate to an imidazolyl nitrogen at 186 ppm. The result is consistent with 
the results obtained from our model complex, histidine methyl ester 
dihydrochloride (figure 3.2.3). For histidine methyl ester dihydrochloride we 
had observed HC2 at 9.2 ppm and HC5(4) at 7.6 ppm both correlate to a single 
imidazolyl nitrogen at 190 ppm. Although we did not visualize resonances 
that correlate to individual imidazolyl units of the four histidine residues it is 
highly likely that they are overlapping. Another possibility is that despite 
addition of 9 equivalents of TFA, not all of the imidazolyl units are protonated. 
As Hst-8 would become more highly charged as a result of TFA addition, it 
becomes more difficult to protonate the various basic sites. So this may 
mean that there are still histidine residues engaging in proton exchange, 
which as we have seen do not appear in 1H-15N HMBC or 1H-15N HSQC 
experiments. 
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Figure 3.2.22. 1H-15N HMBC spectrum of Hst-8 with 9 
eq. TFA in DMSO. 
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Figure 3.2.23 illustrates a calculated structure of Hst-8 that is 
completely protonated. It has been calculated using the semi-empirical AM1 
level of theory. With a total charge of 8+ it is hardly surprising that the 
charged moieties are as distant from each other as possible. The AM1 
calculated structure has adopted a beta sheet. Although this is a calculated 
structure, done for gas phase conditions, the results are consistent with our 
expectations for the solvated structure. Again, the positively charged 
moieties are going to be as distant from each other as possible due to 
Figure 3.2.23. Two views of Hst-8 completely protonated structure 
calculated at the AM1 semi-empirical level of theory (gas phase). The 
back bone has been put in ball and stick, the side chains are wireframe. 
(Colorcode: white – hydrogen, gray – carbon, blue – nitrogen, and red – 
oxygen) 
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electrostatic repulsion. A beta strand is a structure that would certainly move 
charge residues away from each other. The backbone from H3-S8 is fairly 
regular in terms of a beta strand conformation, though it should be noted that 
there is random coil outside this area. We noted in particular the twisting of 
the amide linkages at the N and C terminus ends of the structure. 
 
However, PM3 (figure 3.2.5) and PM3MM (not shown) levels of theory 
were used to generate structures of Hst-8 in its completely protonated form 
as well. However, as illustrated in figure 3.2.24 which illustrates the structure 
Figure 3.2.24. Two views of Hst-8 completely protonated structure 
calculated at the PM3 semi-empirical level of theory (gas phase). The 
back bone has been put in ball and stick, the side chains are wireframe. 
(Colorcode: white – hydrogen, gray – carbon, blue – nitrogen, and red – 
oxygen) 
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of completely protonated Hst-8 as calculated by PM3 semi-empirical level of 
theory, though the protonated moieties have again remained distant from 
each other, there is significantly more twisting of the mostly beta sheet 
structure. Here the beta structure exists only in short stretches, from H3-K5 
and then due to a twisting at K5, another stretch from K5-S8. As in the AM1 
calculated structure we again observe significant disorder at the terminal 
ends of the peptide. That there is general of agreement between the AM1 
PM3 and PM3MM levels of theory in the geometry optimization of Hst-8 
points to the conclusion that either a beta sheet or random coil structure 
exists in the gas phase. Note that the PM3 and PM3MM had only very short 
runs of regular structure and AM1 may weight the beta conformation greatly. 
Calculations at AM1, PM3, and PM3MM were also attempted starting from 
an alpha helix. They were unable to complete as a self consistent field was 
never reached.  
At this point we felt ready to pursue Cu(I)-bound Hst-8. By removing 
protons that would potentially compete for binding with the metal at the 
histidine residues, we believed that metal binding would be made more 
favorable. To this end, we raised the pH to 9 by addition of sodium 
hydroxide, monitored by a pH probe. We then lyophilized the sample and 
dissolved it in DMSO. In the 1-D proton spectrum, figure 3.2.25, we observed 
several broad resonances in the 8-9 ppm region. Such a phenomenon is 
generally indicative of an exchange. This is likely due to imidazolyl units 
undergoing a proton exchange / isomerization. We also noted that despite 
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lyophilization after the pH adjustment, a large quantity of either water or 
hydroxide persists in solution as inferred from large broad peak at 3.4 ppm, 
though we have observed this in prior peptide samples as well. 
 
The 1H-15N HMBC spectrum was acquired, but though it had peaks in 
the imidazole region, they were indistinguishable from noise and we again 
observed streaking (data not shown). The 1H-15N HSQC of the Hst-8 which 
was adjusted to pH 9 and then dissolved in DMSO, as in previous samples, 
had no resonances in the imidazolyl region. However, as the 1H NMR 
spectrum (figure 3.2.25) suggested with its broad peaks, none were expected 
as they were undergoing proton exchange on the NMR time scale (data not 
shown). At this point, Cu(I) was added as Cu(CH3CN)4PF6 to the sample. As 
illustrated in figure 3.2.26, there was a generalized line broadening 
throughout the 1H NMR spectrum. 
Figure 3.2.25. 1H NMR spectrum of Hst-8 adjusted to pH 
9 then lyophilized and dissolved in DMSO. 
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The 1H-15N HSQC and 1H-15N HMBC experiments fared little better. 
The 1H-15N HMBC again had streaking in the imidazolyl region. It also had 
streaking at 3.38 ppm, 2.6 ppm and 2.1 ppm, which is likely due to 
exchanging protons interacting with water in DMSO, DMSO, and acetonitrile 
respectively (data not shown). Thus we were unable to obtain definitive data 
concerning the complexation of Cu(I) to Hst-8 that had been adjusted to pH 
9. However, we can infer binding due to the broadening of imidazolyl related 
signals. 
Figure 3.2.26. 1H NMR spectrum of Cu(CH3CN)4PF6 
and Hst-8 which had been adjusted to pH 9 prior to 
dissolution in DMSO. 
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Table 3.2.3 is a summary of data obtained from 1H NMR and 1H-15N 
HMBC spectra of Hst-8 and other model complexes in a variety of 
environments. We can see that upon protonation or complexation (with the 
exception of the 2-TMIC with Cu(CH3CN)4PF6) that proton and nitrogen 
resonances shift downfield. Upon complexation or protonation, C2 protons (if 
present) shift to the 9.0 ppm region from the 7.5 ppm region and C4 protons 
(if present) shift to the 7.2 ppm region from the 6.7 ppm region. The C5 
protons too show diagnostic shifts upon complexation or protonation. In 4-
TIC they appear at 6.6 ppm yet shift to the 7.5 ppm region upon protonation 
with TFA or complexation with Cu(I) from a CuCl2 and ascorbic acid system. 
In the free 2-TMIC ligand they start at 7.15 ppm and after complexion with 
Cu(I) from a CuCl2 and ascorbic acid system they are shifted downfield to 7.5 
ppm. The nitrogen nuclei also demonstrate a similar trend, that of downfield 
shifting as a result of complexation or protonation. However, since we were 
 HC2 HC4 HC5 N1 N3 
histidine methyl ester dihydrocholoride 9.2 7.6 ~190 ~190 
2-TMIC 6.78 7.15 166.8 168 
2-TMIC with Cu(CH3CN)4PF6 6.73 7.05 N.P. N.P. 
2-TMIC with ascorbic acid 6.78 7.15 N.D. N.D. 
2-TMIC, CuCl2, and ascorbic acid 7.2 7.5 172 240 
4-TIC 7.5 6.6 N.P. N.P. 
4-TIC, 3 eq. TFA 8.9 7.42 183 198 
4-TIC, CuCl2, and ascorbic acid 9.2 7.5 183 188 
Hst-8 and 9 eq. TFA 8.98 7.35 186 186 
 
Table 3.2.3. Summary of chemical shift data from 1H NMR and 1H-15N 
HMBC spectra. (N.P. – not present; N.D. – experiment not done) 
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ultimately unable to see the expected downfield shift of imidazolyl nitrogen 
resonances as a result of coordination of Cu(I) to Hst-8, we decided to 
change to an indirect NMR method for investigation of metal ion coordination 
to Hst-8. 
 
3.3: 1H-13C HSQC 
As has already been demonstrated in the previous section’s work with 
1H-15N HMBC, the protons attached to the carbons on the imidazolyl ring can 
be monitored for evidence of metal ion binding and protonation of the 
imidazolyl motif as demonstrated in the series of figures 3.2.15-3.2.18 in the 
previous section. 4-TIC, which was the subject of study in the 
aforementioned figures, is very similar to the histidine residue. It creates 
isomers simply on the basis of proton exchange and it has attachment at the 
4(5) position. 4-TIC has substantial downfield shifts of both imidazolyl proton 
resonances, particularly that of HC2. As illustrated in figures 3.2.5-3.2.7 2-
TMIC exhibited a marked downfield shift in the nitrogen resonance upon 
binding to Cu(I) as well as movement of the HC4 and HC5 proton resonances. 
Though it would seem it does not complex well with the Cu(CH3CN)4PF6, it 
does complex well with Cu(I) which was formed by the in situ reduction of 
CuCl2 by ascorbic acid. Also, as illustrated in figures 3.2.21, 3.2.24, and 
3.2.25, we observed distinct differences in the 1H NMR spectra of Hst-8 due 
to the differing pH and the presence of metal ion. However, though, by 
inference imidazolyl units are involved in metal binding, we sought more 
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definitive evidence for such an interaction by investigating the carbon 
resonances of the imidazolyl units. 
 
 
The 1H NMR spectrum of the 4-TIC is reproduced above in figure 
3.3.1 to reiterate the point of multiple species being present in the free ligand 
Figure 3.3.1. 1H NMR spectrum of 4-TIC. 
Figure 3.3.2. 1H-13C HSQCAD spectrum of 4-TIC. 
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system. As illustrated in the 1H-13C HSQCAD spectrum of 4-TIC, figure 3.2.2, 
the C2 carbon has multiple resonances all in the 135 ppm region. The HC2 
proton resonances are at 7.60 ppm, 7.54 ppm, and 7.46 ppm. The 
correlations of the C5(4) to the HC5(4) were not able to be observed in this 
experiment. We had expected to observe them in the 6.6 ppm region on the 
basis of the data from the 1H NMR spectrum of 4-TIC (figure 3.3.1). The 
likely reason for being unable to observe them in this experiment is that as 
this 2D experiment is longer than the 1D proton experiment we are losing 
them in the isomerism brought about by proton exchange. 
 
In the 1H-13C HSQCAD spectrum of 4-TIC + 3 eq. TFA (figure 3.3.3), 
we observe a slight downfield shift of the C2 resonance to 141 ppm and its 
associated proton to 8.9 ppm from the free 4-TIC resonances of the C2 at 
135 ppm and the HC2 at 7.60 ppm, 7.54 ppm, and 7.46 ppm as a result of 
addition of 3 equivalents of TFA. Clearly, protonation resulted in the 
Figure 3.3.3. 1H-13C HSQCAD spectrum of 
4-TIC + 3 eq. TFA. 
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resolution of the various forms of 4-TIC (whether they be rotamers or 
isomers) to one form. This downfield shift was of course was expected as we 
had seen similar behavior in previous 1H-15N HMBC experiments (see 
previous section). Now we are able to observe the C5 resonance at 122 ppm. 
Its associated proton moves downfield to the 7.45 ppm region from the 6.6 
ppm region where it was in the free ligand. These assignments are further 
supported by the data shown in figure 3.2.15 which illustrated a strong 1H-15N 
HMBC correlation of the HC2 position to both nitrogen nuclei, but one strong 
and one weak correlation of the HC5 to the individual nitrogen nuclei. 
 
Although we were unable to obtain a satisfactory 1H-13C HSQCAD 
spectrum of a Cu(CH3CN)4PF6 plus 4-TIC sample, as no peaks were 
present, addition of ascorbate to the Cu(CH3CN)4PF6 and 4-TIC solution 
resolves the issue entirely as illustrated in figure 3.3.4. There are two 
Figure 3.3.4. 1H-13C HSQCAD spectrum of 4-TIC + 
Cu(CH3CN)4PF6 + ascorbic acid. 
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correlations. The HC2 peak at 7.96 ppm correlates to the C2 peak at 161 ppm; 
the HC5(4) peak at 7.1 ppm correlates to the C5(4) one at 135 ppm. The C2 and 
its associated proton now on an imidazolyl unit clearly involved in metal 
binding are now farther downfield (figure 3.3.4) than the protonated 4-TIC 
(figure 3.3.3). Though the C5(4) peak has shifted farther downfield to 135 ppm 
upon metal binding compared to the 122 ppm observed for protonation, the 
HC5(4) peak for the metal bound is upfield (7.1 ppm) of the protonated HC5(4) 
(7.45 ppm). We hypothesize that the addition of ascorbate brought about 
these changes as a consequence of it being a stronger ligand for the Hst/Cu 
complex than either the hexafluorophosphate or the acetonitrile. As had been 
observed in model complexes and discussed in the literature, the use of a 
stronger ligand with copper complexes can result in a restoration of signal 
lost as a result of the effects of copper’s quadrupolar nucleus. 
 
Table 3.3.1 presents a summary of NMR data obtained for 4-TIC in a 
variety of environments; as a free ligand, in protonated form, and as a ligand 
to Cu(I). Clearly upon complexation and protonation chemical shifts of 
protons and their corresponding carbons are shifted downfield. This is of 
Table 3.3.1. Summary of 4-TIC NMR chemical shift data in ppm. 
(N.D. – experiment not done; N.P. – not present) 
HC2 HC5 C2 C5 
4-TIC 7.5 6.6 135 N.P. 
4-TIC, 3 eq. TFA 8.9 7.42 141 122 
4-TIC, CuCl2, and ascorbic acid 9.2 7.5 N.D. N.D. 
4-TIC, Cu(CH3CN)4PF6, and ascorbic acid 7.96 7.1 161 135 
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course reasonable as one would expect the electron rich imidazolyl unit to 
donate electron density to the Lewis acidic protons or copper ion. This then 
in turn removes electron density from the imidazolyl unit pushing the 
resonances downfield. What is most curious though is that the 4-TIC, 
Cu(CH3CN)4PF6, and ascorbic acid system has a much smaller shift of 
proton resonances downfield compared to the 4-TIC with TFA and 4-TIC with 
CuCl2 and ascorbic acid, but the carbons are downfield shifted more. A few 
possible explanations exist for this phenomenon. The 4-TIC is likely involved 
in occupying three coordination sites of the Cu(I). There exists then a site 
open for coordination. In the case of the system utilizing CuCl2, a chloride is 
available for coordination. A chloride is a much stronger ligand than either 
acetonitrile or hexafluorophosphate. Previous NMR studies of copper 
complexes have shown that strong ligands are essential for obtaining good 
specta.124 They noted a loss of carbon and copper signal when weak ligands 
were used. Thus the 4-TIC/Cu(I) complex formed by the Cu(CH3CN)4PF6 
alone had no peaks due to there being no available strong ligand. When 
ascorbate was added a stronger ligand was present which enabled a partial 
visualization of the signal from the 4-TIC/Cu(I) complex. However the 
ascorbate ligand is still not as strongly coordinating as others. So there exists 
the possibility that the signal obtained in the 4-TIC, Cu(CH3CN)4PF6, and 
ascorbate system was actually an averaged signal. The 4-TIC/Cu(I) complex 
with the ascorbate as a ligand, which has a downfield shifted signal as a 
result of the copper coordination, is averaged with 4-TIC/Cu(I) complex which 
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does not have the ascorbate ligand and no signal. The other possibility is that 
the 4-TIC/Cu(I)/ascorbate complex simply does not have a very far downfield 
shift of its imidazolyl carbon and hydrogen resonances. 
 
 
Since we had obtained good results that indicated binding of Cu(I) and 
protonation in the 4-TIC model complex using 1H-13C HSQCAD experiments, 
we next looked to investigate the behavior of Hst-8 in similar systems. Prior 
to examining the work done with Hst-8, it is worthwhile to again be reminded 
of how various atoms are identified. Figure 3.3.5 is an illustration of how to 
identify the protons and carbons of amino acids. On the left is phenylalanine 
labeled with its Greek lettering notation. Another aromatic residue that will be 
discussed is tyrosine. Of course, it has similar notation except that a hydroxyl 
unit substitutes for hydrogen at the ζ (zeta) position. The histidine in the 
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Figure 3.3.5. Naming of amino acids. (left) Phenylalanine with 
Greek letters, (middle) histidine with Greek letters, and (right) 
histidine with Greek letters and numbers for imidazolyl motif. 
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middle is labeled using Greek letters. However, in this section we have 
chosen to use the notation on the right, which incorporates the classical 
Greek lettering notation and the organic chemistry numbering approach. The 
reason for this is that the classical Greek lettering is good for static systems, 
but as we have seen already in model system studies the imidazolyl unit 
undergoes proton exchange and the organic chemistry approach to 
numbering the imidazolyl motif acknowledges this phenomenon and allows 
for easier discussion of the system. 
 
As we had been able to observe the carbon attached imidazolyl proton 
in our model complex, 4-TIC, using 1H-13C HSQCAD, we attempted the same 
experiment on Hst-8. Figure 3.3.6 illustrates the 1H-13C HSQCAD of Hst-8 in 
deuterated DMSO. We primarily observe the resonances for the protons 
attached to phenylalanine and tyrosine aromatic motifs. The tyrosine 
Figure 3.3.6. 1H-13C HSQCAD spectrum of Hst-8 
in DMSO. 
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resonances are the Cδ at 141 ppm and its Hδ at 7.0 ppm and the Cε at 125 
ppm and Hε at 6.64 ppm. Whereas the Cζ of the phenylalanine is at 138 ppm 
with the corresponding Hζ is at 7.22 ppm. I am unfortunately not able to 
definitely assign the δ and ε positions in the phenylalanine because of the 
similarity of their proton resonances 7.26 ppm and 7.27 ppm makes it difficult 
to distinguish within reasonable experimental times in a sample at natural 
abundance. Moreover, as we are not particularly interested in those positions 
anyway, it makes little sense to pursue such a line of inquiry. The correlation 
observed between the 128 ppm and 7.26 ppm peaks may be ascribable to 
either the phenylalanine residue or the C5(4) and HC5(4) of the imidazolyl units 
of the histidine residues. Given its movement and disappearance in 
subsequent experiments as well as correlations observed in previous 
experimental series (see previous section), assignment of it as the C5(4) and 
HC5(4) of the imidazolyl unit is most likely. 
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Considering the success of the prior exhaustive protonation 
experiments, we sought to utilize similar methodology with our Hst-8 sample. 
Figure 3.3.7 is the 1H-13C HSQCAD of Hst-8 in DMSO with 9 equiv of added 
TFA. We observe the emergence of the C2 resonance of the imidazolyl motif 
at 144 ppm along with its corresponding HC2 at 8.98 ppm. Given the intensity 
it is likely that there are several histidine residues represented by this peak, 
though we are unable to say for certain which ones. Also, we see that the 
tyrosine and phenylalanine resonances have remained unchanged. Just as 
before, the tyrosine resonances are the Cδ at 141 ppm and its Hδ at 7.0 ppm 
and the Cε at 125 ppm and Hε at 6.64 ppm; the Cζ of the phenylalanine is at 
138 ppm with the corresponding Hζ is 7.22 ppm. Again, I am unfortunately 
not able to definitely assign the δ and ε positions in the phenylalanine as the 
similarity of their proton resonances 7.26 ppm and 7.27 ppm makes it difficult 
Figure 3.3.7. 1H-13C HSQCAD of Hst-8 in DMSO 
+ 9 eq TFA. 
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to distinguish within reasonable experimental times with a natural abundance 
13C sample. Obviously what is missing is the C5(4) and its proton. Given the 
odd peak shape of the 127 ppm by 7.26 ppm peak, as well as the results of 
the 1H-15N HMBC experiment (figure 3.3.8) of the same sample, which 
indicates a correlation to that particular resonance, it is almost certain this is 
the imidazolyl 5(4) peak of possibly several histidine residues. 
 
Figure 3.3.8. 1H-15N HMBC spectrum of Hst-8 with 9 
eq. TFA in DMSO. 
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If instead of adding TFA, one equivalent of Cu(CH3CN)4PF6 is added 
to Hst-8 in DMSO the 1H-13C HSQCAD spectrum shown in figure 3.3.9 was 
obtained. We again can only distinguish peaks from phenylalanine and 
tyrosine. The δ resonances of the tyrosine (135 ppm by 7.0 ppm) are 
observed to decrease in intensity unlike the peak of correlation for the Cε to 
Hε at 120 ppm by 6.66 ppm. In addition, it would seem that one of the peaks, 
which is ascribable to the histidine residues has disappeared. However, we 
clearly observe phenylalanine peaks at 134 ppm and 7.28 ppm and 133 ppm 
and 7.21 ppm. Since we cannot see any of the 5(4) position, it is likely that all 
of the histidine residues are involved with Cu(I) binding in some way. The 
quenching could result from one or a combination of several factors. First, 
any copper present in a Cu(II) form would result in paramagnetic quenching 
of signal, as no external reductant was added to this sample it remains 
Figure 3.3.9. 1H-13C HSQCAD spectrum of Hst-8 
+ Cu(CH3CN)4PF6 in DMSO. 
105 
 
possible that Cu(II) could be present. However, it is far more likely that the 
quenching of signal is the result of exchange. A histidine exchanging with 
another histidine on the peptide would result in a loss of signal if it occurred 
on the NMR timescale. Also, there are protons in the system that compete for 
the basic imidazolyl units with the Cu(I). Hst-8 in this system is already likely 
to have some of its imidazolyl units protonated. In mass spectroscopy 
samples analyzed using MALDI-TOF after isolation on HPLC using 
conditions identical to ours the major protonation state of Hst-8 is +1, 
however, some exists in a +2 state.125 Considering the four imidazolyl units 
competing for the metal just on one peptide strand as well as the possibility 
of inter-strand histidine competition and proton competition with the metal, 
there exist a wide range of exchange possibilities. 
 
Figure 3.3.10. 1H-13C HSQCAD spectrum of Hst-
8 adjusted to pH 9 then dissolved in DMSO. 
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Figure 3.3.10 is the 1H-13C HSQCAD spectrum of Hst-8 adjusted to pH 
9 then dissolved in DMSO. Again we clearly can observe those correlations 
for the tyrosine residue; the Cδ at 141 ppm and its Hδ at 6.88 ppm and the Cε 
at 124 ppm and Hε at 6.58 ppm. We cannot observe the phenylalanine 
correlations due to overlap of the imidazolyl resonances. Given the streaking 
observed in the 1H-15N HMBC of the Hst-8 adjusted to pH 9 then dissolved in 
DMSO sample (data not shown), the peak for the correlation of 7.86 ppm to 
139 ppm is the 2 position of the imidazolyl motifs of the histidine residues. 
We can also see C5(4) and HC5(4) of imidazolyl units at 138 ppm with 7.2 ppm 
and 7.28 ppm and at 145 ppm correlating with 7.45 ppm and 7.52 ppm. As 
we observed streaking in the 1H-15N HMBC spectrum it is likely then there 
remains some exchange.  
 
Figure 3.3.11. 1H-13C HSQCAD spectrum of Hst-
8 adjusted to pH 9 then dissolved in DMSO + 
Cu(CH3CN)4PF6. 
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Considering the shape of the correlation peak observed in the 1H-13C 
HSQCAD spectrum of Hst-8 adjusted to pH 9 then dissolved in DMSO plus 
Cu(CH3CN)4PF6 (figure 3.3.11), it is likely that there are multiple overlapping 
resonances present. Also given the chemical shifts of the resonances as well 
as the fact that metal ion complexation is not likely to involve the aromatic 
motif of the phenylalanine residue, I would assign this to be phenylalanine. 
The tyrosine resonances have disappeared as a result of the combination of 
the high pH and the copper addition. Recall that in the non pH adjusted Hst-8 
sample with copper (I) (figure 3.3.9), the tyrosine resonances persisted. In all 
likelihood, the high pH resulted in a deprotonated phenol unit of the tyrosine 
which allowed for interaction with the copper ion. This in turn resulted in 
signal quenching. Note also, that there are no imidazolyl resonances present. 
It is therefore likely that the histidine residues too are involved with 
complexing the copper (I) ion and are also quenched. 
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We had observed a reemergence of signal in previous trials upon 
addition of ascorbic acid to the system, so we tried such an approach here. It 
worked very well as illustrated in figure 3.3.12. The correspondence peak at 
140 ppm and 7.9 ppm results from a C2–HC2 on the imidazolyl unit of a 
histidine involved in complexation. The phenylalanine peaks remain, though 
they have been slightly moved to 138.5 ppm at 7.39 ppm and 139 ppm at 
7.22 ppm. Unfortunately, these may also be imidazolyl peaks, however since 
1H-15N HMBC experiments to investigate if they were imidazolyl and 1H-13C 
HMBC experiments to investigate if they were phenylalanine did not provide 
a definitive answer, the assignment is unclear. Again we observe that the 
tyrosine residues peaks have completely disappeared. Although the 1H-13C 
HMBC did not have any data save for that of the solvents, DMSO and 
Figure 3.3.12. 1H-13C HSQCAD spectrum of Hst-8 
adjusted to pH 9 then dissolved in DMSO + 
Cu(CH3CN)4PF6 + ascorbic acid. 
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acetonitrile (data not shown), the 1H-15N HMBC (streaked, data not shown), 
indicates that the 7.9 ppm hydrogen resonance is part of an imidazolyl unit. 
 
As illustrated in table 3.3.2, which summarizes the histidine chemical 
shifts (in ppm) of Hst-8 under a variety of conditions, we still encountered a 
great deal of difficulty in probing the imidazolyl units of Hst-8. In +1 to +2 
charged Hst-8 we were unable to detect individual imidazolyl residues; the 5 
position of perhaps an averaged histidine was all that was observable. 
Although the chemical shift of the hydrogen seems to be rather downfield, 
when compared to the free 4-TIC, the upfield chemical shift of the carbon 
combined with the NOESY data in the previous section, as well as other 
published literature79 indicate that this is in fact a 5 position of a histidine 
imidazolyl unit. In all likelihood this is of a protonated histidine, as the 
chemical shifts are similar to that of the Hst-8 with 9 eq. of TFA and the 4-TIC 
with 3 eq. of TFA. Unfortunately, we were unable to detect the 2 position of 
H-HC2 H-HC5 H-C2 H-C5 
Hst-8 Am. 7.3 Am. 128 
Hst-8 and 9 eq. TFA 8.98 7.3 144 127 
Hst-8 with Cu(CH3CN)4PF6 N.P. N.P. N.P. N.P. 
Hst-8 adjusted to pH 9 7.86 7.2 139 138 
7.28 138 
7.45 145 
7.52 145 
Hst-8 pH 9 with Cu(CH3CN)4PF6 N.P. N.P. N.P. N.P. 
Hst-8 pH 9 with Cu(CH3CN)4PF6 with 
ascorbic acid 7.9 Am. 140 Am. 
 
Table 3.3.2. Summary of histidine chemical shifts (in ppm) of Hst-8 
under a variety of conditions. (N.P. – not present; Am. – ambiguous) 
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any imidazolyl unit in free Hst-8. However, we were able to visualize it, as 
well as the 5 position, in the Hst-8 with 9eq. of TFA solution. Here the 
chemical shifts match up nicely to those of our model 4-TIC with 3 eq. TFA.  
We were unable to detect any relevant resonances when we added 
Cu(CH3CN)4PF6 to Hst-8. When the Hst-8 was adjusted to pH 9, several new 
resonances were observed. Given the correlations of two protons to one 
carbon in the 1H-13C HSQCAD spectrum, the assignment is made to the 5(4) 
positions. This was observed in prior experiments illustrated in the spectra of 
4-TIC (figures 3.3.1 and 3.3.2). As previously mentioned, 4-TIC, like histidine 
residues, can undergo facile isomerization by proton exchange between the 
nitrogen on the imidazolyl unit. An alternative explanation is that these are in 
fact unique resonances of the 5 positions of the four histidine residues of Hst-
8. Nonetheless, we were also able to observe the C2 and the HC2 of a 
histidine’s imidazolyl unit at 139 ppm and 7.86 ppm respectively. Despite our 
success with the pH 9 adjusted Hst-8 sample, we were unable to visualize 
any imidazolyl resonances when Cu(CH3CN)4PF6 was added to Hst-8, which 
had been adjusted to pH 9. When ascorbic acid was added to the Hst-8, 
which had been adjusted to pH 9, / Cu(CH3CN)4PF6 sample, we were able to 
observe an imidazolyl C2-HC2 correlation at 140 ppm and 7.9 ppm. Although 
the ascorbic acid addition to the Hst-8 pH 9 with Cu(CH3CN)4PF6 
undoubtedly added protons to the system, it did not adjust the pH enough to 
return the Hst-8 to the monocationic state of the initial sample because we 
were clearly unable to visualize the tyrosine’s phenolic protons like we were 
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able to in the Hst-8 with Cu(CH3CN)4PF6 in DMSO sample. It is likely that the 
additional proton equivalent became involved with the amino-ammonium 
equilibrium. 
 
 
Although histidine residues of Hst-8 seem to have the most dynamic 
role in the environments examined for metal complexation and protonation, 
we noted over the course of our studies that the tyrosine residue also seems 
to play a role in metal complexation as the data in table 3.3.3 suggests. We 
found the tyrosine to be insensitive to the various pH environments tested 
except under conditions of high pH with copper. Note that the +1 / +2 
charged Hst-8, the Hst-8 with 9 eq. of TFA, and Hst-8 that was adjusted to 
pH 9 all had Cδ, Hδ, Cε, and Hε at 141 ppm, 7 ppm, 125 ppm, and 6.6 ppm 
respectively. However, addition of Cu(CH3CN)4PF6 to Hst-8 results in an 
upfield shift of the carbon resonances, the Cδ moved from 141 ppm to 135 
ppm and the Cε moved from 125 ppm to 120 ppm. Curiously though, the 
protons proved to be mostly insensitive to the addition. However, in the high 
Y-Cδ Y-Hδ Y-Cε Y-Hε 
Hst-8 141 7 125 6.6 
Hst-8 and 9 eq. TFA 141 7 125 6.6 
Hst-8 with Cu(CH3CN)4PF6 135 7 120 6.7 
Hst-8 adjusted to pH 9 141 6.9 124 6.6 
Hst-8  pH 9 with Cu(CH3CN)4PF6 N.P. N.P. N.P. N.P. 
Hst-8  pH 9 with Cu(CH3CN)4PF6 with 
ascorbic acid N.P. N.P. N.P. N.P. 
 
Table 3.3.3. Summary of NMR data in ppm of the tyrosine residue in 
Hst-8 under a variety of conditions. (N.P. – not present) 
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pH environments the data, or rather the lack of data allows for interpretation. 
As none of the resonances were observed, this leads us to the conclusion 
that the tyrosine residue is deprotonated and involved with copper ion 
coordination in the two samples that have both high pH and copper ion. 
 
Group Proton 
Shift 
for 1 
eq. 
Cu(I) 
Shift 
for 0 
eq. 
Cu(I) difference 
K1 α 3.72 3.71 -0.01 
K1 β Am. 1.65 N.M. 
K1 γ Am. 1.46 N.M. 
K1 δ Am. 2.73 N.M. 
K1 ε Am. 1.29 N.M. 
F2 N 8.63 8.62 0.00 
F2 α 4.58 4.57 -0.02 
F2 β1 2.80 2.80 -0.01 
F2 β2 3.01 3.01 0.00 
F2 2,6H 7.27 N.P. N.M. 
H3 N N.P. 8.63 N.M. 
H3 α N.P. 4.63 N.M. 
H3 β1 Am. 2.96 N.M. 
H3 β2 Am. 3.06 N.M. 
E4 N 8.19 8.22 0.03 
E4 α 4.28 4.29 0.00 
E4 β1 1.75 1.75 0.00 
E4 β2 1.89 1.89 0.00 
E4 γ 2.26 2.26 0.00 
K5 N N.P. 8.24 N.M. 
K5 α N.P. 4.20 N.M. 
K5 β1 Am. 1.59 N.M. 
Table 3.3.4. Summary of resonances of protons in Hst-8 with 1 eq. 
Cu(CH3CN)4PF6 in DMSO compared to Hst-8 in DMSO. (N.M. - not 
meaningful; Am. – ambiguous; N.P. - not present) 
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K5 δ Am. 1.50 N.M. 
K5 ε N.P. 2.74 N.M. 
H6 N 8.34 8.33 -0.01 
H6 α N.P. 4.57 N.M. 
H6 β1 2.96 2.95 -0.01 
H6 β2 Am. 3.04 N.M. 
H6 4H Am. 7.33 N.M. 
H7 N N.P. 8.32 N.M. 
H7 α N.P. 4.63 N.M. 
H7 β1 N.P. 2.95 N.M. 
H7 β2 N.P. 3.06 N.M. 
S8 N 8.26 8.29 0.03 
S8 α 4.31 4.30 0.00 
S8 β1 N.P. 3.61 N.M. 
S8 β2 3.57 3.56 -0.02 
H9 N 8.38 8.39 0.01 
H9 α 4.62 4.63 0.01 
H9 β1 2.97 2.98 0.02 
H9 β2 3.10 3.11 0.01 
R10 N 8.19 8.16 -0.02 
R10 α 4.27 4.26 -0.01 
R10 β1 1.68 1.67 -0.01 
R10 β2 3.07 3.07 0.00 
R10 γ 1.50 1.49 -0.01 
R10 NH1 7.56 7.61 0.06 
G11 N 8.29 8.31 0.02 
G11 α 3.74 3.73 0.00 
Y12 N 8.21 8.22 0.00 
Y12 α 4.34 4.35 0.00 
Y12 β1 2.75 2.75 0.00 
Y12 β2 2.91 2.90 0.00 
Y12 2,6H 6.99 6.99 0.00 
Y12 3,5H 6.64 6.64 0.00 
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Table 3.3.4 was drawn from the conformational studies of Hst-8 by 
NOESY, ROESY, and TOCSY experiments and will be discussed in chapter 
4.3 in greater detail. However, it does contain data, which is important in the 
metal binding studies. Firstly one can notice that we observe chemical shifts 
for the phenylalanine amide proton (F2HN) in the Hst-8 sample with the Cu(I). 
Such an observation necessarily precludes ACTUN like binding on the part of 
Hst-8. Recall that ACTUN like binding would involve the amino terminus, the 
nitrogen atoms of the first two amide linkages of the peptide and the 
imidazolyl unit of the histidine residue in the third position. In the classical 
ACTUN model the first residue is an aspartic acid. Other data to note is that 
the chemical shifts of the vast majority of Hst-8 are not affected very much at 
all as a result of metal binding. The obvious conclusion is that those 
particular residues that are not dramatically shifted are not involved in metal 
ion binding. Also those resonances that disappear are likely involved in metal 
ion binding. Though one would initially expect a mere downfield shift in 
residues involved in metal ion binding, a loss of signal points to a different 
conclusion. Namely that metal ion binding is not very tight and an equilibrium 
on and off the metal is occurring on the NMR time frame. The data with 
respect to which residues are involved in metal ion binding fit with our 
hypothesis as to where the metal likely binds: the histidine residues in the 3, 
6, and 7 positions. The equilibrium exchange on and off the metal not only 
affects the chemical shifts of the imidazolyl units of the residues, but also the 
beta, alpha, and amide protons as a consequence of the conformational 
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changes occurring resulting from the metal binding equilibrium. Granted this 
is not conclusive evidence, but the data certainly fits the hypothesis. 
 
 
Presented in figures 3.3.13 and 3.3.14 are molecular mechanics 
minimized structures of Hst-8 complexed to copper via its H3, H6, and H7 
residues. The copper’s fourth ligand is water. The difference between the two 
Figure 3.3.13. Structure of Hst-8/Cu complex and a water ligand. 
Minimized with UFF MM (gas phase). The Hst-8 was initially a beta sheet. 
(Colorcode: white – hydrogen, gray – carbon, blue – nitrogen, red – 
oxygen, and peach - copper) 
Figure 3.3.14. Structure of Hst-8/Cu complex and a water ligand. 
Minimized with UFF MM (gas phase). The Hst-8 was initially an alpha 
helix. (Colorcode: white – hydrogen, gray – carbon, blue – nitrogen, red – 
oxygen, and peach - copper) 
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structures is the starting points of the minimization. For figure 3.3.13, the 
starting point was Hst-8 in a beta strand. Hst-8 initially was in an alpha helix 
for the result of the calculation illustrated in figure 3.3.14. Unfortunately, we 
were unable to obtain a final minimized structure at PM3 level of theory for 
either starting point. Figure 3.3.13 is obviously unstructured; meaning that 
there are no beta strand or alpha helical secondary structures. In the first part 
of the structure the complexing histidine residues are a tight turn. The beta 
strand structure in the last half as well has been disrupted. Notice that the 
amide functionalities on the H9 residue are clearly not that of either a beta 
strand or alpha helix. Similarly, the secondary structural elements of the 
structure illustrated in 3.3.14 have been disrupted. Beta strand elements can 
be observed between H7-H9. 
The unstructured nature of the Hst-8 when bound with copper as 
determined by computational chemistry methods is certainly in line with our 
interpretation of figure 4.3.1 (Part of the NOESY spectrum of Hst-8 and Cu(I) 
in DMSO illustrating amide alpha and amide beta interactions) and the rest of 
the conformational data. We found in our analysis of the conformational data, 
Chapter 4, that Hst-8 is unstructured when it is complexed with copper. Also 
supporting the idea of exchange, that of multiple conformations, was the 
interpretation of figure 4.3.1. The lack of peaks in the alpha amide region for 
the H3-H7 region, as summarized in table 3.3.4, is the result of exchange of 
the ligating histidine residues on and off the metal. When copper (I) is tightly 
bound such as in prior studies121-123 and our studies on model complexes the 
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imidazolyl resonances were downfield shifted. We also observed downfield 
shifts of proton, nitrogen, and carbon resonances of imidazolyl units when 
those units were protonated.  
Exchange can result in many types of spectral changes. Amino proton 
peaks are broad and often not observed as a result of proton exchange. 
Conformational exchange often results in signal averaging and the averaged 
signal is also often broad. A common solution to this problem is lowering the 
temperature of sample. This technique results in the separation of the 
averaged peak into two distinct separate peaks. However, as our sample 
was already at 20ºC, the hopes of freezing out two conformations as close to 
the DMSO freezing point, 18.5ºC, was unlikely. Nonetheless, such examples 
demonstrate the effects of exchange upon NMR spectra. Such illustrative 
examples of exchange then help to rationalize our conclusions as to the 
location and nature of ligation of the Hst-8 to the copper. 
 
3.4: EPR Studies on Copper(II)-Hst-8 
As aforementioned, EPR studies have been used to investigate metal 
ligand environments.119, 126, 127 We sought to utilize this tool to investigate the 
metal binding environment of Cu(II) with Hst-8. As before, we used model 
complexes to test our experimental techniques and setup. Although we can 
clearly see the EPR signal for the unpaired electron in the copper, there is no 
discernable hyperfine coupling (hfc) in the 2900-3100 g region. 
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Similar results were also obtained for a Cu(II)-2-TMIC complex in that 
no hfc was discernable (data not shown). We had undertaken many different 
attempts to improve resolution and adapt our experiments to the equipment. 
The apparatus used was a liquid nitrogen dewar, which due to boil off, shifted 
the sample inside the microwave cavity which resulted in noise. Also as 
bumping was a problem scan times were shortened. Multiple scans were 
taken and averaged to improve signal to noise. We also attempted less 
conventional measures such as smaller samples, which we considered, as 
water (the solvent) may be absorbing radiation and resulting in a loss of 
sensitivity. Despite our many attempts to visualize an hfc in copper 
complexes, we were unable to obtain satisfactory results and this line of 
inquiry was abandoned. 
 
Figure 3.4.1. EPR spectrum of Cu(II) bis L-histidine complex. 
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3.5: Experimental Section 
 
3.5.1: General NMR Procedure, Materials, and Methods 
A Varian Unity/Inova 400 MHz system upgraded to VNMRS with an 
auto-tunable Dual Broadband 15N-31P {1H} PFG probe utilizing the VNMRJ 
software suite for collection and processing or a Varian VXR 500 MHz 
system upgraded to VNMRS with a triplet resonance 1H{13C/15N} PFG probe 
utilizing VNMRJ software suite for collection and processing was employed. 
Samples were maintained at 20ºC for the duration of the experiment. Prior to 
collection of 2D homonuclear or heteronuclear experiments each sample had 
its 90º pulsewidth (PW90) determined, which then was input as a parameter 
into subsequent experiments. 
For experiments involving air and moisture sensitive copper(I) 
species, including those species that were reduced in situ, samples were 
placed in a J. Young NMR tube (600 MHz glass, Wilmad Labglass). This 
allowed the sample to be maintained under inert atmospheric conditions 
(either argon or nitrogen). Also manipulation of Cu(CH3CN)4PF6 was done in 
a glovebox (VAC model MO-M). 
Histatin-8 was purchased as a crude solid phase preparation product 
(55-60% purity depending on batch) from the Molecular Biology Proteomics 
Facility of the University of Oklahoma Health Sciences Center. It was isolated 
and purified by HPLC by dissolving the sample in a small volume of 0.1% 
TFA/water and injection onto a C18 RP-Prep-HPLC column (Biorad 
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BioLogic). Elution with a linear solvent gradient from 100% water (0.1% TFA) 
to 60% H2O (0.1% TFA) / 40% 4:1 acetonitrile:H2O (0.1%TFA) (4 mL/min) 
over 74 min afforded Hst-8 with a typical retention time of 9 min. The Hst-8 
fraction was determined by ESI-MS. 
L-Ascorbic acid (99+% A.C.S. reagent), 
tetrakis(acetonitrile)copper(I)hexafluorophosphate, and L-histidine methyl 
ester dihydrochloride (97%) were obtained from Aldrich. Copper chloride 
hexahydrate (analytical reagent) from Mallinkrodt. L-Histidine was obtained 
from Matheson, Coleman, & Bell. Sodium hydroxide (ACS grade pellets) was 
obtained from EMD. Trifluoroacetic acid (99% extra pure) was obtained from 
Acros. Dimethylsulfoxide-D6 (D 99.9%) was obtained from Cambridge 
Isotope Laboratories. 
4-Trisimidazoylcarbinol (4-TIC) was the generous gift of Jerome 
Volkman who synthesized it by a published procedure.128 
2-Tris(N-methylimidazoyl)carbinol (2-TMIC) was synthesized via 
literature procedure.36 
For experiments involving adjustment to pH 9 prior to dissolution in 
DMSO, first a solution of dilute sodium hydroxide was made that was 
approximately 0.01 M. The sample was dissolved in DD/DI water and the pH 
of the solution was monitored by pH meter. The NaOH solution was added 
drop wise until pH 9.0 was obtained. The sample was then lyophilized and 
dissolved in DMSO. 
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3.5.2: 1H-15N HMBC 
A 3 Hz J was input and the experimentally obtained PW90 was input 
as parameters for collection. For observing imidazolyl motif nitrogen nuclei a 
decoupler offset frequency (dof) was routinely set at 120 ppm (on the 400 
MHz instrument in DMSO d6 this corresponds 695.4 Hz). 
 
3.5.3: 1H-15N HSQC 
Here a J value of 93 Hz was used as well as the experimentally 
collected PW90 parameter. The dof was again routinely set at 120 ppm. 
 
3.5.4: 1H-13C HSQCAD 
For these experiments a J value of 200 Hz was used as well as the 
experimentally collected PW90 parameter. The dof was not altered from the 
standard experimental settings. 
 
3.5.5: EPR Studies 
In a typical experiment the reactants were mixed in an Eppendorf 
tube. These were then transferred to a quartz 4mm tube cell and placed in a 
dewar containing liquid nitrogen in the microwave cavity. The instrument was 
a Bruker EMX EPR system using an ER041XG X-band microwave bridge 
and an ER4102ST microwave cavity. Spectra were collected using the 32-bit 
WinEPR ver. 4.32 Rev. 10 software from Bruker. Typical spectral acquisition 
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parameters for the experiment were modulation frequency 100 kHz; 
modulation amplitude 1.0 G; microwave power 10 mW; amplifier time 
constant 0.1 s; and filed sweep rate 1500 G / 80 s. The static field was set at 
3480 G and the center of the field set at 3250 G. Generally, 1 scan was 
collected and then the data was exported to Microsoft Excel where it was 
averaged and combined to generate spectra. The concentration of the 
copper species was generally 5 mM in the sample. 
 
3.5.6: Computational Chemistry Methods 
ArgusLab (ArgusLab 4.0.1 written by Mark A. Thompson of Planaria 
Software LLC, Seattle, WA (http://www.arguslab.com)) was used for 
molecular mechanics calculations, PM3 calculations that involved metals, 
and AM1 calculations that involved metals. 
For PM3 and AM1 calculations, as well as PM3MM and higher levels 
of theory Gaussian 03 was used.129 
Results from both computational suites were visualized and exported 
to JPEG files using Gaussview (Gaussian, Inc., Wallingford CT 
http://www.gaussian.com) or ArgusLab. 
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Chapter 4: Conformation Studies 
 
4-1: Introduction 
The conformation of the Hst is of interest because as aforementioned 
in the introductory chapter many proteins’s activity depends greatly on its 
conformation. Hst’s mode of action of antimicrobial activity on the basis of 
pore formation was ruled out. This was done not only on the basis of the 
studies with lysomes,24, 25 the observation that active transport is required for 
uptake16, 17 and the observation that only a few intracellular species are 
observed to have an increase in extracellular fluids upon Hst exposure,19, 20 
but also in part due to the conformational studies already done on both Hst-
578 and Hst-8.79 
As we have shown in previous work a Hst-copper complex can in a 
reducing environment produce ROS.70 As has been illustrated with the 
previous NMR and CD work on Hst, the ability for Hst to adopt a helical 
conformation in membrane mimicking solvents has been positively correlated 
to its antimicrobial activity. Given the labile pool of copper in the cellular 
environment that Hst could potentially recruit a copper ion from, as well as a 
gap in the scientific literature about the conformation of Hst in the presence 
of metal ion; we sought to undertake such a study. Of course the 
conformation of peptides has been studied by X-ray crystallography, NMR, 
CD, and even vibrational spectroscopies. Each of these techniques has its 
own strengths and weaknesses. We choose to use NMR as it would give us 
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a solution state structure that was highly detailed. CD can only indicate the 
presence or absence of helical structures and X-ray characterization requires 
a crystal. Histatin’s high solubility as well as the potential for peptide 
aggregation precluded such an investigation. 
 
Hst-5 has had its conformation studied in a number of solvents by 
different methods. In aqueous systems as investigated by circular dichroism, 
CD, Hst-5 was observed to be unstructured (random coil) over a pH range of 
3.8 to 8.3.81 Similar results were also obtained using NMR, though they 
restricted their measurements to pH 3.8.78 It has also been determined that 
in DMSO Hst-5 adopts an alpha helical conformation both by CD and 
NMR.78, 81 Chain length and composition has been shown to be influential in 
this behavior of transitioning between unstructured in aqueous environments 
and alpha helical in DMSO. As chain length and composition have also been 
shown to affect the antimicrobial activity of histatins and various histatin-like 
derivatives, a study was done that correlates these factors to the ability to 
undergo a conformational transition from unstructured in an aqueous system 
to alpha helical in DMSO. The study using CD found that those derivatives 
and analogues that underwent transition similar to that of Hst-5 were more 
active than those that did not.80, 81, 130 These findings then support the idea 
Hst-5: Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr 
Hst-8:                                                            Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr 
Figure 4.1.1. Primary structures of Hst-5 and Hst-8. 
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that the ability to adopt an alpha helical structure may be important in the 
functioning of Hst-5 as an antimicrobial agent. 
Just as Hst-5 has been shown to undergo a conformational transition, 
Hst-8 has also been shown by NMR to undergo a conformational transition 
from a beta-pleated structure in an aqueous environment to an alpha helix in 
a less polar solvent system.79 In this study Hst-8 was adjusted to pH 4.0 and 
then either used directly as an aqueous NMR sample or else freeze dried 
and then dissolved in the desired solvent. Just as with Hst-5, they observed 
that Hst-8 did not adopt an alpha helix in a simple aqueous environment. 
However, unlike Hst-5, Hst-8 did not adopt an alpha helical conformation in 
DMSO. Hst-8 did adopt an alpha helical conformation in a solvent system 
containing 40% hexafluoroacetone (HFA), 55% H2O and 5% D2O. A major 
difference between DMSO and HFA is the dielectric constant of the solvents. 
DMSO has a dielectric constant of 47.2 and a dipole moment of 3.96. HFA is 
significantly less polar with a dielectric constant reported between 2.4 and 
1.9 and a dipole moment of between 0.61 and 0.64.131 Of course, HFA will 
react with water to form the corresponding gem-diol,132 so the actual nature 
of the 40% HFA / 60% aqueous solvent system used in the NMR study is not 
such a clear system to interpret. This is especially true given that formation of 
the gem-diol results in the release of one equivalent of proton. So the pH 
adjustment to 4.0 prior to addition of this solvent system is fairly meaningless 
as the solvent system itself is highly acidic. Nonetheless they were able to 
observe a conformational transition to an alpha helix on the basis of 
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alteration of the solvent environment. 
The Hst conformation is likely to play a role in its ability to recruit and 
complex metal ions. As a beta strand or simply unstructured, the residue side 
chains capable of engaging in metal binding activities are far apart. Thus 
such a conformation would preclude chelation as other ligating moieties are 
distant. However, a change in conformation could bring metal ligating 
moieties in close proximity, which would favor chelation. An alpha helical 
conformation would certainly be a structure that would favor metal ion 
chelating activities. Shown in figure 4.1.2 is monocationic Hst-8 in a beta 
strand. Notice that the histidine residues’ imidazolyl units are distant from 
one another. The only possibility for chelation to occur is with the H7 and H9 
residues. The H6 residue is on the other side of the molecule and H3 is quite 
distant. However, that same monocationic Hst-8 in an alpha helical 
conformation has three histidine residues in close proximity. 
 
Figure 4.1.2. Monocationic Hst-8 in a beta strand. (Colorcode: white – 
hydrogen, gray – carbon, blue – nitrogen, and red – oxygen) 
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Figure 4.1.3 illustrates one view of monocationic Hst-8 where the 
helical axis is in the plane of the page. The majority of the molecule is in tube 
display form. However, to clearly indicate the imidazolyl units and highlight 
their proximity, they have been displayed in ball and bond form. Figure 4.1.4 
illustrates another view of monocationic Hst-8 where the view is down the 
helical axis. The majority of the molecule is in tube display form. However, to 
clearly indicate the imidazolyl units and highlight their proximity, they have 
been displayed in ball and bond form. 
Figure 4.1.3. Monocationic Hst-8 in an alpha helical form. Imidazolyl units 
of histidine residues 3, 6, and 7 are in ball and bond display form the 
remainder is in tube display form. (Colorcode: white – hydrogen, gray – 
carbon, blue – nitrogen, and red – oxygen) 
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Metal ion interaction itself could potentially drive the conformational 
change from random coil or beta sheet to alpha helix. The increase in 
entropy by displacement of ligands to the copper could offset the entropy lost 
by reduction of the degrees of freedom available to the peptide in addition to 
enthalpy gains. This is not to say that histidine coordination in an alpha 
helical peptide to metal ions is the only possibility for the conformation of the 
peptide that results from the metal ion binding. As discussed in the 
introductory section, a histidine residue in the 3 position along with amide 
nitrogen atoms can interact with metal ions at the N terminus. This mode of 
biding is known as ACTUN type binding In addition nitrogen residues on 
lysine and arginine as well as carboxylate units can interact with cationic 
Figure 4.1.4. Monocationic Hst-8 in an alpha helical form looking down 
the helical axis. Imidazolyl units of histidine residues 3, 6, and 7 are in ball 
and bond display form the remainder is in tube display form. (Colorcode: 
white – hydrogen, gray – carbon, blue – nitrogen, and red – oxygen) 
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species. 
NMR has a host of techniques for the purposes of studying 
conformation in solution.78, 79, 133 Many are based around the Nuclear 
Overhauser Effect, or NOE. Key to the technique is the observed 
phenomenon of nuclear spin transfer through space. This spatial transfer of 
spin occurs only across short distances of about 5 Å or less. Additionally the 
intensity and time required for spin transfer are both proportional to the 
distance through space. Thus protons that are in closer proximity will transfer 
spin faster and the intensity of the spin transferred will be of greater 
compared to protons that are more remote. In addition protons that will have 
a greater average time spent in close proximity will demonstrate a greater 
NOE compared to those that can more freely move away. NOESY 
experiments then can investigate the spatial relationship of protons by 
observation of NOE signals and assignments can be made of relative 
positions be variation of the mixing times when spin transfer is allowed to 
occur. A similar technique, which takes advantage of the same phenomenon, 
is ROESY. This technique however utilizes a rotating frame so that it is 
possible to differentiate between actual spatial positions of close proximity 
and close proximity that is gained as a result of exchange. In this experiment 
NOE that is a result of exchangeable protons will be in the opposite phase of 
NOE that is solely the result of close proximity. Of course before one can 
begin to assign spatial data, the specific resonances must be assigned. 
In a system such as Hst-8, the assignment of individual resonances is 
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made substantially more difficult as a result of overlap of signals. This is due 
in large part to the fact that the environments are so similar. The best 
examples of this are the 4 histidine residues and the 2 lysine residues that 
are present in the peptide. Are the protons at the alpha position on the 
peptide backbone going to be substantially dissimilar let alone those protons 
on the imidazolyl motifs of the histidine residues? In order to differentiate 
these very similar proton environments from one another, other techniques 
are employed. Total correlation spectroscopy (TOCSY) is a technique that 
tracks spin information through proton-proton J type couplings. In this way 
spin systems can be isolated investigated and quantified. This particular 
experiment is very well suited for peptide investigation as there is no inter-
residue couplings because there are no protons on the amide carbon. 
However, because resonance systems are not part of aliphatic spin systems, 
one cannot for example see correlation in the TOCSY from the alpha proton 
of histidine into the imidazolyl motif. Figure 4.1.5 illustrates the TOCSY 
signals observed. Note that the amino terminus does not have a correlation 
with the alpha proton. In solution the protein is in its zwitterionic form, so the 
amino-terminus is actually an ammonium terminus. In this form these acidic 
protons can engage in exchange with other acidic protons, basic sites, or 
perhaps solvent. As proton exchange is a very fast chemical process the 
relatively slower process of NOE spin exchange (ms) cannot be observed. 
Also the protons on the delta and epsilon carbons do not have observable 
correlations due to exchange of the imidazolyl attachment that arises from 
131 
 
the protonation state of the two nitrogen atoms in the motif. Though TOCSY 
works very well for amino acids that have only aliphatic carbons, one must 
use other techniques to probe amino acids with aromatic residues. NOESY 
then can aid us in assigning these systems. Additionally, though TOSCY can 
aid in making intra-residue assignments, NOESY can be used to make inter-
residue assignments.  
 
Figure 4.1.6 illustrates some of the more important NOESY 
correlations for assignment of resonances. Notice the correlation of the beta 
protons into their respective resonance systems on both the His and Phe. 
Also the alpha proton on the His has a correlation to the amide proton on the 
Phe. Of course additional NOESY correlations are possible, however, the 
figure merely provides hypothetical correlations as an illustration of principle. 
A final major technique that is useful in residue assignments is the 
heteronuclear single quantum coherence (HSQC). Here the connectivity of 
Figure 4.1.5. TOCSY correlations 
in a His-Phe dipeptide. 
Figure 4.1.6. NOESY correlations 
in a His-Phe dipeptide. 
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different atomic nuclei is investigated across one bond. Figure 4.1.7 
illustrates correlations observed in a 1H-13C HSQC experiment. 1H-15N 
HSQC experiments are also possible and they will be explored in a later 
chapter for purposes of metal ion binding studies. 
 
Once the residue assignments have been made then the next step is 
determination of the spatial relationship of those now assignable protons to 
each other. The assignments that are the most important at this point are the 
inter-residue correlations, particularly those of side chain interactions. After 
the assignments have been made the peak intensity data is obtained. As 
aforementioned the spatial proximity and amount of time spent in spatial 
proximity have a direct effect of the intensity of correlation in NOESY and 
ROESY experiments. MARDIGRAS, which stands for matrix analysis of 
relaxation for discerning the geometry of an aqueous structure, is a program 
that was developed at the University of California San Francisco that will 
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Figure 4.1.7. 1H-13C HSQC 
correlations in a His-Phe dipeptide. 
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generate distance constraints using a computer model and NOESY intensity 
data. Another program that was used for generating spatial restraint data and 
eventually outputting a molecular dynamic generated structure is 
crystallography and NMR system (CNS or CNSsolve), which was developed 
at Yale., CNS has the option of utilizing internally generated restraint data 
from NOESY correlations or they can be generated from MARDIGRAS and 
used in CNS MD simulations. Regardless of the method used the lowest 
energy conformation of the structure is output from CNS using the restraint 
data input. 
 
4.2: Assignment of Proton Resonances Hst-8 in DMSO d6 
The first major undertaking in assigning the proton resonances of the 
various 2D spectra that were collected stem from the amide-alpha proton 
interaction section. Comparison of the TOCSY spectrum to the NOESY 
spectrum allows for identification of inter-residue NOESY interactions which 
are critical to the technique of NOESY jumping. The NOESY jump enables 
easy identification of residue order. One thing that made identification easier 
for our analysis was that prior studies had already assigned many of the 
proton resonances albeit under different solvent and pH conditions as 
aforementioned in the introduction to this chapter. So overlay of the TOCSY 
spectrum on the NOESY spectrum identified which peaks in the NOESY 
amide region were inter-residual. Figure 4.2.1 is part of the NOESY spectrum 
of Hst-8 in DMSO illustrating amide alpha and amide beta interactions. We 
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can clearly observe large poorly resolved peaks in the 7.8 ppm, 8.1 ppm, 8.9 
ppm, and 9.3 ppm regions.  
 
Figure 4.2.2 is part of the ROESY spectrum of Hst-8 in DMSO 
illustrating amide alpha and amide beta interactions. We clearly observed 
that those are exchanging proton peaks as they are not present in the 
ROESY spectrum. Also it was expected given the peak broadness. To further 
the point of exchange we observe that they are absent in figure 4.2.3, part of 
the TOCSY spectrum of Hst-8 in DMSO, which illustrates the same region. 
Figure 4.2.1. Part of the NOESY spectrum of Hst-8 in DMSO illustrating 
amide alpha and amide beta interactions. 
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The place at which an exchangeable proton would be observed in the alpha 
region of the NOESY spectrum of Hst-8 in DMSO (figure 4.2.1) would be the 
proton exchanging on the amino terminus of the K1 with the K1Hα. As the N-
terminal lysine only has one inter-residual correlation, that of the K1Hα to 
F2HN the correlation peak at 3.71 ppm and 8.62 was fairly easily identifiable. 
Further evidence for the assignment of the K1Hα resonance would be that 
K1Hβ protons would have no amide correlation. This is illustrated in figures 
4.2.7, 4.2.8, and 4.2.9 which are the NOESY, ROESY, and TOCSY spectra 
of Hst-8 in DMSO respectively. A final factor was the upfield chemical shift of 
the K1Hα, as a consequence of not being next to an amide motif. Returning 
to the spectra illustrated in figures 4.2.1, 4.2.2, and 4.2.3, we then move 
along the F2HN axis to the F2Hα-F2HN peak at 4.57 ppm and 8.62 ppm. We 
should have then moved to the F2Hα-H3HN peak, however, there was no 
such peak to identify in the NOESY or ROESY spectra. We made the 
identification of the H3HN resonance using the TOCSY spectrum, figure 4.2.3 
as the full NOESY spectrum. 
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The TOCSY spectrum, figure 4.2.3, illustrates the H3HN–H3Hα, H3HN-
H3Hβ1, and H3HN-H3Hβ2 peaks. To confirm that these were histidine beta 
protons we used NOESY data (not shown), which illustrated the imidazolyl 
protons correlating to the beta protons. The position was confirmed by 
performing a NOESY jump to the E4HN from the H3Hα illustrated in figure 
4.2.1 and obviously from there to the E4HN-E4Hα peak. This was confirmed 
by the ROESY spectrum, figure 4.2.2; however, the intense peaks in the 
TOCSY spectrum (figure 4.2.3) of the tyrosine and arginine amide alpha 
Figure 4.2.2. Part of the ROESY spectrum of Hst-8 in DMSO illustrating 
amide alpha and amide beta interactions. 
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correlations obscured the glutamate amide alpha peak. The carboxylate unit 
of the glutamate residue allowed for easy identification in the TOCSY as 
illustrated in figure 4.2.7, which shows the correlation of E4Hγ to E4Hα. So 
this combined evidence confirms the assignment of the E4HN-E4Hα. We 
were unable to NOESY hop from the E4Hα to the K5HN as the region in the 
area was filled with other peaks. So the K5HN-K5Hα correlation was 
confirmed using other spectra, back correlating to either the K5HN or the 
K5Hα. This was fairly easy to accomplish as few residues had extended 
aliphatic chains, those of K1, K5, and R10. Figure 4.2.7 and 4.2.9 the 
NOESY and TOCSY spectra of Hst-8 in DMSO respectively, clearly 
illustrated the Hα-Hβ and Hα-Hδ correlations of the lysine in the fifth position. 
We then comparing the data of the NOESY and TOCSY spectra (figures 
4.2.1 and 4.2.3), NOESY jumped from the K5 to the H6. This allowed for 
easy identification of the H6HN-H6Hα. The H7 was unfortunately completely 
obscured by the H6. So at this point we worked backward from the tyrosine 
to reach the H7 resonances. Gratifyingly, we could easily NOESY jump all 
the way back to the H7 from the Y12 using only the NOESY and TOCSY 
spectra (figures 4.2.1 and 4.2.3). Now the entire backbone of the peptide was 
assigned (as well as a few other resonances). Using the horizontal lines from 
the alpha amide correlations, one could then assign the beta amide 
correlations in figures 4.2.1, 4.2.2, and 4.2.3 the NOESY, ROESY, and 
TOCSY spectra respectively of Hst-8 in DMSO. 
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Figure 4.2.3. Part of the TOCSY spectrum of Hst-8 in DMSO illustrating 
amide alpha and amide beta interactions. 
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Figures 4.2.4, 4.2.5, and 4.2.6, which are the NOESY, ROESY, and 
TOCSY spectra respectively of Hst-8 in DMSO illustrate the area where 
some alpha-beta correlations occur. These assignments were made by 
laying vertical lines in the area illustrated in figures 4.2.1, 4.2.2, and 4.2.3 
which are again the NOESY, ROESY, and TOCSY spectra respectively of 
Hst-8 in DMSO, which illustrate the alpha and beta protons correlating with 
amide protons. In addition horizontal lines were drawn from the areas that 
represent the reciprocal correlations of the areas illustrated in figures 4.2.1, 
4.2.2, and 4.2.3. At the intersections of these lines then assignments are 
made at clear peaks. Thus the alpha-beta correlations are assigned. 
Figure 4.2.4. Part of the NOESY spectrum of Hst-8 in DMSO illustrating 
alpha beta proton interactions. 
140 
 
 
 
Figure 4.2.5. Part of the ROESY spectrum of Hst-8 in DMSO illustrating 
alpha beta proton interactions. 
Figure 4.2.6. Part of the TOCSY spectrum of Hst-8 in DMSO illustrating 
alpha beta proton interactions. 
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Figures 4.2.7, 4.2.8, and 4.2.9 are the NOESY, ROESY, and TOCSY 
spectra respectively of Hst-8 in DMSO, which illustrate the alpha protons of 
aliphatic residues K1, K5, and R10 correlating to various resonances in the 
residue. These correlations were already discussed at length earlier in the 
section. 
Figure 4.2.7. Part of the NOESY spectrum illustrating alpha beta and 
alpha other interactions of Hst-8 in DMSO. 
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Figure 4.2.8. Part of the ROESY spectrum illustrating alpha beta and 
alpha other interactions of Hst-8 in DMSO. 
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Figure 4.2.9. Part of the TOCSY spectrum illustrating alpha beta and 
alpha other interactions of Hst-8 in DMSO. 
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Figures 4.2.10, 4.2.11, and 4.2.12 are NOESY, ROESY, and TOCSY 
spectra respectively of Hst-8 in DMSO illustrating the aromatic proton region. 
The correlation that is clearly identifiable is the Y12Hδ-Y12Hε peak. Not only 
is this clearly identifiable by its characteristic shift, but we also confirmed this 
assignment by observing NOESY correlations of the Y12Hδ to the Y12Hβ and 
Y12Hα protons (data not shown). Unfortunately the phenylalanine 
Figure 4.2.10. Part of the NOESY spectrum illustrating aromatic proton 
interactions of Hst-8 in DMSO. 
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correlations in the region of 7.2 ppm (illustrated in the previous chapter in 
figures 3.3.6, which was a 1H-13C-HSQC spectrum of Hst-8 in DMSO) are 
obscured by the exchange of protons on the various imidazolyl motifs. The 
exchange is clearly illustrated in figure 4.2.11, the ROESY spectrum of Hst-8 
in DMSO that illustrates the aromatic region. Clearly the three bands in the 
7.0 ppm, 7.1 ppm, and 7.2 ppm regions are the opposite phase of the real 
correlation peak the Y12Hδ-Y12Hε. The band at 7.2 ppm could certainly 
obscure the phenylalanine peaks. 
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Figure 4.2.11. Part of the ROESY spectrum illustrating aromatic proton 
interactions of Hst-8 in DMSO. 
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Figure 4.2.12. Part of the TOCSY spectrum illustrating aromatic proton 
interactions of Hst-8 in DMSO. 
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Figure 4.2.13 is a section of the NOESY spectrum of Hst-8 in DMSO 
illustrating some miscellaneous proton interactions. The peaks are not able 
to be definitively assigned as they result from the imidazolyl units interacting 
with various beta protons. As shown in figure 4.2.14, a ROESY spectrum of 
Hst-8 in DMSO that illustrates the same region, they are absent as a result of 
their proton exchange and resulting isomerization. 
Figure 4.2.13. Part of the NOESY spectrum illustrating miscellaneous 
proton interactions of Hst-8 in DMSO. 
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Figure 4.2.15 is the TOCSY spectrum of Hst-8 in DMSO illustrating 
the same region as figures 4.2.13 and 4.2.14. In this we can see some of the 
protons attached to nitrogen atoms of various residues interacting with 
aliphatic protons.  
Figure 4.2.14. Part of the ROESY spectrum illustrating miscellaneous 
proton interactions of Hst-8 in DMSO. 
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Figure 4.2.15. Part of the TOCSY spectrum illustrating miscellaneous 
proton interactions of Hst-8 in DMSO. 
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This 
study 
pH 4.0 
DMSO79 
pH4.0 
water79 
40% 
HFA79 
K1 N 
α 3.71 3.74 3.96 4.00 
β 1.65 1.69 1.85 1.87 
γ 1.29 1.33 1.39 1.43 
δ 1.46 1.56 1.68 1.73 
ε 2.73 2.77 2.98 3.05 
F2 N 8.62 8.64 8.46 8.07 
α 4.57 4.61 4.56 4.57 
β1 2.80 3.07 3.01 3.12 
β2 3.01 2.84 3.09 
2,6H 7.29 7.23 7.27 
3,5H 7.33 7.36 
H3 N 8.63 8.63 8.46 8.07 
α 4.63 4.65 4.50 4.59 
β1 2.96 3.06 3.05 3.11 
β2 3.06 3.00 3.18 3.28 
4H 7.62 7.23 
E4 N 8.22 8.18 8.52 8.04 
α 4.29 4.32 4.18 4.41 
β1 1.75 1.81 1.93 2.04 
β2 1.89 1.94 2.07 2.16 
γ 2.26 2.31 2.30 2.54 
K5 N 8.24 8.29 8.12 8.16 
α 4.20 4.25 4.09 4.40 
β1 1.59 1.65 1.73 1.85 
β2 1.80 1.96 
γ 1.34 1.40 1.51 
δ 1.50 1.54 1.68 1.74 
ε 2.74 2.77 2.98 3.04 
εNH2 6.85 7.50 
H6 N 8.33 8.34 7.15 8.72 
α 4.57 4.58 4.52 
Table 4.2.1. Summary of the individual resonances identified in Hst-8 in 
DMSO (this study) as well as a summary of previously published work of 
Hst-8 in a variety of solvents79. 
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β1 2.95 3.10 3.06 3.39 
β2 3.04 3.00 3.18 
4H 7.33 7.31 7.43 
H7 N 8.32 8.34 7.15 8.72 
α 4.63 4.58 4.52 
β1 2.95 3.10 3.06 3.39 
β2 3.06 3.00 3.18 
4H 7.31 7.43 
S8 N 8.29 8.33 8.81 8.42 
α 4.30 4.35 4.41 4.53 
β1 3.61 3.65 3.83 3.90 
β2 3.56 3.94 
H9 N 8.39 8.40 8.74 8.45 
α 4.63 4.65 4.66 4.77 
β1 2.98 3.15 3.11 3.20 
β2 3.11 3.02 3.20 3.33 
4H 7.34 7.31 
R10 N 8.16 8.19 8.48 8.23 
α 4.26 4.29 4.26 4.36 
β1 1.67 1.72 1.70 1.79 
β2 1.74 1.85 
γ1 1.49 1.52 1.46 1.64 
γ2 1.56 
δ 3.07 3.11 3.06 3.19 
NH1 7.61 6.98 6.96 
G11 N 8.31 8.35 8.52 8.13 
α1 3.73 3.78 3.81 3.92 
α2 3.96 4.00 
Y12 N 8.22 8.23 7.60 7.70 
α 4.35 4.39 4.36 4.67 
β1 2.75 2.79 2.89 3.02 
β2 2.90 2.95 3.06 3.16 
2,6H 6.99 7.03 7.03 7.13 
3,5H 6.64 6.67 6.85 
 
Table 4.2.1 summarizes my work in identifying unique chemical 
resonances of Hst-8 in DMSO and compares it with previously published 
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work.79 There is fairly good agreement between the data I was able to obtain 
and interpret from my Hst DMSO sample and the previously published work 
which was Hst-8 pH adjusted to 4.0 and dissolved in DMSO. However, I was 
unable to definitively assign the 4H of histidine residues 3, 7, and 9. I was 
also unable to definitively assign two resonances at 7.26 ppm and 7.27 ppm 
to either the 2,6H or 3,5H of phenylalanine. We were unable to observe a 
NOE correlation of the 2,6H to the beta protons of the phenylalanine. One 
last assignment that I was unable to make was the Hγ of the fifth lysine, 
which may be the result of overlap of the Hγ of the first lysine or that of 
another resonance. Nonetheless the assignment was fairly complete and 
certainly included the important backbone resonances. These backbone 
resonances are perhaps the most critical in determining if secondary 
structural elements are present. 
 
4.3: Assignment of Proton Resonances of Hst-8 with Cu(I) in DMSO d6 
With the free Hst-8 resonances assigned the next phase was to add 
Cu(I) and then look at its effect upon the various NMR spectra and by 
extension the conformation of the peptide. One equivalent of 
Cu(CH3CN)4PF6 was then added to the Hst-8 in DMSO sample. This was 
kept under a nitrogen atmosphere to prevent oxidation of the copper to the 
paramagnetic Cu(II). Illustrated in figures 4.3.1, 4.3.2, and 4.3.3 are the 
NOESY, ROESY, and TOSCY NMR spectra of Hst-8 and Cu(I) in DMSO 
illustrating amide alpha and amide beta interactions. Once again we go 
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through the same process as before. However, it is quite apparent at first 
glance comparing figure 4.2.1 to figure 4.3.1 that the addition of copper has 
had a pronounced effect upon the NOESY spectrum. Namely, we observe a 
broadening or eliminating peaks throughout the spectrum particularly in the 
central region of residues, H3-H7. 
 
Figure 4.3.1. Part of the NOESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating amide alpha and amide beta interactions. 
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The correlation peak for the F2HN-K1Hα remains in the same place as 
the metal free series. Further the beta protons of the phenylalanine are in the 
same place. These assignments were for the most part very easy. In fact that 
is the major trend observed throughout the study of the Hst-8 with Cu(I) in 
DMSO. This trend is apparent in table 4.3.1, a summary of resonances of 
protons in Hst-8 with 1 eq. Cu(CH3CN)4PF6 in DMSO compared to Hst-8 in 
DMSO. One of the major things we observed in figure 4.3.1 was that not only 
do we not observe the peaks correlating the alpha protons to amide protons 
from neighboring residues in the region from the H3 to the H9, but we also do 
not observe the intra-residue correlations of the alpha and amide protons. 
Further, these correlations are also absent in the ROESY and TOCSY 
spectra illustrated in figures 4.3.2 and 4.3.3 respectively.  
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Figure 4.3.2. Part of the ROESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating amide alpha and amide beta interactions. 
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Given what was observed in the previous chapter discussing the 
coordination of the Hst-8 peptide to the metal, the data combined speaks to a 
coordination that is not very tight and is undergoing dynamic exchange. 
Unfortunately, isothermal calorimetry studies have not been performed on 
Figure 4.3.3. Part of the TOCSY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating amide alpha and amide beta interactions. 
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Hst-8 to evaluate either Cu(I) or Cu(II) binding. The closest approximation 
that we have is the values given for the binding of Cu(II) by Hst-5.71 Using a 
single site model the binding constant was found to be 2.6x107. However, as 
aforementioned there are actually three distinct moieties that often engage in 
metal ion binding; the ACTUN motif and two His-X-Y-Z-His motifs. Using a 
multisite model the researchers determined the binding constants to be 
3.8x105, 1.2x104, and 5.2x104. However, they made no comment as to which 
site correlated to which binding constant. Of course, copper (II) is not copper 
(I) Cu(I) prefers tetrahedral geometry and is softer and larger than Cu(II), 
which prefers square planer geometry. 
The loose binding causes residues H3, H6, and H7 to be exchanging 
on and off the metal. This in turn results in a loss of NMR signal as the ligand 
exchange occurs more quickly than the millisecond timescale on which these 
NMR experiments are preformed. The loss of signal can result from one or a 
combination of several conditions. Firstly metal binding can cause nearby 
proton residues to shift. An averaging can then result moving the signal to 
unexpected places. Also the averaging causes signal broadening. If the shift 
then is large enough the peak then can be averaged over such a large range 
that it is indistinguishable from noise. Also one should consider that metal 
binding, particularly dynamic metal binding could result in a conformation 
whereby the interresidual correlations are unable to be observed simply by 
the fact that those alpha and amide protons are not in close proximity. Lastly 
of course, remains the possibility remains that protons, particularly amide 
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protons, are not observed as a result of ACTUN like binding interactions with 
the metal. Though we feel that this is unlikely given our observation of the 
phenylalanine amide proton, we would be remiss if we did not mention the 
possibility. One of the strongest indications we are dealing with an exchange 
phenomenon of the conformation involving the H3 residue is that no distinct 
alpha amide proton correlation is observed in figure 4.3.3, the TOCSY 
spectrum of Hst-8 with Cu(I) in DMSO. Further, we observe large amorphous 
areas in the region where we had expected to observe many of our missing 
correlations. As TOCSY relies on J couplings to transfer spin information, a 
change in coupling conditions by means of dynamic conformation could give 
rise to broadened peaks. 
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Figures 4.3.4, 4.3.5, and 4.3.6 are the NOESY, ROESY, and TOCSY 
spectra, respectively, of Hst-8 and Cu(I) in DMSO illustrating alpha beta and 
other proton interactions. As before lines were drawn from those resonances 
that had been definitively assigned in the alpha amide and beta amide 
region. At the intersections of those lines drawn from alpha and beta 
resonances the peaks were definitively assigned.  
Figure 4.3.4. Part of the NOESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating alpha/beta and other proton interactions. 
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Although we suspected the assignments of the unassigned 
correlations in figures 4.3.4, 4.3.5, and 4.3.6, we were regrettably unable to 
definitively assign them. Definitive assignment of the correlation peaks in the 
2.0 ppm to 1.5 ppm range of the ω2 axis to either the K1 or K5 was 
impossible. This was because without the alpha and amide peaks of K5 the 
rest of the residue’s resonances are impossible to trace. However, these 
aliphatic resonances have little to do with being able to construct a picture of 
the global conformation of the Hst-8 peptide upon metal binding, particularly 
Figure 4.3.5. Part of the ROESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating alpha beta and other proton interactions. 
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those observed in figure 4.3.6, the TOCSY spectrum of Hst-8 and Cu(I) in 
DMSO, which contains no spatial information. 
 
Figure 4.3.6. Part of the TOCSY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating alpha beta and other proton interactions. 
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Figure 4.3.7. Part of the NOESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating histidine exchange. 
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Figures 4.3.7, 4.3.8, and 4.3.9 illustrate the NOESY, ROESY, and 
TOCSY spectra, respectively, of Hst-8 and Cu(I) in DMSO suggesting 
histidine exchange. Figure 4.3.8, the ROESY spectrum, is the best illustration 
of this as it clearly shows the peak to be in the opposite phase and thus 
arises from a situation that has exchange involved. This fits into the larger 
Figure 4.3.8. Part of the ROESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating histidine exchange. 
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picture that the imidazolyl units of the various histidine residues are not 
statically bound to the copper ion on the NMR timescale. 
 
Figure 4.3.9. Part of the TOCSY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating histidine exchange. 
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Figure 4.3.10 is part of the ROESY spectrum of Hst-8 and Cu(I) in 
DMSO illustrating the aromatic region. It again illustrates the histidine 
exchange observed in figure 4.3.8. Exchanging protons or protons on an 
exchanging motif like the C2 protons on histidine are found in the negative 
phase of ROESY spectra. Alternatively they can also disappear from the 
spectrum. We observe evidence of histidine exchange in two places, first the 
Figure 4.3.10. Part of the ROESY spectrum of Hst-8 and Cu(I) in 
DMSO illustrating the aromatic region. 
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correlation peak in the negative phase at 8.0 ppm and 8.9 ppm as well as the 
negative phase region from 6.7 ppm to 7.4 ppm that obscures the 
phenylalanine Hδ and Hε correlation. However, we are able to observe in 
both figure 4.3.10 and figure 4.3.11, part of the TOCSY spectrum of Hst-8 
and Cu(I) in DMSO illustrating the aromatic region, including the aromatic 
protons of the tyrosine. 
 
Figure 4.3.11. Part of the TOCSY spectrum of Hst-8 and Cu(I) in 
DMSO illustrating the aromatic region. 
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Figure 4.3.12. Part of the NOESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating miscellaneous proton interactions. 
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Figure 4.3.13. Part of the ROESY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating miscellaneous proton interactions. 
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Figure 4.3.14. Part of the TOCSY spectrum of Hst-8 and Cu(I) in DMSO 
illustrating miscellaneous proton interactions. 
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Figures 4.3.12, 4.3.13, and 4.3.14 are the NOESY, ROESY, and 
TOCSY spectra of Hst-8 and Cu(I) in DMSO illustrating miscellaneous proton 
interactions. From the data obtained in the ROESY spectrum illustrating 
histidine exchange and the aromatic region, figures 4.3.10 and 4.3.8 
respectively, we believe that the unassigned correlation peaks are those of 
imidazolyl units of histidines correlating to beta protons of their respective 
residues. However, because we were unable to assign alpha amide 
correlations of H3, H6, and H7, we were ultimately unable to definitively 
assign the beta protons either. However, here again, assigning these at this 
point was of no consequence, because there would be no effect on the 
global conformation if restrictions were not assigned to these as the 
connectivity of the imidazolyl unit to the beta carbon is set by consequence of 
the carbon connectivity. 
 
Group Proton 
Shift 
for 1 
eq. 
Cu(I) 
Shift 
for 0 
eq. 
Cu(I) difference 
K1 α 3.72 3.71 -0.01 
K1 β Am. 1.65 N.M. 
K1 γ Am. 1.46 N.M. 
K1 δ Am. 2.73 N.M. 
K1 ε Am 1.29 N.M. 
F2 N 8.63 8.62 0.00 
F2 α 4.58 4.57 -0.02 
Table 4.3.1. Summary of resonances of protons in Hst-8 with 1 eq. 
Cu(CH3CN)4PF6 in DMSO compared to Hst-8 in DMSO. (N.M. - not 
meaningful; Am. – ambiguous; N.P. - not present) 
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F2 β1 2.80 2.80 -0.01 
F2 β2 3.01 3.01 0.00 
F2 2,6H 7.27 N.M. 
H3 N N.P. 8.63 N.M. 
H3 α N.P. 4.63 N.M. 
H3 β1 Am. 2.96 N.M. 
H3 β2 Am. 3.06 N.M. 
E4 N 8.19 8.22 0.03 
E4 α 4.28 4.29 0.00 
E4 β1 1.75 1.75 0.00 
E4 β2 1.89 1.89 0.00 
E4 γ 2.26 2.26 0.00 
K5 N N.P. 8.24 N.M. 
K5 α N.P. 4.20 N.M. 
K5 β1 Am. 1.59 N.M. 
K5 δ Am. 1.50 N.M. 
K5 ε N.P. 2.74 N.M. 
H6 N 8.34 8.33 -0.01 
H6 α N.P. 4.57 N.M. 
H6 β1 2.96 2.95 -0.01 
H6 β2 Am. 3.04 N.M. 
H6 4H Am. 7.33 N.M. 
H7 N N.P. 8.32 N.M. 
H7 α N.P. 4.63 N.M. 
H7 β1 N.P. 2.95 N.M. 
H7 β2 N.P. 3.06 N.M. 
S8 N 8.26 8.29 0.03 
S8 α 4.31 4.30 0.00 
S8 β1 N.P. 3.61 N.M. 
S8 β2 3.57 3.56 -0.02 
H9 N 8.38 8.39 0.01 
H9 α 4.62 4.63 0.01 
H9 β1 2.97 2.98 0.02 
H9 β2 3.10 3.11 0.01 
R10 N 8.19 8.16 -0.02 
R10 α 4.27 4.26 -0.01 
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R10 β1 1.68 1.67 -0.01 
R10 β2 3.07 3.07 0.00 
R10 γ 1.50 1.49 -0.01 
R10 NH1 7.56 7.61 0.06 
G11 N 8.29 8.31 0.02 
G11 α 3.74 3.73 0.00 
Y12 N 8.21 8.22 0.00 
Y12 α 4.34 4.35 0.00 
Y12 β1 2.75 2.75 0.00 
Y12 β2 2.91 2.90 0.00 
Y12 2,6H 6.99 6.99 0.00 
Y12 3,5H 6.64 6.64 0.00 
 
Table 4.3.1 was drawn from the conformational studies of Hst-8 by 
NOESY, ROESY, and TOCSY. It contains data, which is important not only 
in the conformational analysis but also in the metal binding studies as 
discussed earlier. As discussed in the prior chapter, one can notice that we 
observe a resonance for the phenylalanine amide proton (F2 N) in the Hst-8 
sample with the Cu(I). Such an observation necessarily precludes ACTUN 
like binding on the part of Hst-8. Other data to note is that the chemical shifts 
of the vast majority of Hst-8 are not affected very much at all as a result of 
metal binding. The obvious conclusion is that those particular residues that 
are not dramatically shifted are not involved in metal ion binding. Also those 
resonances that disappear are likely involved in metal ion binding. Though 
one would initially expect a mere downfield shift in residues involved in metal 
ion binding, a loss of signal points to a different conclusion. Namely that 
metal ion binding is not very tight and an equilibrium on and off the metal is 
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occurring on the NMR time frame. The data in the respect of which residues 
are involved in metal ion binding fit with our hypothesis as to where the metal 
likely binds: the histidine residues in the 3, 6, and 7 positions. The equilibrium 
exchange on and off the metal not only affects the chemical shifts of the 
imidazolyl units of the residues, but also the beta, alpha, and amide protons 
as a consequence of the conformational changes occurring resulting from the 
metal binding equilibrium. Granted this is not conclusive evidence, but the 
data certainly fits the hypothesis. 
In terms of analysis of the remainder of the data related to the 
conformational analysis. The inability to locate the amide peak for the lysine 
of the fifth position affected our ability to definitively assign the aliphatic 
chains that correlated together to either the lysine in the first position or the 
fifth position. This was really the only major obstacle encountered that 
resulted in the inability to assign a great number of peaks. The reason for our 
inability to observe the amido proton of the K5 results from the dynamic 
conformation of the backbone starting at the H3 and ending at the H7. The 
dynamic conformation is a result of the weak interaction of the H3, H6, and 
H7 with the metal ion. 
 
4.4: Use of MARDIGRAS for Creation of Spatial Constraints 
After obtaining the raw spatial information of Hst-8 in DMSO and that 
of the Hst-8 and Cu(I) in DMSO in the form of NOESY and ROESY spectra, 
we then sought to perform a conformational analysis. First we needed to 
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generate boundary restraint data from the raw NOESY and ROESY peak 
intensities. We used MARDIGRAS and its suite of helper programs to 
generate boundary restraint data.134-138 One initially begins with a model. We 
choose to utilize two models as starting points. Our first model was Hst-8 in 
an alpha helix and the second model was Hst-8 as a beta strand. From there 
MARDIGRAS output boundary restraint data. MARDIGRAS is a program that 
takes NOESY intensity data and translates it to spatial restraint data. First a 
model is input and MARDIGRAS makes initial measurements of distances 
between protons with identified NOESY correlations. It then weights the 
intensity data from most to least intense. Finally, it generates spatial restraint 
data such that the intense correlations have minimal distances and the 
weaker correlations have comparatively longer restraint distances. It does 
this by using the starting model and then performing minimizations according 
to the weighted restraint data. The final data are output in the following 
format. The first and third columns are specific proton locations on residues 
identified in the second and fourth columns. The distance between the two 
protons in a row is defined by the lower and upper boundaries identified in 
the fifth and sixth columns respectively. The width is the distance between 
the lower and upper boundaries. 
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Figure 4.4.1 is a graphical illustration of the process described in detail 
above. The raw NOESY data contains two pieces of information the specific 
contacts between protons and the intensity of that contact correlation. 
CORMA (complete relaxation matrix analysis) has a model structure input 
into it. It then creates restraint information by measuring the distance 
between protons identified by the contact data from the NOESY spectrum 
(light green arrow). This initial structure with its identified restraints is then fed 
into MARDIGRAS along with the intensities of all the proton correlations 
identified in the NOESY spectrum (light blue arrows). MARDIGRAS then 
weights the NOESY data according to intensity and minimizes the restraints 
in the CORMA processed structure according to the weighting. MARDIGRAS 
then outputs restraint data (dark blue arrow). Both the restraints that 
Figure 4.4.1. A graphical illustration of the information flow and 
processing done to generate restraint data from NOESY data using 
MARDIGRAS and its helper program, CORMA. 
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MARDIGRAS has determined to be ideal, as well as an upper and lower 
boundary for those restraints are output. Tables 4.4.1 and 4.4.2 summarize 
the upper and lower boundaries obtained for Hst-8 in DMSO. Table 4.4.1 is 
that obtained when CORMA had an initial model of Hst-8 in an alpha helix 
input and Table 4.4.2 is data obtained when a beta strand conformation of 
Hst-8 was input into CORMA. 
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ATOM_i ATOM_j LOW_BNDS UP_BNDS WIDTH 
QB K1 HA K1 4.341 5.543 1.202 
H F2 HA K1 4 4.713 0.713 
HA F2 H F2 3.419 3.926 0.507 
HB1 F2 H F2 3.94 5.035 1.096 
HB2 F2 H F2 3.694 4.267 0.573 
HB2 F2 HA F2 1.911 1.962 0.051 
HA H3 H H3 2.711 2.822 0.111 
HB1 H3 H H3 2.91 3.196 0.287 
HB1 H3 HA H3 2.326 2.352 0.026 
HB2 H3 HA H3 2.247 2.27 0.023 
HA E4 H E4 2.272 2.301 0.03 
HB1 E4 HA E4 2.015 2.08 0.065 
QG E4 HB1 E4 4.231 5.548 1.317 
QG E4 HB2 E4 3.924 4.873 0.95 
HA K5 H K5 1.678 1.701 0.023 
QD K5 HA K5 2.398 2.482 0.084 
H H6 HA K5 1.589 1.621 0.031 
HA H6 H H6 1.808 1.836 0.028 
HB1 H7 H H7 2.047 2.121 0.074 
H S8 HA H7 2.098 2.117 0.019 
HB1 S8 H S8 2.117 2.16 0.043 
H H9 HA S8 1.948 1.965 0.017 
H H9 HB2 S8 3.042 3.336 0.294 
HA H9 H H9 2.052 2.085 0.033 
HB1 H9 H H9 1.939 1.997 0.058 
HB1 H9 HA H9 2.291 2.32 0.029 
HB2 H9 HA H9 2.196 2.245 0.049 
H R10 HA H9 3.214 3.498 0.283 
H R10 HB1 H9 2.949 3.132 0.183 
H R10 HB2 H9 2.828 2.971 0.143 
HA R10 H R10 2.299 2.328 0.03 
QB R10 HA R10 2.621 2.687 0.066 
QG R10 HA R10 3.041 3.135 0.094 
Table 4.4.1. Summary of boundary data from MARDIGRAS using the 
peak intensity data from Hst-8 in DMSO using an alpha helix as a 
starting model. Note that Q is a variable that substitutes for methylene 
and R is a variable indicating its position on a ring. 
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QD R10 HA R10 4.429 6.997 2.568 
QD R10 QG R10 5.005 5.646 0.641 
HE R10 QD R10 4.307 5.696 1.389 
H G11 HA R10 2.372 2.407 0.035 
HA Y12 H Y12 1.896 1.921 0.026 
HB1 Y12 HA Y12 3.008 3.527 0.52 
HB2 Y12 H Y12 1.873 1.933 0.06 
RD Y12 HB1 Y12 4.028 4.87 0.842 
RE Y12 RD Y12 4.161 5.061 0.9 
 
 
ATOM_i ATOM_j LOW_BNDS UP_BNDS WIDTH 
QB K1 HA K1 4.273 5.432 1.158 
H F2 HA K1 3.641 4.302 0.661 
HA F2 H F2 3.449 3.941 0.492 
HB1 F2 H F2 3.938 5.001 1.063 
HB2 F2 H F2 3.426 3.962 0.537 
HB2 F2 HA F2 1.94 1.993 0.053 
HA H3 H H3 2.723 2.838 0.116 
HB1 H3 H H3 2.956 3.257 0.302 
HB1 H3 HA H3 2.284 2.309 0.025 
HB2 H3 HA H3 2.225 2.248 0.023 
HA E4 H E4 2.289 2.318 0.029 
HB1 E4 HA E4 1.995 2.056 0.061 
QG E4 HB1 E4 4.303 5.489 1.186 
QG E4 HB2 E4 4.134 5.063 0.929 
HA K5 H K5 1.838 1.855 0.017 
QD K5 HA K5 2.487 2.574 0.086 
H H6 HA K5 1.754 1.77 0.016 
HA H6 H H6 1.849 1.865 0.016 
HB1 H7 H H7 2.089 2.133 0.045 
H S8 HA H7 2.106 2.124 0.017 
HB1 S8 H S8 2.134 2.178 0.044 
H H9 HA S8 1.956 1.972 0.015 
H H9 HB2 S8 3.012 3.282 0.27 
Table 4.4.2. Summary of boundary data from MARDIGRAS using the 
peak intensity data from Hst-8 in DMSO using a beta sheet as a 
starting model. Note that Q is a variable that substitutes for methylene 
and R is a variable indicating its position on a ring. 
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HA H9 H H9 2.075 2.104 0.029 
HB1 H9 H H9 1.955 2.004 0.049 
HB1 H9 HA H9 2.309 2.337 0.028 
HB2 H9 HA H9 2.223 2.264 0.041 
H R10 HA H9 3.193 3.464 0.271 
H R10 HB1 H9 2.954 3.131 0.177 
H R10 HB2 H9 2.842 2.983 0.141 
HA R10 H R10 2.286 2.312 0.026 
QB R10 HA R10 2.624 2.701 0.077 
QG R10 HA R10 3.197 3.293 0.096 
QD R10 QG R10 4.15 4.672 0.522 
HE R10 QD R10 4.33 5.648 1.318 
H G11 HA R10 2.316 2.354 0.038 
HA Y12 H Y12 1.905 1.922 0.017 
HB1 Y12 HA Y12 3.01 3.578 0.568 
HB2 Y12 H Y12 1.913 1.964 0.051 
RD Y12 HB1 Y12 4.764 5.781 1.016 
RE Y12 RD Y12 4.125 4.976 0.85 
 
The differences in the boundary widths between the two models used 
were not that great, usually varying by one to two hundredths of an angstrom 
(data not shown). So although differences were slight, the starting point for 
the MARDIGRAS analysis makes a difference. MARDIGRAS also outputs 
the distances between the correlated protons in both its minimized structure 
and that of the starting point of the model (data not shown). This data was 
not used in subsequent CNS MD simulations, it merely compares the start 
points and end points of inter-proton distances. It is not a full structural 
model.  
We then performed the same MARDIGRAS analysis of the NOESY 
intensity data from the Hst-8 with 1 eq. Cu(CH3CN)4PF6 in DMSO data. 
Again we used two different starting models, an alpha helix and a beta sheet. 
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The boundary restriction data for the alpha helix model is given in table 4.4.3. 
The boundary restriction data for the beta sheet model is given in table 4.4.4. 
As before, we noted that there was little difference between the data 
obtained using an alpha helix or beta sheet as a starting point. MARDIGRAS 
merely uses the initial model as a starting point and generates a final proton 
map based on the connectivity of the initial model and the intensity data that 
it weights to generate boundary restriction data. 
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Table 4.4.3. Summary of boundary data from MARDIGRAS using the 
peak intensity data from Hst-8 with 1 eq. Cu(CH3CN)4PF6 in DMSO 
using an  alpha helix as a starting model. Note that Q is a variable 
that substitutes for methylene. 
ATOM_ i ATOM_ j LOW_BNDS UP_BNDS WIDTH 
H 2 HA 1 3.271 3.541 0.27 
HA 2 H 2 2.963 3.111 0.148 
HB1 2 H 2 3.684 4.176 0.492 
HB1 2 HA 2 2.317 2.344 0.027 
HB2 2 H 2 3.182 3.442 0.26 
HB2 2 HA 2 2.398 2.431 0.034 
RD 2 HB2 2 3.024 3.306 0.282 
HA 4 H 4 2.162 2.182 0.02 
HB1 9 HA 9 2.267 2.293 0.027 
HB2 9 HA 9 2.272 2.299 0.027 
H 10 HA 9 2.327 2.361 0.034 
HA 10 H 10 2.163 2.189 0.025 
QG 10 H 10 2.764 2.854 0.09 
QG 10 HA 10 3.201 3.332 0.131 
QD 10 H 10 3.09 3.252 0.162 
HE 10 QG 10 4.271 5.059 0.788 
HE 10 QD 10 3.772 4.216 0.443 
H 11 HA 10 2.157 2.181 0.024 
QA 11 H 11 2.009 2.017 0.007 
H 12 QA 11 2.282 2.294 0.012 
HA 12 H 12 1.946 1.957 0.011 
HB1 12 H 12 3.443 3.922 0.479 
HB1 12 HA 12 3.7 4.258 0.559 
HB2 12 H 12 3.09 3.392 0.302 
HB2 12 HA 12 3.263 3.582 0.319 
RD 12 HB1 12 4.037 5.882 1.845 
RD 12 HB2 12 4.335 5.75 1.415 
RE 12 RD 12 3.6 3.848 0.248 
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One can clearly see from the data that the boundaries computed by 
MARDIGRAS for our system are very tight in the case of our starting from a 
Table 4.4.4. Summary of boundary data from MARDIGRAS 
using the peak intensity data from Hst-8 with 1 eq. 
Cu(CH3CN)4PF6 in DMSO using a beta sheet as a starting 
model. Note that Q is a variable that substitutes for methylene. 
ATOM_ i ATOM_ j LOW_BNDS UP_BNDS WIDTH 
H 2 HA 1 3.2 3.5 0.3 
HA 2 H 2 3 3.1 0.1 
HB1 2 H 2 3.7 4.2 0.5 
HB1 2 HA 2 2.3 2.3 0 
HB2 2 H 2 3.2 3.4 0.3 
HB2 2 HA 2 2.5 2.5 0 
RD 2 HB2 2 3.1 3.4 0.3 
HA 4 H 4 2.2 2.2 0 
HB1 9 HA 9 2.3 2.3 0 
HB2 9 HA 9 2.3 2.3 0 
H 10 HA 9 2.4 2.4 0 
HA 10 H 10 2.2 2.2 0 
QG 10 H 10 2.8 2.8 0.1 
QG 10 HA 10 3.8 4 0.2 
QD 10 H 10 3 3.2 0.2 
HE 10 QG 10 4.2 5 0.8 
HE 10 QD 10 3.7 4.1 0.4 
H 11 HA 10 2.1 2.1 0 
QA 11 H 11 1.9 1.9 0 
H 12 QA 11 2.3 2.4 0 
HA 12 H 12 2 2 0 
HB1 12 H 12 3.5 4 0.5 
HB1 12 HA 12 3.7 4.2 0.6 
HB2 12 H 12 3.2 3.5 0.3 
HB2 12 HA 12 3.2 3.6 0.3 
RD 12 HB1 12 4.5 6.4 1.9 
RD 12 HB2 12 4 5.4 1.4 
RE 12 RD 12 3.6 3.9 0.2 
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beta sheet model. This is likely a function of there being much fewer data 
points available to work with rather than simply that the beta sheet secondary 
structure is the conformation adopted by Hst-8 when Cu(I) is present. 
 
4.5: Use of CNS for MD Studies 
 
CNS is a program that grew out of the XPLOR program.139 It can be 
used for molecular dynamic studies using structural and boundary restraint 
data. We ran two separate simulations using CNS. Figure 4.5.1 illustrates the 
information flow and processing done to generate a structure from the 
NOESY data using CNS. First we ran a simulation using the boundary 
restraint data obtained from MARDIGRAS. The first step as discussed in the 
previous section utilized an initial starting model and the contact data from 
Figure 4.5.1. A graphical illustration of the information flow and 
processing done to generate a structure from NOESY data using 
MARDIGRAS using CNS. 
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the NOESY spectrum input into CORMA (light green arrow). Next the 
CORMA processed data as well as the intensity data for the proton 
correlations was input into MARDIGRAS (light blue arrows). MARDIGRAS 
output upper and lower restraint boundaries, which were both input into CNS 
(dark blue arrow). CNS then uses an internally generated structure along 
with the MARDIGRAS generated restraint data to perform a molecular 
dynamics simulation to output a structure. Alternatively the black arrow 
represents a pathway whereby we used the NOESY contact data and 
generic restraints as input into CNS. CNS then performed the same 
molecular dynamics simulation with the generic restraint data and its 
internally generated structure. 
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Figure 4.5.2. Two views of an Hst-8 structure generated as CNS output of 
a MD simulation using MARDIGRAS generated restraint data from 
contacts identified in Hst-8 in DMSO NOESY data. The back bone has 
been put in ball and stick, the side chains are wireframe. (Colorcode: 
white – hydrogen, gray – carbon, blue – nitrogen, and red – oxygen) 
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Figure 4.5.3. Two views of an Hst-8 structure generated as CNS output of 
a MD simulation using generic restraint data from contacts identified in 
Hst-8 in DMSO NOESY data. The back bone has been put in ball and 
stick, the side chains are wireframe. (Colorcode: white – hydrogen, gray – 
carbon, blue – nitrogen, and red – oxygen) 
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As illustrated in figures 4.5.2 and 4.5.3 both structures generated from 
the CNS MD minimization of the NOESY restraint data resulted in structures 
that contained no elements of secondary structure. One can see elements of 
a helical twist on the backbone of both structures; however, it is most 
certainly not an alpha helical twist. A sharp turn in both of the structures 
occurs at the H7 and is again, not a part of any secondary structural feature. 
This differs from the previously published literature79 on the conformation of 
Hst-8 in DMSO. However, it should be noted that they adjusted their Hst-8 
sample to pH 4.0 prior to dissolving it in DMSO. This may result in more 
histidine residues being protonated and thus electrostatically repelled. The 
beta strand is a very effective structure at maximizing the distance between 
residue side chains. Residues alternate sides along the peptide backbone 
which is completely extended with φ and ψ angles of 180º. This could then 
explain why the beta strand exists in their system. When we calculated the 
structure of Hst-8 in its completely protonated form at AM1, PM3, and 
PM3MM levels of theory, we clearly observed beta strand elements in the 
structure (figures 3.2.23 and 3.2.24). With at most one histidine residue 
protonated, our sample of Hst-8 is freer to adopt a greater array of 
conformations. Also one should consider that molecular dynamics 
simulations are not particularly sophisticated simulations. The difference 
between a beta sheet and random coil is not all that significant. It only takes 
a few degrees of divergence at each individual φ and ψ angle along the 
amide backbone to go from beta strand to lacking of any secondary structural 
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characteristics. Thus it could merely be that the computer programs that 
were used for their MD simulations weighted beta strand formation more than 
degrees of freedom. Our finding of a lack of alpha helical or beta strand 
secondary structural characteristics of Hst-8 in DMSO is similar to the lack of 
alpha helical and beta strand secondary structural elements observed for 
Hst-5 in an aqueous solution78 and a lack of such secondary structural 
elements observed for many of the cationic antimicrobial peptides.140, 141 As 
discussed in the introductory chapter these secondary structural is critical to 
the function of many of the short antimicrobial peptides.  
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Figure 4.5.3 illustrates the structure of Hst-8 generated by CNS using 
generic restraint data from contacts identified in NOESY data of the sample 
Hst-8 with Cu(I) in DMSO. Here again, we observe that the structure that 
Figure 4.5.4. Two views of an Hst-8 structure generated as CNS output of 
a MD simulation using generic restraint data from contacts identified in 
Hst-8 with Cu(I) in DMSO NOESY data. The back bone has been put in 
ball and stick, the side chains are wireframe. (Colorcode: white – 
hydrogen, gray – carbon, blue – nitrogen, and red – oxygen) 
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results from our MD simulation is lacking of alpha helical or beta strand 
secondary structural elements. The MD simulation took into account only the 
NOESY data, as it was incapable of handling metal binding restrictions. 
Nonetheless the structure obtained for Hst-8 plus Cu(I) in DMSO is certainly 
in line with our expectations given the results of our metal binding studies 
and our previous MD simulations (figures 4.5.1 and 4.5.2). Attempts to utilize 
the boundary restriction data calculated by MARDIGRAS for use in CNS MD 
studies failed. Both of the simulations using either the alpha helix model and 
beta sheet failed to reach a convergence. This is likely due to the fact that 
MARDIGRAS output such tight boundaries. This then resulted in CNS being 
unable to adopt any other conformations except that which was highly 
unstable and was minimized to initially using the distance restraints. This 
conclusion follows because when the boundary restrictions were replaced 
with generic contacts we were able to obtain a minimized structure. 
Although this is the structure of Hst-8 plus Cu(I) in DMSO as 
determined from the simulations on the data available, I am ultimately not 
altogether confident in the results. This stems from the fact that there are 
many fewer NOESY contacts utilized in the analysis of the metal containing 
system than the sample, which contained no metal. Also consider that as all 
evidence points to a dynamic structure in the presence of copper(I), a 
structure arrived at by molecular dynamics minimization hardly fits all of the 
evidence. So ultimately while this does give us insight into the structure of 
Hst-8 plus Cu(I) in DMSO the output structure hardly tells the whole story. 
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Again the same hypotheses that were raised in the metal binding 
chapter could be tested. If utilization of stronger ligands enabled the 
visualization of more NOESY peaks in those samples containing Cu(I) then 
more contacts could be input into both MARDIGRAS and CNS. Another 
experimental series that would also aid in our understanding both of the free 
and copper bound Hst-8 would be to conduct the NOESY and ROESY 
experiments over an array of mixing times, both longer and shorter than the 
150 ms we used. From this we may be able to generate even more contacts 
using the longer mixing times and the closest most important NOESY 
contacts could be confirmed using the shorter mixing times. These 
suggestions could generate data that when utilized in conjunction with our 
existing data could lead to conclusions that have a higher confidence level. 
 
4.7: Experimental Procedures 
 
4.7.1: General NMR Procedure, Materials, and Methods 
A Varian Unity/Inova 400 MHz system upgraded to VNMRS with an 
auto-tunable Dual Broadband 15N-31P {1H} PFG probe utilizing the VNMRJ 
software suite for collection and processing or a Varian VXR 500 MHz 
system upgraded to VNMRS with a triplet resonance 1H{13C/15N} PFG probe 
utilizing VNMRJ software suite for collection and processing was employed. 
Samples were maintained at 20ºC for the duration of the experiment. Prior to 
collection of 2D homonuclear or heteronuclear experiments each sample had 
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its 90º pulsewidth (PW90) determined, which then was input as a parameter 
into subsequent experiments. 
For experiments involving air and moisture sensitive copper(I) 
species, samples were placed in a J. Young NMR tube (600 MHz glass, 
Wilmad Labglass). This allowed the sample to be maintained under inert 
atmospheric conditions (either argon or nitrogen). Also manipulation of 
Cu(CH3CN)4PF6 was done in a glovebox (VAC model MO-M). 
Histatin-8 was purchased as a crude solid phase preparation product 
(55-60% purity depending on batch) from the Molecular Biology Proteomics 
Facility of the University of Oklahoma Health Sciences Center. It was isolated 
and purified by HPLC by dissolving the sample in a small volume of 0.1% 
TFA/water and injection onto a C18 RP-Prep-HPLC column (Biorad 
BioLogic). Elution with a linear solvent gradient from 100% water (0.1% TFA) 
to 60% H2O (0.1% TFA) / 40% 4:1 acetonitrile:H2O (0.1%TFA) (4 mL/min) 
over 74 min afforded Hst-8 with a typical retention time of 9 min. The Hst-8 
fraction was determined by ESI-MS. 
Tetrakis(acetonitrile)copper(I)hexafluorophosphate, was obtained from 
Aldrich. Dimethylsulfoxide-D6 (D 99.9%) was obtained from Cambridge 
Isotope Laboratories. 
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4.7.2: General NOESY Parameters 
Here the experimentally collected PW90 parameter was input and the 
mixing time for the sample was 150 ms. All other parameters were standard 
parameters. 
 
4.7.3: General ROESY Parameters 
Here the experimentally collected PW90 parameter was input and the 
mixing time for the sample was 150 ms. All other parameters were standard 
parameters. 
 
4.7.4: General TOCSY Parameters 
Here the experimentally collected PW90 parameter was input. All 
other parameters were standard parameters. 
 
4.7.5: General 1H-13C HSQC Parameters 
Here the experimentally collected PW90 parameter was input. All 
other parameters were standard parameters. 
 
4.7.6: Analysis of Combined Collected NMR Spectra 
Analysis of collected NMR data was done simultaneously by SPARKY 
3, which is a very useful piece of software that handles assignment, 
integration, and exporting of data. It was written by T. D. Goddard and D. G. 
195 
 
Kneller at the University of California San Francisco. It is available free of 
charge at http://www.cgl.ucsf.edu/home/sparky/. 
 
4.7.7: MARDIGRAS Analysis 
 MARDIGRAS and its suite of programs ultimately produce boundary 
restraint data from NOESY intensity data.134-138 First models in .pdb format 
are processed by CORMA. A list of NOESY correlations and intensities are 
then also processed by CORMA. Then MARDIGRAS is run using the 
processed model and processed intensity files. One need only input the 
mixing time and the frequency of the protons in the magnetic field used and 
the data is output. 
 
4.7.8: CNS Molecular Dynamics Simulations 
CNS was used according to standard protocols.139 Generally this 
involved generation of a .pdb file by CNS from user input sequence. Then 
NOESY restraint data was input into a space separated table. When 
MARDIGRAS restraint was used the data was input as output by 
MARDIGRAS using the calculated distance and the upper boundary and 
lower boundary limits. When generic restraint data was used the distance 
used was 4.0 Å, a lower boundary of 1.8 Å and an upper boundary of 5.5 Å. 
At this point the annealing script is run and a structure is obtained. The final 
structure output is an average of 5-15 structures minimized by the CNS 
algorithm. 
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4.7.9: Computational Chemistry Methods 
ArgusLab (ArgusLab 4.0.1 written by Mark A. Thompson of Planaria 
Software LLC, Seattle, WA (http://www.arguslab.com)) was used for 
molecular mechanics calculations, PM3 calculations that involved metals, 
and AM1 calculations that involved metals. 
For PM3 and AM1 calculations, as well as PM3MM and higher levels 
of theory Gaussian 03 was used.129 
Results from both computational suites were visualized and exported 
to JPEG files using Gaussview (Gaussian, Inc., Wallingford CT 
http://www.gaussian.com) and ArgusLab. 
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Chapter 5: Project Summary 
 
5.1: Conclusions 
We have sought to add to the knowledge base of the antimicrobial Hst 
peptides in terms of meeting several project objectives. First, since there is 
still debate whether ROS are involved in the antimicrobial activity of the Hst, 
we sought to investigate the possibility in an in vitro system. In this way all 
external variables and possible side reactions would be eliminated and there 
would be definitive and quantifiable evidence for ROS production by Hst 
systems. We have clearly succeeded in meeting this major objective. Our 
published findings reveal that Hst-5 and Hst-8 systems in pH 7.4 MOPS 
buffer are capable of ROS production at levels comparable to free copper 
itself. As MOPS is a buffering agent that does not engage in complexation 
with copper we are assured that ROS production is the result of peptide 
metal complexes. In addition as a result of our spin trapping studies, we have 
observed that the specific ROS produced by an Hst-8 copper complex is 
superoxide. This is in contrast to the spin trapping studies done with only free 
copper where only hydroxyl radical adducts are observed. 
Another major gap identified in the literature is that there has not yet 
been a definitive study on the metal binding environment of the peptides 
themselves. Many peptide analogues have been made and their metal 
binding activity studied. However as most of them delete histidine residues, 
and are very short in length, a comprehensive understanding of the metal 
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binding environment has yet to be investigated. Our efforts to investigate 
metal binding activity of Hst-8 to copper ions met with limited success. 
Ultimately we were able to observe fundamental changes in the NMR spectra 
we collected. Further, we could rationalize these changes based on 
exchange of the imidazolyl residues on and off the metal as a result of weak 
binding. The residues we believe are primarily involved in metal binding are 
the H3, H6, and H7 residues. Unfortunately, we are not able prove this, as 
resonances disappeared from the spectra rather than simply become 
downfield shifted as a result of metal ion binding. This broadening of peaks 
extended to the alpha amide region of the NOESY, ROESY, and TOCSY 
spectra, which impeded our efforts to assign the precise residues. Other 
efforts to investigate the ligand environment of the copper, such as EPR also 
met with failure.  
Our final investigation dealt with uncovering the conformation of Hst-8 
after metal ion binding. Many studies have already been done both on Hst 
conformation in the free state and Hst metal binding activity, however, there 
had not yet been a study that has integrated both metal binding and global 
conformation of the peptide until this work. We did have success in this 
endeavor. Using NMR NOESY and ROESY data we were able to obtain 
distance restraint data. The data, when input into a molecular dynamics 
simulator, resulted in a structure that was in line with expectations, namely 
that such a short peptide would exist largely unstructured. In fact in aqueous 
solution Hst-5 was found to be unstructured.78, 80, 81 Moreover, it was 
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observed that chain length greatly influence the ability of Hst-5 and 
derivatives of Hst-5 to adopt secondary structure in non-aqueous 
environments.80, 81 Although, a previous study had found the structure to be a 
beta sheet in DMSO, ultimately their conditions were different. As 
aforementioned this likely resulted in an Hst-8 species of different protonation 
state than our sample. The resulting electrostatic repulsion could favor the 
adaptation of a regular secondary structure due to the loss of favorable 
conformations.  
 
5.2: Future Work 
There is of course plenty of room for additional work. First and 
foremost it remains that there were a few resonances that were unable to be 
definitively assigned in the Hst-8 in the absence of the metal and several 
more in the presence of the metal. Using a higher field instrument to collect 
the NMR spectra combined with an increase in resolution could potentially be 
of benefit in assigning these resonances. Also collecting the NOESY and 
ROESY experiments with variable mixing times may have given more distant 
spatial contacts with longer mixing and eliminated all but those most close 
contacts for short mixing times. This could have aided in the confirmation of 
the boundary restrictions we obtained and added other more distant 
contacts.  
Next we could expand the metal binding and global conformation 
study upon metal binding to include Hst-5. Hst-5 is comparatively a much 
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larger peptide, essentially twice as large as Hst-8. It also contains a true 
ACTUN type site that could potentially compete for metal binding interaction 
with copper. Also it contains two copper binding sites with the sequence His-
X-Y-Z-His. These of course could potentially engage in an equilibrium 
binding, which would necessarily complicate the data collection and 
interpretation. 
I foresee a major experimental undertaking to clarify some of the 
interpretations and hypotheses regarding the metal binding sites and the 
conformation. First to clarify as to whether or not the metal binding of the 
Cu(I) species to the Hst-8 isothermal calorimetry could be performed. Data is 
already available for Cu(II), but no data exists for the Hst and Cu(I). 
Ultimately one would also expand such work to include the model complexes 
and Hst-5. Also one could follow up on the possibility that utilization of 
stronger ligands with copper(I) could allow for the visualization of the 
imidazolyl motifs and perhaps the remainder of the histidine residues. 63Cu 
NMR as a rule generally requires very tight binding on the part of the metal 
ligand complex. So if ITC studies indicated tight enough binding, one could 
consider attempting such experiments. 
Further experiments that would be more focused on the conformation 
of the peptide and peptide metal systems could also be done in addition to 
seeing if perhaps ligands greatly affected the NMR. Obviously, a CD 
experiment could be performed on Hst-8 both in the presence and absence 
of copper (I) or (II). This would give definitive data as to if there were an 
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alpha helix adopted by Hst-8 upon metal binding. Though our studies 
suggest this is not the case, additional evidence is always welcome to 
support the case. A major issue here though is that a different solvent would 
have to be used as DMSO absorbs strongly in that region, so another study 
should accompany this particular investigation. 
 One should also consider using 15N and 13C labeled peptide; this 
would make NMR experiments much shorter. Also one could identify with 
much greater ease residues involved in binding as 15N-13C connectivity data 
could be obtained. Also using a fully isotopic ally enriched peptide, one could 
perform 3D NMR experiments involving a 15N-13C HSQC as the initial 
experiment. These additional NMR experiments could give connectivity data 
of the specific imidazolyl units to the alpha or amide protons more quickly 
and reliably than relying on NOESY experiments to connect the imidazolyl 
units to the backbone alpha and amide protons. Further, one could 
investigate the 15N shifts directly without having to use indirect detection 
experiments like HSQC and HMBC experiments. These are much faster 
experiments and thus could give much more information. 
Finally, as a last point to the metal binding studies, one could also add 
ascorbic acid that has been pH adjusted to 9, and then dried and added to 
the Hst-8 which had been adjusted to pH 9 and dried prior to addition of Cu(I) 
in DMSO system. This would just be a point to balance the experiment that 
we did in which we added ascorbic acid to the Hst-8, which had been pH 
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adjusted to 9 and then dried prior to addition of Cu(I) in DMSO. The ascorbic 
acid obviously added a proton equivalent, which undoubtedly altered the pH. 
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DFT  density functional theory 
TON  turnover number 
HRP  horseradish peroxidase  
EDTA  ethylenediaminetetraacetic acid 
NTB  nitrotetrazolium blue chloride (nitro blue tetrazolium) 
DEPMPO 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide 
DMPO 5-dimethyl-1-pyrroline N-oxide 
DD  double distilled 
DI  deionized 
UV/Vis ultraviolet / visible 
RP  reverse phase 
HPLC  high performance liquid chromatography 
TFA  trifluoroacetic acid 
Kdal  kilodalton 
2-TMIC 2-tris(N-methylimidazolyl)carbinol 
TMS  tetramethylsilane 
4-TIC  4-trisimidazolylcarbinol 
CPMG Carr-Purcell-Meiboom-Gill 
ROESY rotating frame Overhauser spectroscopy 
